Documente Academic
Documente Profesional
Documente Cultură
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Ram Dev Madhok Pt. Location: OPD Referred By: Dr.H.N.Tripathi Specimen: Blood
IRON 14
T.I.B.C
415
g/dl
35-150
% Saturation
3.4
20-55
*Levels of serum Iron is lower in iron deficiency , also in infections and in anemia of chronic disease,while serum Iron Binding Capacity is increased in iron deficiency anemia and is normal or decreased in anemia of chronic disease.If chronic infection coexists with chronic blood loss,the TIBC may be decreased ,even though the patient is iron deficient %Saturation of TIBC is the ratio of serum iron toTIBC.It is the percent saturation of TIBC.Normally this is 20-55%;values below 15% indicate iron deficient erythropoiesis
The test was performed at RELIGARE SRL Diagnostics
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW e-mail:saharahospitals.com
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Prashant Tripathi Pt. Location: EMERGENCY Referred By: Dr. Specimen: Blood
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail:saharahospitals.com
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Pushplata Tiwari Pt. Location: OPD Referred By: M.H.C Specimen: Blood Tr.No.7350 PARAMETER RESULT Age/Sex: 43y/F MRN:SH/LKO/007794/09 Lab No.:B-/08/1223 Date: 18.8.2009 REFERENCE RANGE
UNIT
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail:saharahospitals.com
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Abhinandan Swaroop Pt. Location: IPD/Neuro.ICU Referred By: Dr.Abhishek Specimen: Blood PARAMETER RESULT Serum Urea
Methodology- Urease- GLDH, Kinetic
Age/Sex: 67y/M MRN:SH/LKO/007651/09 Lab No.:B-/08/1387 Date: 20.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30
118 2.49
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
137.0 3.3
nmol/l nmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail:saharahospitals.com
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Girja Shanker Tripathi Pt. Location: IPD/G.W Referred By: Dr.Swadesh Singh Specimen: Blood PARAMETER RESULT Age/Sex: 62y/M MRN:SH/LKO/007765/09 Lab No.:B-/08/1389 Date: 20.8.2009 REFERENCE RANGE
UNIT
151.6
mg/dl
70 - 110
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail:saharahospitals.com
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Girja Shanker Tripathi Pt. Location: IPD/G.W Referred By: Dr.Swadesh Singh Specimen: Blood PARAMETER RESULT
LIPID PROFILE
Total Serum Cholesterol
206 mg/dl
UNIT
(Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl) Serum Triglycerides 190 mg/dl (Method-GPO-PAP) (Desirabl <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 40 mg/dl
(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)
128
mg/dl
38
mg/dl
10 to 40
5.15
mg/dl
Less 4.5
3.2
mg/dl
Less 3.0
Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail:saharahospitals.com
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Anarpati Pt. Location: IPD/E.W Referred By: Dr.Swadesh Singh Specimen: Blood PARAMETER RESULT Age/Sex: 60y/F MRN:SH/LKO/007920/09 Lab No.:B-/08/1392 Date: 20.8.2009 REFERENCE RANGE
UNIT
Serum Urea
Methodology- Urease- GLDH, Kinetic
128 3.6
mg/dl mg/dl
13 - 43 0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
156.0 3.7
nmol/l nmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
128
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail:saharahospitals.com
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Upasana Pt. Location: OPD Referred By: Dr.Anjali Somani Specimen: Blood PARAMETER RESULT Age/Sex: 31y/F MRN:SH/LKO/007445/09 Lab No.:B-/08/1311 Date: 19.8.2009 REFERENCE RANGE
UNIT
ORAL GLUCOSE TOLERANACE TEST G.T.T (after 100 gram of glucose) Fasting plasma glucose 1 hour plasma glucose 2 hour plasma glucose 79.8 97.2 90.6 mg/dl mg/dl mg/dl 95 180 155
*Gestational diabetes mellitus diagnosed if 2 plasma glucose levels are exceeded (American Diabetes Association ,2004b).
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail:saharahospitals.com
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Upasana Pt. Location: OPD Referred By: Dr.Anjali Somani Specimen: Blood PARAMETER RESULT Age/Sex: 31y/F MRN:SH/LKO/007445/09 Lab No.:B-/08/1311 Date: 19.8.2009 REFERENCE RANGE
UNIT
ORAL GLUCOSE TOLERANACE TEST G.T.T (after 100 gram of glucose) Fasting plasma glucose 1 hour plasma glucose 2 hour plasma glucose 79.8 97.2 90.6 mg/dl mg/dl mg/dl 95 180 155
*Gestational diabetes mellitus diagnosed if 2 plasma glucose levels are exceeded (American Diabetes Association ,2004b).
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail:saharahospitals.com
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs Ratna Mukharjee Pt. Location: IPD/E.W Referred By: Dr.Swadesh Singh Specimen: Blood PARAMETER RESULT Age/Sex: 54y/F MRN:SH/LKO/007612/09 Lab No.:B-/08/1393 Date: 20.8.2009 REFERENCE RANGE
UNIT
201.8
mg/dl
70 - 140
Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail:saharahospitals.com
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Dinesh Bajpai Pt. Location: IPD/G.W Referred By: Dr.Swadesh Singh Specimen: Blood PARAMETER RESULT Serum Urea
Methodology- Urease- GLDH, Kinetic
Age/Sex: 65y/M MRN:SH/LKO/007336/09 Lab No.:B-/08/1403 Date: 20.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30
59 0.85
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail:saharahospitals.com
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Shanti Devi Pt. Location: IPD/N.ICU Referred By: Dr.M.Husain Specimen: Blood PARAMETER Serum Urea
Methodology- Urease- GLDH, Kinetic
RESULT 32 0.61
Age/Sex: 60y/F MRN:SH/LKO/007741/09 Lab No.:B-/08/1404 Date: 20.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
142.0 3.40
nmol/l nmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail:saharahospitals.com
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Shanti Devi Age/Sex: 60y/F Pt. Location: IPD/N.ICU MRN:SH/LKO/007741/09 Referred By: Dr.M.Husain Lab No.:B-/08/1404 Specimen: Blood Date: 20.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 0.39 Total Serum Bilirubin mg/dl 0.30 - 1.20
(Method: Walter And Gerarde)
0.09 0.3
mg/dl mg/dl
54
IU/I
0 - 42
62
IU/I
0 - 42
104
IU/I
42 - 128
6.28
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
g/dl
3.2 - 5.0
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail:saharahospitals.com
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Santosh Kumar Sahu Age/Sex: 29y/M Pt. Location: IPD/G.W MRN:SH/LKO/007925/09 Referred By: Dr.M.Ahamad Lab No.:B-/08/1406 Specimen: Blood Date: 20.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 0.29 Total Serum Bilirubin mg/dl 0.30 - 1.20
(Method: Walter And Gerarde)
0.1 0.19
mg/dl mg/dl
36
IU/I
0 - 42
34
IU/I
0 - 42
106
IU/I
42 - 128
7.14
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
g/dl
3.2 - 5.0
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail:saharahospitals.com
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Santosh Kumar Sahu Pt. Location: IPD/G.W Referred By: Dr.M.Ahamad Specimen: Blood PARAMETER RESULT Blood Urea Nitrogen
Method Urease GLDH Kinetic
97.92 11.83
6 to 20
0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
139.0
nmol/l nmol/l
2.90
0.81
mmol/l
1.12 1.32
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail:saharahospitals.com
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: B/O Shubhadra Pandey Pt. Location: IPD/P.ICU Referred By: Dr.M.U.Hasan. Specimen: Blood PARAMETER RESULT Total Serum Bilirubin
(Method: Walter And Gerarde)
UNIT
mg/dl mg/dl mg/dl
12 0.6 11.4
C reactive protein(C.R.P)
< 3.08
mg/L
less than 3
*CRP is an acute phase reactant appeared in plasma during many infectious or inflammatory conditions CRP assay provides useful information for the diagnosis,therapy and monitoring of inflammatory processes and associated diseases. Increase in CRP values are non specific and should not be interpreted without a complete clinical history.
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail:saharahospitals.com
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: B/O Gudiya Pt. Location: IPD/P.ICU Referred By: Dr.M.U.Hasan. Specimen: Blood PARAMETER Spot urine Chloride Age/Sex: NB/F MRN:SH/LKO/007666/09 Lab No.:B-/08/1409 Date: 20.8.2009 REFERENCE RANGE
RESULT 109
UNIT
mmol/l
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail:saharahospitals.com
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mast Ankit Pt. Location: IPD/MICU Referred By: Dr.M..Husain. Specimen: Blood PARAMETER Serum Urea
Methodology- Urease- GLDH, Kinetic
RESULT 31 0.56
Age/Sex: 15y/M MRN:SH/LKO/007559/09 Lab No.:B-/08/1410 Date: 20.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
135.0 5.20
nmol/l nmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail:saharahospitals.com
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Asha Rawat Pt. Location: IPD/E.W Referred By: Dr.Sandeep Specimen: Blood PARAMETER Blood Urea Nitrogen
Method Urease GLDH Kinetic
RESULT 16.9
UNIT mg/dl
6 to 20
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
0.56
mg/dl
0.70 - 1.30
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Surendra Kumar Pt. Location: OPD Referred By: MHC Age/Sex: 45y/M MRN:SH/LKO/007583/09 Lab No.:B-/08/1405
6 to 20
0.70 - 1.30 8.4- 10.4
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Serum Calcium
(Method: arsenazo III)
Phosphorus
(Method: phosphomolybdate UV
2.5 - 4.5
4.16
mg/dl
2.5 6.8
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
1.16
mmol/l
1.12 1.32
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Surendra Kumar Pt. Location: OPD Referred By: MHC Specimen: Blood Tr.No-7281 Age/Sex: 45y/M MRN:SH/LKO/007583/09 Lab No.:B-/08/1405 Date: 20.8.2009
PARAMETER
RESULT
UNIT
REFERENCE RANGE
8.6 5.6% %
A 1C
(%)
* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Surendra Kumar Pt. Location: OPD Referred By: MHC Specimen: Blood Tr.No-7281 Age/Sex: 45y/M MRN:SH/LKO/007583/09 Lab No.:B-/08/1405 Date: 20.8.2009
PARAMETER
ApolipoProtein Estimation Apolipoprotein A1 (Apo-A1)
(Method :Immunonephelometric assay)
RESULT
UNIT
REFERENCE RANGE
110
Apolipoprotein B (Apo-B)
(Method :Immunonephelometric assay)
54.7
apo-A1/apo-B Ratio
2.01
( Elevation of apo B (present in chylomicrons, VLDL, HDL and LDL), decrease in apo A-1 (present mostly in HDL), and decrease in the apo A -1/apo B ratio have been associated with increased risk of CHD)
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Surendra Kumar Pt. Location: OPD Referred By: MHC Specimen: Blood Tr.No-7281 Age/Sex: 45y/M MRN:SH/LKO/007583/09 Lab No.:B-/08/1405 Date: 20.8.2009
PARAMETER
RESULT
UNIT
REFERENCE RANGE
13.9
IU/I
0 - 42
22.5
IU/I
0 - 42
51.7
IU/I
42 - 128
7.29
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
g/dl
3.2 - 5.0
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs .Promita Chakraborty Pt. Location: OPD Referred By: Dr.Manjusha Specimen: Blood Tr.No-19609 Age/Sex: 27y/F MRN:SH/LKO/004163/09 Lab No.:B-/08/1401 Date: 20.8.2009
PARAMETER
RESULT
UNIT
REFERENCE RANGE
ORAL GLUCOSE TOLERANACE TEST G.T.T (after 100 gram of glucose) Fasting plasma glucose 1 hour plasma glucose 2 hour plasma glucose 97 144 122 mg/dl mg/dl mg/dl 95 180 155
*Gestational diabetes mellitus diagnosed if 2 plasma glucose levels are exceeded (American Diabetes Association ,2004b).
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Vishal Verma Pt. Location: OPD Referred By: Dr.P.K.Shamshery Specimen: Blood Tr.No-19609 Age/Sex: 37y/M MRN:SH/LKO/007939/09 Lab No.:B-/08/1395 Date: 20.8.2009
PARAMETER
C reactive protein(C.R.P)
RESULT 15.8
UNIT
REFERENCE RANGE
mg/L
less than 3
*CRP is an acute phase reactant appeared in plasma during many infectious or inflammatory conditions CRP assay provides useful information for the diagnosis,therapy and monitoring of inflammatory processes and associated diseases. Increase in CRP values are non specific and should not be interpreted without a complete clinical history.
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Sumit Ranjan Pt. Location: OPD Referred By: MHC Specimen: Blood Age/Sex: 40y/M MRN:SH/LKO/007933/09 Lab No.:B-/08/1397 Date: 20.8.2009
RESULT 100.0
UNIT mg/dl
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
118.0
mg/dl
70 - 140
Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004
6 to 20
0.70 - 1.30 8.4- 10.4
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Serum Calcium
(Method: arsenazo III)
Phosphorus
(Method: phosphomolybdate UV
2.5 - 4.5
7.4
mg/dl
2.5 6.8
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
1.22
mmol/l
1.12 1.32
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Sumit Ranjan Pt. Location: OPD Referred By: MHC Specimen: Blood Age/Sex: 40y/M MRN:SH/LKO/007933/09 Lab No.:B-/08/1397 Date: 20.8.2009
PARAMETER
RESULT
UNIT
REFERENCE RANGE
6.2 5.6% %
A 1C
(%)
* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Sumit Ranjan Pt. Location: OPD Referred By: MHC Specimen: Blood Age/Sex: 40y/M MRN:SH/LKO/007933/09 Lab No.:B-/08/1397 Date: 20.8.2009
PARAMETER
ApolipoProtein Estimation Apolipoprotein A1 (Apo-A1)
(Method :Immunonephelometric assay)
RESULT
UNIT
REFERENCE RANGE
159
Apolipoprotein B (Apo-B)
(Method :Immunonephelometric assay)
80
apo-A1/apo-B Ratio
1.98
( Elevation of apo B (present in chylomicrons, VLDL, HDL and LDL), decrease in apo A-1 (present mostly in HDL), and decrease in the apo A -1/apo B ratio have been associated with increased risk of CHD)
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Sumit Ranjan Pt. Location: OPD Referred By: MHC Specimen: Blood Age/Sex: 40y/M MRN:SH/LKO/007933/09 Lab No.:B-/08/1397 Date: 20.8.2009
PARAMETER
RESULT
UNIT
REFERENCE RANGE
12.1
IU/I
0 - 42
19.6
IU/I
0 - 42
80
IU/I
42 - 128
7.5
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
g/dl
3.2 - 5.0
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Sumit Ranjan Pt. Location: OPD Referred By: MHC Specimen: Blood Age/Sex: 40y/M MRN:SH/LKO/007933/09 Lab No.:B-/08/1397 Date: 20.8.2009
PARAMETER
RESULT
LIPID PROFILE
UNIT
REFERENCE RANGE
180.9
mg/dl
(Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl) Serum Triglycerides 153.9 mg/dl (Method-GPO-PAP) (Desirabl <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 61.4 mg/dl
(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)
88.8
mg/dl
30.79
mg/dl
10 to 40
2.95
mg/dl
Less 4.5
1.45
mg/dl
Less 3.0
Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Anil Kumar Chaudhary Pt. Location: OPD Referred By: MHC Specimen: Blood PARAMETER RESULT Age/Sex: 48y/M MRN:SH/LKO/007923/09 Lab No.:B-/08/1398 Date: 20.8.2009 REFERENCE RANGE
UNIT
84.5
mg/dl
70 - 110
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
116.1
mg/dl
70 - 140
Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004
6 to 20
0.70 - 1.30 8.4- 10.4
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Serum Calcium
(Method: arsenazo III)
Phosphorus
(Method: phosphomolybdate UV
2.5 - 4.5
3.47
mg/dl
2.5 6.8
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
1.24
mmol/l
1.12 1.32
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Anil Kumar Chaudhary Pt. Location: OPD Referred By: MHC Specimen: Blood PARAMETER RESULT Age/Sex: 48y/M MRN:SH/LKO/007923/09 Lab No.:B-/08/1398 Date: 20.8.2009 REFERENCE RANGE
UNIT
6.2 6.1% %
A 1C
(%)
* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Anil Kumar Chaudhary Pt. Location: OPD Referred By: MHC Specimen: Blood PARAMETER RESULT Age/Sex: 48y/M MRN:SH/LKO/007923/09 Lab No.:B-/08/1398 Date: 20.8.2009 REFERENCE RANGE
UNIT
Apolipoprotein B (Apo-B)
(Method :Immunonephelometric assay)
83.7
apo-A1/apo-B Ratio
1.52
( Elevation of apo B (present in chylomicrons, VLDL, HDL and LDL), decrease in apo A-1 (present mostly in HDL), and decrease in the apo A -1/apo B ratio have been associated with increased risk of CHD)
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Anil Kumar Chaudhary Pt. Location: OPD Referred By: MHC Specimen: Blood PARAMETER RESULT Age/Sex: 48y/M MRN:SH/LKO/007923/09 Lab No.:B-/08/1398 Date: 20.8.2009 REFERENCE RANGE
UNIT
53
IU/I
0 - 42
22
IU/I
0 - 42
68.4
IU/I
42 - 128
7.2
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
g/dl
3.2 - 5.0
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Anil Kumar Chaudhary Pt. Location: OPD Referred By: MHC Specimen: Blood PARAMETER RESULT Age/Sex: 48y/M MRN:SH/LKO/007923/09 Lab No.:B-/08/1398 Date: 20.8.2009 REFERENCE RANGE
UNIT
LIPID PROFILE
Total Serum Cholesterol
169.8 mg/dl
(Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl) Serum Triglycerides 101.5 mg/dl (Method-GPO-PAP) (Desirabl <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 43.9 mg/dl
(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)
105.6
mg/dl
20.31
mg/dl
10 to 40
3.87
mg/dl
Less 4.5
2.41
mg/dl
Less 3.0
Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Saroj Chaudhary Pt. Location: OPD Referred By: MHC Specimen: Blood PARAMETER RESULT Blood Sugar Fasting 91.1 Age/Sex: 46y/F MRN:SH/LKO/007924/09 Lab No.:B-/08/1402 Date: 20.8.2009 REFERENCE RANGE 70 - 110
UNIT mg/dl
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
112
mg/dl
70 - 140
Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004
6 to 20
0.70 - 1.30 8.4- 10.4
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Serum Calcium
(Method: arsenazo III)
Phosphorus
(Method: phosphomolybdate UV
2.5 - 4.5
6.85
mg/dl
2.5 6.8
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
1.15
mmol/l
1.12 1.32
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Saroj Chaudhary Age/Sex: 46y/F Pt. Location: OPD MRN:SH/LKO/007924/09 Referred By: MHC Lab No.:B-/08/1402 Specimen: Blood Date: 20.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 0.30 Total Serum Bilirubin mg/dl 0.30 - 1.20
0.10 0.20
mg/dl mg/dl
10
IU/I
0 - 42
12
IU/I
0 - 42
112
IU/I
42 - 128
7.48
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Saroj Chaudhary Pt. Location: OPD Referred By: MHC Specimen: Blood PARAMETER RESULT
LIPID PROFILE
UNIT
172 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)
Serum Triglycerides 143 mg/dl (Method-GPO-PAP) (Desirabl <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 48.3 mg/dl
(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)
95.4
mg/dl
28.6
mg/dl
10 to 40
3.57
mg/dl
Less 4.5
1.98
mg/dl
Less 3.0
Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Saroj Chaudhary Pt. Location: OPD Referred By: MHC Specimen: Blood PARAMETER RESULT
ApolipoProtein Estimation
UNIT
Apolipoprotein A1 (Apo-A1)
(Method :Immunonephelometric assay)
149
Apolipoprotein B (Apo-B)
(Method :Immunonephelometric assay)
77.8
apo-A1/apo-B Ratio
1.91
( Elevation of apo B (present in chylomicrons, VLDL, HDL and LDL), decrease in apo A-1 (present mostly in HDL), and decrease in the apo A -1/apo B ratio have been associated with increased risk of CHD)
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Saroj Chaudhary Pt. Location: OPD Referred By: MHC Specimen: Blood PARAMETER RESULT Age/Sex: 46y/F MRN:SH/LKO/007924/09 Lab No.:B-/08/1402 Date: 20.8.2009 REFERENCE RANGE
UNIT
8.6 5.7% %
A 1C
(%)
* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Ram Shankar Mishra Pt. Location: OPD Referred By: MHC Specimen: Blood PARAMETER RESULT Blood Sugar Fasting 120 Age/Sex: 41y/M MRN:SH/LKO/007935/09 Lab No.:B-/08/1400 Date: 20.8.2009 REFERENCE RANGE 70 - 110
UNIT mg/dl
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl According to Amercian diabetes association, 2004
9.38
mg/dl
6 to 20
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
0.62
mg/dl
0.70 - 1.30
Serum Calcium
(Method: arsenazo III)
9.25
mg/dl
8.4- 10.4
6.63
mg/dl
2.5 6.8
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
1.18
mmol/l
1.12 1.32
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Ram Shankar Mishra Age/Sex: 41y/M Pt. Location: OPD MRN:SH/LKO/007935/09 Referred By: MHC Lab No.:B-/08/1400 Specimen: Blood Date: 20.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 0.40 Total Serum Bilirubin mg/dl 0.30 - 1.20
(Method: Walter And Gerarde)
0.10 0.30
mg/dl mg/dl
103
IU/I
0 - 42
60
IU/I
0 - 42
116
IU/I
42 - 128
7.91
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Ram Shankar Mishra Pt. Location: OPD Referred By: MHC Specimen: Blood PARAMETER RESULT
LIPID PROFILE
Total Serum Cholesterol
235.1 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)
UNIT
Serum Triglycerides 229.7 mg/dl (Method-GPO-PAP) (Desirabl <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 41.7 mg/dl
(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)
147.7
mg/dl
45.94
mg/dl
10 to 40
5.63
mg/dl
Less 4.5
3.53
mg/dl
Less 3.0
Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Amit Kumar Pt. Location: OPD Referred By: MHC Specimen: Blood PARAMETER RESULT Blood Sugar Fasting 99 Age/Sex: 27y/M MRN:SH/LKO/007883/09 Lab No.:B-/08/1399 Date: 20.8.2009 REFERENCE RANGE 70 - 110
UNIT mg/dl
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl According to Amercian diabetes association, 2004
8.13
mg/dl
6 to 20
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
0.62
mg/dl
0.70 - 1.30
Serum Calcium
(Method: arsenazo III)
9.71
mg/dl
8.4- 10.4
Phosphorus
(Method: phosphomolybdate UV
2.79
mg/dl
2.5 - 4.5
2.5 6.8
7.2
mg/dl
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
1.2
mmol/l
1.12 1.32
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Amit Kumar Age/Sex: 27y/M Pt. Location: OPD MRN:SH/LKO/007883/09 Referred By: MHC Lab No.:B-/08/1399 Specimen: Blood Date: 20.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 0.53 Total Serum Bilirubin mg/dl 0.30 - 1.20
(Method: Walter And Gerarde)
0.15
mg/dl
0 - 0.20
0.38
mg/dl
0.08 - 0.75
35
IU/I
0 - 42
25
IU/I
0 - 42
110
IU/I
42 - 128
8.30
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Amit Kumar Pt. Location: OPD Referred By: MHC Specimen: Blood PARAMETER RESULT
LIPID PROFILE
Total Serum Cholesterol
187.2 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl) 97 mg/dl
UNIT
(Desirabl <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 39 mg/dl
(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)
128.8
mg/dl
19.41
mg/dl
10 to 40
4.8
mg/dl
Less 4.5
3.3
mg/dl
Less 3.0
Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Amit Kumar Pt. Location: OPD Referred By: MHC Specimen: Blood PARAMETER RESULT
ApolipoProtein Estimation Apolipoprotein A1 (Apo-A1)
(Method :Immunonephelometric assay) 121
UNIT
142 105
Apolipoprotein B (Apo-B)
(Method :Immunonephelometric assay)
95.3
apo-A1/apo-B Ratio
1.26
1.35
Ratio Ratio
( Elevation of apo B (present in chylomicrons, VLDL, HDL and LDL), decrease in apo A-1 (present mostly in HDL), and decrease in the apo A -1/apo B ratio have been associated with increased risk of CHD)
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Amit Kumar Pt. Location: OPD Referred By: MHC Specimen: Blood PARAMETER RESULT Age/Sex: 27y/M MRN:SH/LKO/007883/09 Lab No.:B-/08/1399 Date: 20.8.2009 REFERENCE RANGE
UNIT
8.6 5.8% %
A 1C
(%)
<7 4 -- 6
* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Raja Singh Pt. Location: OPD Referred By: Dr. I.Tyagi Specimen: Blood PARAMETER Serum Urea
Methodology- Urease- GLDH, Kinetic
RESULT 30 0.85
Age/Sex: 37y/M MRN:SH/LKO/00/09 Lab No.:B-/08/1426 Date: 20.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. G.S Triphati Pt. Location: IPD/G/W Referred By: Dr Specimen: BLOOD PARAMETER Age/Sex: 56/M MRN:SH/LKO/007785/08/09 Lab No.:B-/08/1424 Date: 20.8.2009 REFERENCE RANGE
RESULT
UNIT
214.0
mg/dl
70 - 140
Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Surender Bahadev Pt. Location: IPD/G/W Referred By: Dr. I.Tygi Specimen: BLOOD PARAMETER RESULT Blood Sugar Random 90 Age/Sex: 32/M MRN:SH/LKO/007748/08/09 Lab No.:B-/08/1425 Date: 20.8.2009 REFERENCE RANGE 70 - 140
UNIT mg/dl
(Method: - GOD-POD) (Normal 140mg/dl, Impaired glucose tolerance 140-199 mg/dl, Diabetes mellitus 200mg/dl According to Amercian diabetes association, 2004
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
0.89
mg/dl
0.70 - 1.30
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Bharat Lal Pt. Location: IPD/G/W Referred By: Dr. H.N Triphati Specimen: BLOOD PARAMETER Serum Urea
Methodology- Urease- GLDH, Kinetic
Age/Sex: 51/M MRN:SH/LKO/006354/08/09 Lab No.:B-/08/1427 Date: 20.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
121.0 4.70
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mast. Avi Age/Sex: 8y/M Pt. Location: IPD/ PICU MRN:SH/LKO/006693/08/09 Referred By: Dr. M.U Hasan Lab No.:B-/08/1428 Specimen: BLOOD Date: 20.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 0.40 Total Serum Bilirubin mg/dl 0.30 - 1.20
(Method: Walter And Gerarde)
0.10 0.30
mg/dl mg/dl
27
IU/I
0 - 42
21
IU/I
0 - 42
231
IU/I
42 - 128
5.83
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mast. Avi Pt. Location: IPD/ PICU Referred By: Dr. M.U Hasan Specimen: BLOOD PARAMETER Blood Urea Nitrogen
Method Urease GLDH Kinetic
RESULT 14.56
UNIT mg/dl
6 to 20
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
0.35
mg/dl
0.70 - 1.30
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
132.0 4.40
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Sunita Malhotra Pt. Location: IPD/ MICU Referred By: Dr. S.K Somani Specimen: BLOOD PARAMETER RESULT Age/Sex: 51y/F MRN:SH/LKO/007253/08/09 Lab No.:B-/08/1429 Date: 20.8.2009 REFERENCE RANGE
UNIT
156.0 3.0
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Kamlesh Kumari Pt. Location: IPD/ MICU Referred By: Dr. R. Kohli Specimen: BLOOD PARAMETER RESULT Age/Sex: 35y/F MRN:SH/LKO/007860/08/09 Lab No.:B-/08/1430 Date: 20.8.2009 REFERENCE RANGE
UNIT
136.0 3.70
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Fzhar Ahmed Pt. Location: IPD/ G/W Referred By: Dr. P.Gupta Specimen: BLOOD PARAMETER RESULT Serum Urea
Methodology- Urease- GLDH, Kinetic
Age/Sex: 47y/F MRN:SH/LKO/007958/08/09 Lab No.:B-/08/1423 Date: 20.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30
28 0.87
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Fzhar Ahmed Age/Sex: 47y/F Pt. Location: IPD/ G/W MRN:SH/LKO/007958/08/09 Referred By: Dr. P.Gupta Lab No.:B-/08/1423 Specimen: BLOOD Date: 20.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 0.30 Total Serum Bilirubin mg/dl 0.30 - 1.20
(Method: Walter And Gerarde)
0.10 0.20
mg/dl mg/dl
31
IU/I
0 - 42
28
IU/I
0 - 42
163
IU/I
42 - 128
8.0
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Vishi Devi Pt. Location: IPD/ M.I.C.U Referred By: Dr. M.Husain Specimen: BLOOD PARAMETER Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
RESULT 0.52
UNIT mg/dl
Age/Sex: 50y/F MRN:SH/LKO/007639/08/09 Lab No.:B-/08/1434 Date: 20.8.2009 REFERENCE RANGE 0.70 - 1.30
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Serum Sodium
146.0
mmol/l
135 - 145
Serum Potassium
3.3
mmol/l
3.5 - 5.5
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Rukaiya Baua Pt. Location: IPD/ G/W Referred By: Dr. Rajesh Arora Specimen: BLOOD PARAMETER RESULT Blood Sugar Random 92.1 Age/Sex: 30y/F MRN:SH/LKO/007837/08/09 Lab No.:B-/08/1435 Date: 20.8.2009 REFERENCE RANGE 70 - 140
UNIT mg/dl
(Method: - GOD-POD) (Normal 140mg/dl, Impaired glucose tolerance 140-199 mg/dl, Diabetes mellitus 200mg/dl According to Amercian diabetes association, 2004
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Ramesh Kumar Pt. Location: IPD/ E/W Referred By: Dr. Somani Specimen: BLOOD PARAMETER RESULT Serum Urea
Methodology- Urease- GLDH, Kinetic
Age/Sex: 55y/M MRN:SH/LKO/005994/08/09 Lab No.:B-/08/1436 Date: 20.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30
122.4 1.31
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
126.0 3.5
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Ramesh Kumar Age/Sex: 55y/M Pt. Location: IPD/ E/W MRN:SH/LKO/005994/08/09 Referred By: Dr. Somani Lab No.:B-/08/1436 Specimen: BLOOD Date: 20.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 18.18 Total Serum Bilirubin mg/dl 0.30 - 1.20
(Method: Walter And Gerarde)
15.25 2.93
mg/dl mg/dl
103.8
IU/I
0 - 42
165.3
IU/I
0 - 42
147.2
IU/I
42 - 128
5.32
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Izahar Ahmed Pt. Location: IPD/ G/W Referred By: Dr. Puneet Gupta Specimen: BLOOD PARAMETER RESULT Age/Sex: 47y/M MRN:SH/LKO/007958/08/09 Lab No.:B-/08/1437 Date: 20.8.2009 REFERENCE RANGE
UNIT
138.0 3.9
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Ram Avtar Dwivedi Pt. Location: OPD Referred By: Dr.Mufazal Ahmad Specimen: BLOOD PARAMETER RESULT Blood Sugar Fasting 108.5 Age/Sex: 45y/M MRN:SH/LKO/002004/08/09 Lab No.:B-/08/1461 Date: 21.8.2009 REFERENCE RANGE 70 - 110
UNIT mg/dl
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
183.7
mg/dl
70 - 140
Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
1.47
mg/dl
0.70 - 1.30
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
140.0 3.9
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Sunita Malhotra Pt. Location: IPD/MICU Referred By: Dr. S.K.Somani Specimen: BLOOD PARAMETER RESULT Serum Urea
Methodology- Urease- GLDH, Kinetic
Age/Sex: 54y/F MRN:SH/LKO/007253/08/09 Lab No.:B-/08/1442 Date: 21.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30 28 - 100 13 - 60
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
153.0 3.6
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Sunita Malhotra Age/Sex: 54y/F Pt. Location: IPD/MICU MRN:SH/LKO/007253/08/09 Referred By: Dr. S.K.Somani Lab No.:B-/08/1442 Specimen: BLOOD Date: 21.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 3.09 Total Serum Bilirubin mg/dl 0.30 - 1.20
(Method: Walter And Gerarde)
2.44 0.65
mg/dl mg/dl
48.6
IU/I
0 - 42
46.5
IU/I
0 - 42
84.3
IU/I
42 - 128
5.98
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Hari Shanker Shukla Pt. Location: IPD/MICU Referred By: Dr.H.N.Tripathi Specimen: BLOOD PARAMETER RESULT Age/Sex: 70y/M MRN:SH/LKO/007921/08/09 Lab No.:B-/08/1443 Date: 21.8.2009 REFERENCE RANGE
UNIT
133.0 4.1
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Ashish Mitra Pt. Location: IPD/MICU Referred By: Dr.Mazhar Husain Specimen: BLOOD PARAMETER RESULT Age/Sex: 38y/M MRN:SH/LKO/007836/08/09 Lab No.:B-/08/1444 Date: 21.8.2009 REFERENCE RANGE
UNIT
143.0 3.6
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Kamlesh Kumari Pt. Location: IPD/MICU Referred By: Dr.Vaibhav Khanna Specimen: BLOOD PARAMETER RESULT Age/Sex: 35y/F MRN:SH/LKO/007860/08/09 Lab No.:B-/08/1445 Date: 21.8.2009 REFERENCE RANGE
UNIT
137.0 3.5
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Rasna Devi Pt. Location: IPD/MICU Referred By: Dr.H.N.Tripathi Specimen: BLOOD PARAMETER Blood Urea Nitrogen
Method Urease GLDH Kinetic
6 to 20
0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
134.0 3.3
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mast.Ankit Pt. Location: IPD/MICU Referred By: Dr.Mazhar Husain Specimen: BLOOD PARAMETER RESULT Serum Urea
Methodology- Urease- GLDH, Kinetic
Age/Sex: 15y/M MRN:SH/LKO/007559/08/09 Lab No.:B-/08/1448 Date: 21.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30
25.3 0.45
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
133.0 4.7
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Brij Nath Yadav Pt. Location: IPD/MICU Referred By: Dr.Sandeep Agarwal Specimen: BLOOD PARAMETER RESULT Serum Urea
Methodology- Urease- GLDH, Kinetic
Age/Sex: 45y/M MRN:SH/LKO/007653/08/09 Lab No.:B-/08/1449 Date: 21.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30
240 8.15
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
135.0 4.4
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Tara Singh Pt. Location: OPD Referred By: Dr.Self Specimen: BLOOD PARAMETER Serum Urea
Methodology- Urease- GLDH, Kinetic
Age/Sex: 51y/F MRN:SH/LKO/006664/08/09 Lab No.:B-/08/1394 Date: 20.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Vishi Devi Pt. Location: IPD/MICU Referred By: Dr. Specimen: BLOOD PARAMETER Serum Sodium Serum Potassium Age/Sex: 50y/F MRN:SH/LKO/007639/08/09 Lab No.:B-/08/1450 Date: 21.8.2009 REFERENCE RANGE 135 - 145 3.5 - 5.5
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Asha Rawat Pt. Location: IPD/E.W Referred By: Dr.Sandeep Agarwal Specimen: BLOOD PARAMETER RESULT Blood Urea Nitrogen
Method Urease GLDH Kinetic
50.38 1.06
6 to 20
0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
143.0 4.4
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Ratna Mukharjee Pt. Location: IPD/E.W Referred By: Dr.Swadesh Singh Specimen: BLOOD PARAMETER RESULT Blood Urea Nitrogen
Method Urease GLDH Kinetic
18.71 1.37
6 to 20
0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
134.0 4.1
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Abhinandan Pt. Location: IPD/N.ICU Referred By: Dr.Abhishek Specimen: BLOOD PARAMETER Blood Urea Nitrogen
Method Urease GLDH Kinetic
6 to 20
0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
138.0 3.2
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.G.C.Metha Pt. Location: IPD/M.ICU Referred By: Dr.Alok Specimen: BLOOD PARAMETER Serum Urea
Methodology- Urease- GLDH, Kinetic
Age/Sex: 80y/M MRN:SH/LKO/007405/08/09 Lab No.:B-/08/1454 Date: 21.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Kamla Kapoor Pt. Location: IPD/T.ICU Referred By: Dr.H.N.Tripathi Specimen: BLOOD PARAMETER RESULT Blood Urea Nitrogen
Method Urease GLDH Kinetic
43.83 3.82
6 to 20
0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
132.0 3.4
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Sushma Pandey Pt. Location: IPD/SICU Referred By: Dr.Swadesh Singh Specimen: BLOOD PARAMETER RESULT Age/Sex: 41y/F MRN:SH/LKO/007236/08/09 Lab No.:B-/08/1457 Date: 21.8.2009 REFERENCE RANGE
UNIT
137.0 3.2
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Avadesh Narain Pt. Location: IPD/SICU Referred By: Dr.Mufazal Ahmad Specimen: BLOOD PARAMETER RESULT Blood Urea Nitrogen
Method Urease GLDH Kinetic
31 2.28
6 to 20
0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
134.0 3.3
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Shakuntla Pt. Location: IPD/SICU Referred By: Dr.Mufazal Ahmad Specimen: BLOOD PARAMETER RESULT Blood Urea Nitrogen
Method Urease GLDH Kinetic
38.05 2.13
6 to 20
0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
124.0 3.6
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Anita Chatarjee Pt. Location: IPD/SICU Referred By: Dr.Mufazal Ahmad Specimen: BLOOD PARAMETER RESULT Blood Urea Nitrogen
Method Urease GLDH Kinetic
47.9 0.42
6 to 20
0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
121.0 3.8
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Ramesh Kumar Puri Age/Sex: 55y/M Pt. Location: IPD/CCU MRN:SH/LKO/007985/08/09 Referred By: Dr.S,K,Somani Lab No.:B-/08/1462 Specimen: BLOOD Date: 21.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 18.83 Total Serum Bilirubin mg/dl 0.30 - 1.20
(Method: Walter And Gerarde)
14.46 4.38
mg/dl mg/dl
106.9
IU/I
0 - 42
174.5
IU/I
0 - 42
144.5
IU/I
42 - 128
5.43
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Ramesh Kumar Puri Pt. Location: IPD/CCU Referred By: Dr.S,K,Somani Specimen: BLOOD PARAMETER RESULT Serum Urea
Methodology- Urease- GLDH, Kinetic
Age/Sex: 55y/M MRN:SH/LKO/007985/08/09 Lab No.:B-/08/1462 Date: 21.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30
115 1.61
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Sunanda Sudhir Pt. Location: OPD Referred By: Dr.Himani Negi Specimen: BLOOD Tr.No.19772 PARAMETER RESULT Age/Sex: 32y/F MRN:SH/LKO/007001/08/09 Lab No.:B-/08/1463 Date: 21.8.2009 REFERENCE RANGE
UNIT
77.0
mg/dl
70 - 110
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Safiya Begam Pt. Location: OPD Referred By: Dr.S.K.Singh Specimen: BLOOD Tr.No.19963 PARAMETER RESULT Blood Sugar Random 137.3 Age/Sex: 65y/F MRN:SH/LKO/007132/08/09 Lab No.:B-/08/1478 Date: 21.8.2009 REFERENCE RANGE 70 - 140
UNIT mg/dl
(Method: - GOD-POD) (Normal 140mg/dl, Impaired glucose tolerance 140-199 mg/dl, Diabetes mellitus 200mg/dl According to Amercian diabetes association, 2004
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
1.02
mg/dl
0.70 - 1.30
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
136.0 4.3
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Poonam Ranjan Pt. Location: OPD Referred By: MHC Specimen: BLOOD Tr.No.23 PARAMETER RESULT Blood Sugar Fasting 80 Age/Sex: 41y/F MRN:SH/LKO/007985/08/09 Lab No.:B-/08/1465 Date: 21.8.2009 REFERENCE RANGE 70 - 110
UNIT mg/dl
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
6 to 20
0.70 - 1.30 8.4- 10.4
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Serum Calcium
(Method: arsenazo III)
Phosphorus
(Method: phosphomolybdate UV
2.5 - 4.5
3.5
mg/dl
2.5 6.8
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
1.15
mmol/l
1.12 1.32
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Poonam Ranjan Age/Sex: 41y/F Pt. Location: OPD MRN:SH/LKO/007985/08/09 Referred By: MHC Lab No.:B-/08/1465 Specimen: BLOOD Tr.No.23 Date: 21.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 0.42 Total Serum Bilirubin mg/dl 0.30 - 1.20
(Method: Walter And Gerarde)
0.12 0.3
mg/dl mg/dl
20
IU/I
0 - 42
18
IU/I
0 - 42
66
IU/I
42 - 128
7.2
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
4.2 3 1.4
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Poonam Ranjan Pt. Location: OPD Referred By: MHC Specimen: BLOOD Tr.No.23 PARAMETER RESULT
Total Serum Cholesterol
UNIT
146 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)
Serum Triglycerides 93 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 35 mg/dl
(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)
92.4
mg/dl
18.6
mg/dl
10 to 40
4.17
mg/dl
Less 4.5
2.64
mg/dl
Less 3.0
Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Poonam Ranjan Pt. Location: OPD Referred By: MHC Specimen: BLOOD Tr.No.23 PARAMETER RESULT
ApolipoProtein Estimation Apolipoprotein A1 (Apo-A1)
(Method :Immunonephelometric assay) 112
UNIT
Apolipoprotein B (Apo-B)
(Method :Immunonephelometric assay)
86.3
apo-A1/apo-B Ratio
1.29
( Elevation of apo B (present in chylomicrons, VLDL, HDL and LDL), decrease in apo A-1 (present mostly in HDL), and decrease in the apo A -1/apo B ratio have been associated with increased risk of CHD)
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Poonam Ranjan Pt. Location: OPD Referred By: MHC Specimen: BLOOD Tr.No.23 PARAMETER RESULT Age/Sex: 41y/F MRN:SH/LKO/007985/08/09 Lab No.:B-/08/1465 Date: 21.8.2009 REFERENCE RANGE
UNIT
5.6%
A 1C
(%)
* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Poonam Saluja Pt. Location: OPD Referred By: MHC Specimen: BLOOD Tr.No.24 PARAMETER RESULT Blood Sugar Fasting 83 Age/Sex: 49y/F MRN:SH/LKO/007985/08/09 Lab No.:B-/08/1466 Date: 21.8.2009 REFERENCE RANGE 70 - 110
UNIT mg/dl
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
6 to 20
0.70 - 1.30 8.4- 10.4
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Serum Calcium
(Method: arsenazo III)
Phosphorus
(Method: phosphomolybdate UV
2.5 - 4.5
5.2
mg/dl
2.5 6.8
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
1.14
mmol/l
1.12 1.32
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Poonam Saluja Age/Sex: 49y/F Pt. Location: OPD MRN:SH/LKO/007985/08/09 Referred By: MHC Lab No.:B-/08/1466 Specimen: BLOOD Tr.No.24 Date: 21.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 1.03 Total Serum Bilirubin mg/dl 0.30 - 1.20
(Method: Walter And Gerarde)
0.2 0.83
mg/dl mg/dl
53
IU/I
0 - 42
45
IU/I
0 - 42
99
IU/I
42 - 128
7.45
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Poonam Saluja Pt. Location: OPD Referred By: MHC Specimen: BLOOD Tr.No.24 PARAMETER RESULT
Total Serum Cholesterol
UNIT
160 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)
Serum Triglycerides 117 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 44 mg/dl
(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)
92.6
mg/dl
24.4
mg/dl
10 to 40
3.63
mg/dl
Less 4.5
2.1
mg/dl
Less 3.0
Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Poonam Saluja Pt. Location: OPD Referred By: MHC Specimen: BLOOD Tr.No.24 PARAMETER RESULT
ApolipoProtein Estimation Apolipoprotein A1 (Apo-A1)
(Method :Immunonephelometric assay) 149
UNIT
Apolipoprotein B (Apo-B)
(Method :Immunonephelometric assay)
92
apo-A1/apo-B Ratio
1.61
( Elevation of apo B (present in chylomicrons, VLDL, HDL and LDL), decrease in apo A-1 (present mostly in HDL), and decrease in the apo A -1/apo B ratio have been associated with increased risk of CHD)
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Poonam Saluja Pt. Location: OPD Referred By: MHC Specimen: BLOOD Tr.No.24 PARAMETER RESULT Age/Sex: 49y/F MRN:SH/LKO/007985/08/09 Lab No.:B-/08/1466 Date: 21.8.2009 REFERENCE RANGE
UNIT
6.2%
A 1C
(%)
* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Chandani Shukla Pt. Location: OPD Referred By: Dr.Manjusha Specimen: BLOOD Tr.No.19895 PARAMETER RESULT Blood Sugar Random 82.5 Age/Sex: 30y/F MRN:SH/LKO/007981/08/09 Lab No.:B-/08/1467 Date: 21.8.2009 REFERENCE RANGE 70 - 140
UNIT mg/dl
(Method: - GOD-POD) (Normal 140mg/dl, Impaired glucose tolerance 140-199 mg/dl, Diabetes mellitus 200mg/dl According to Amercian diabetes association, 2004
Serum Calcium
(Method: arsenazo III)
8.78 4.45
mg/dl mg/dl
8.4- 10.4
Phosphorus
(Method: phosphomolybdate UV
2.5 - 4.5
Serum Urea
Methodology- Urease- GLDH, Kinetic
23 0.75
mg/dl mg/dl
13 - 43 0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
138.0 4.0
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
Associate Consultant
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Chandani Shukla Age/Sex: 30y/F Pt. Location: OPD MRN:SH/LKO/007981/08/09 Referred By: Dr.Manjusha Lab No.:B-/08/1467 Specimen: BLOOD Tr.No.19895 Date: 21.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 0.53 Total Serum Bilirubin mg/dl 0.30 - 1.20
(Method: Walter And Gerarde)
0.14 0.39
mg/dl mg/dl
29
IU/I
0 - 42
25
IU/I
0 - 42
46
IU/I
42 - 128
7.61
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Chandani Shukla Pt. Location: OPD Referred By: Dr.Manjusha Specimen: BLOOD Tr.No.19895 PARAMETER RESULT
C reactive protein(C.R.P)
UNIT
<3.08
mg/L
less than 3
*CRP is an acute phase reactant appeared in plasma during many infectious or inflammatory conditions CRP assay provides useful information for the diagnosis,therapy and monitoring of inflammatory processes and associated diseases. Increase in CRP values are non specific and should not be interpreted without a complete clinical history.
Note : above test carried out by BN ProSpec Nephlometer Automated Analyzer .
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Bharat Lal Pt. Location: IPD/G/W Referred By: Dr. H.N Triphati Specimen: BLOOD PARAMETER Blood Sugar Random Age/Sex: 57/M MRN:SH/LKO/006354/08/09 Lab No.:B-/08/1468 Date: 21.8.2009 REFERENCE RANGE 70 - 140
RESULT 97.8
UNIT mg/dl
(Method: - GOD-POD) (Normal 140mg/dl, Impaired glucose tolerance 140-199 mg/dl, Diabetes mellitus 200mg/dl According to Amercian diabetes association, 2004
92.5
mg/dl
6 to 20
0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
6.54
mg/dl
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
123.0 4.8
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: B/O Gudiya Pt. Location: IPD/P.ICU Referred By: Dr.M.U.Hasan. Specimen: Blood PARAMETER Serum Calcium
(Method: arsenazo III)
Age/Sex: NB/F MRN:SH/LKO/007666/09 Lab No.:B-/08/1469 Date: 21.8.2009 REFERENCE RANGE 8.4- 10.4 13 - 43 0.70 - 1.30
Serum Urea
Methodology- Urease- GLDH, Kinetic
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
136.0 5.4
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: B/O.Subhdra Pt. Location: IPD/P.ICU Referred By: Dr.M.U.Hasan. Specimen: Blood PARAMETER Total Serum Bilirubin
(Method: Walter And Gerarde)
Age/Sex: NB/F MRN:SH/LKO/007784/09 Lab No.:B-/08/1470 Date: 21.8.2009 REFERENCE RANGE 0.30 - 1.20 0 - 0.20 0.08 - 0.75
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
q
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Prakash Lal Age/Sex: 84y/M Pt. Location: OPD MRN:SH/LKO/006773/09 Referred By: Dr.Swadesh Lab No.:B-/08/1471 Specimen: BLOOD Tr.No.19922 Date: 21.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 1.19 Total Serum Bilirubin mg/dl 0.30 - 1.20
(Method: Walter And Gerarde)
0.50 0.69
mg/dl mg/dl
29
IU/I
0 - 42
33
IU/I
0 - 42
125
IU/I
42 - 128
7.70
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
3.2 - 5.0 g/dl 2.0 - 3.5 2.0- 3.5 ratio >1 70 - 140
(Method: - GOD-POD) (Normal 140mg/dl, Impaired glucose tolerance 140-199 mg/dl, Diabetes mellitus 200mg/dl
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Subhash Chandra Pt. Location: IPD/G.W Referred By: Dr.S.Garg Specimen: Blood PARAMETER RESULT Blood Sugar Fasting 99.3 Age/Sex: 51/M MRN:SH/LKO/007928/09 Lab No.:B-/08/1472 Date: 21.8.2009 REFERENCE RANGE 70 - 110
UNIT mg/dl
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
Serum Urea
Methodology- Urease- GLDH, Kinetic
26 1
mg/dl mg/dl
13 - 43 0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Ketki Devi Pt. Location: IPD/E.W Referred By: Dr.S.K.Somani Specimen: Blood PARAMETER Serum Urea
Methodology- Urease- GLDH, Kinetic
RESULT 71 1.30
Age/Sex: 47/F MRN:SH/LKO/008004/09 Lab No.:B-/08/1473 Date: 21.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Ketki Devi Age/Sex: 47/F Pt. Location: IPD/E.W MRN:SH/LKO/008004/09 Referred By: Dr.S.K.Somani Lab No.:B-/08/1473 Specimen: Blood Date: 21.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 13.43 Total Serum Bilirubin mg/dl 0.30 - 1.20
(Method: Walter And Gerarde)
10.14 3.10
mg/dl mg/dl
51
IU/I
0 - 42
105
IU/I
0 - 42
358
IU/I
42 - 128
4.35
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Shanti Singh Pt. Location: OPD Referred By: Dr.H.N.Tripathi Specimen: BLOOD PARAMETER RESULT Serum Urea
Methodology- Urease- GLDH, Kinetic
Age/Sex: 70y/F MRN:SH/LKO/007995/09 Lab No.:B-/08/1475 Date: 21.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30
38 1.2
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Microalbuminuria is the presence of albumin in the urine above the normal levels bu below the detectable range of conventional methods. Urine albumin levels from 20-200 mg/L are an indicator of early or possibly reversible glomerular damage.In diabetic patients ,microalbulinemia is associated with a four to six fold increase in cardiovascular mortality,and an independent risk factor for renal mortality.It is also more prevelant in hypertensive subjects Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Shanti Singh Pt. Location: OPD Referred By: Dr.H.N.Tripathi Specimen: BLOOD PARAMETER RESULT Age/Sex: 70y/F MRN:SH/LKO/007995/09 Lab No.:B-/08/1475 Date: 21.8.2009 REFERENCE RANGE
UNIT
6.4%
A 1C
(%)
* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications
Checked by..
SAHARA HOSPITAL
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mast.Ayub Khan Pt. Location: IPD/CTSTD Referred By: Dr.M.Husain Specimen: Blood PARAMETER RESULT Total Serum Bilirubin
(Method: Walter And Gerarde)
Age/Sex: 12/M MRN:SH/LKO/006861/09 Lab No.:B-/08/1476 Date: 21.8.2009 REFERENCE RANGE 0.30 - 1.20 0 - 0.20 0.08 - 0.75
11
IU/I
0 - 42
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Vikash Sinha Pt. Location: Dialysis Referred By: Dr.M.Ahamad Specimen: BLOOD PARAMETER RESULT
SERUM IRON 57.1
UNIT
g/dl
g/dl g/dl %
Iron is transported as Fe(111) bound to the plasma protein apotransferrin.Normally only about one third of the iron binding sites of transferrin are occupied by Fe(111).The additional amount of iron that can be bound is the unsaturated iron binding capacity (UIBC). The sum of the serum iron and UIBC represents TIBC.TIBC is a measurement for the maximum iron concentration that transferrin can bind. The serum TIBC varies in disorders of iron metabolism .In iron dediciency anemia the TIBC is elevated and the transferring saturation is lowered to 15% or less. Low serum iron associated with low TIBC is characteristic of the anemia of chronic disorders,malignant tumors,and infections. Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Sonika Mishra Pt. Location: IPD/G.W Referred By: Dr.S.N.Gupta Specimen: Blood PARAMETER RESULT Blood Sugar Random 82.9 Age/Sex: 37/F MRN:SH/LKO/007819/09 Lab No.:B-/08/1479 Date: 21.8.2009 REFERENCE RANGE 70 - 140
UNIT mg/dl
(Method: - GOD-POD) (Normal 140mg/dl, Impaired glucose tolerance 140-199 mg/dl, Diabetes mellitus 200mg/dl According to Amercian diabetes association, 2004
Serum Urea
Methodology- Urease- GLDH, Kinetic
14.4 0.97
mg/dl mg/dl
13 - 43 0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Sonika Mishra Pt. Location: IPD/G.W Referred By: Dr.S.N.Gupta Specimen: Blood PARAMETER RESULT Age/Sex: 37/F MRN:SH/LKO/007819/09 Lab No.:B-/08/1479 Date: 21.8.2009 REFERENCE RANGE
UNIT
13.2
IU/I
0 - 42
29.6
IU/I
0 - 42
66
IU/I
42 - 128
6.20
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Avi Satija Pt. Location: IPD/Picu Referred By: Dr.M.U.Hasan Specimen: CSF PARAMETER C.S.F C.S.F Protein Glucose Age/Sex: MRN:SH/LKO/006693/09 Lab No.:B-/08/1481 Date: 21.8.2009 REFERENCE RANGE 15 - 45 40 - 80
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Gulam Ashraf Pt. Location: IPD/N.ICU Referred By: Dr. Specimen: Blood PARAMETER RESULT Serum Urea
Methodology- Urease- GLDH, Kinetic
Age/Sex:42/M MRN:SH/LKO/007800/09 Lab No.:B-/08/1482 Date: 21.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30
22.2 0.95
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Laxmi Singh Age/Sex: 54y/M
Pt. Location: OPD Referred By: Dr.S.Dabadghao Specimen: BLOOD PARAMETER Serum LDH
Method: DGKC IFCC
UNIT U/I
Haptoglobin
0.629
g/L
0.3 to 2.0
Serum Haptoglobin is an acute phase reactant rises in response to stress,infection,acute inflammation and tissue necrosis. Levels increases after a hemolytic episode,which is dramatic following massive hemolytic episode in situations of hemolytic transfusion reaction,thermal burns,or autoimmune hemolytic anemia.It is also a useful measurement for serially monitoring patients who have a slow but steady rate of red cell breakdown such as by mechanical heart valves,,hemoglobinopathies,or exercise associated trauma Low Haptoglobin concentrations may be seen in liver diasese when hepatic synthetic capacity is impaired
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Taseem Fatima Pt. Location: IPD/G.W Referred By: Dr.Neelam Vinay Specimen: Blood PARAMETER RESULT
C reactive protein(C.R.P)
UNIT
15.3
mg/L
less than 3
*CRP is an acute phase reactant appeared in plasma during many infectious or inflammatory conditions CRP assay provides useful information for the diagnosis,therapy and monitoring of inflammatory processes and associated diseases. Increase in CRP values are non specific and should not be interpreted without a complete clinical history.
Note : above test carried out by BN ProSpec Nephlometer Automated Analyzer .
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Surender Nath Pt. Location: OPD Age/Sex: 54y/M MRN:SH/LKO/008026/09
UNIT mg/dl
(Method: - GOD-POD) (Normal 140mg/dl, Impaired glucose tolerance 140-199 mg/dl, Diabetes mellitus 200mg/dl According to Amercian diabetes association, 2004
35.5
mg/dl
6 to 20
0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
2.56
mg/dl
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
135.0 4.0
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Ram Bahadur Pt. Location: OPD Age/Sex: 48y/M MRN:SH/LKO/008020/09
Tr.No-20026 RESULT
UNIT
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
1.26
mg/dl
0.70 - 1.30
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY
Mr. K.K Singh IPD/G.W Dr. S.K Singh Blood RESULT UNIT
Serum Albumin
(Method: Bromo Cresol Green BCG))
2.4
g/dl
3.2 - 5.0
131.0 4.3
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY
UNIT mg/dl
6 to 20
Serum Calcium
(Method: arsenazo III)
9.66
mg/dl
8.4- 10.4
Serum Urea
Methodology- Urease- GLDH, Kinetic
45 2.38
mg/dl mg/dl
13 - 43 0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY
Mrs. Saraswati Devi Age/Sex:70/F IPD/G.W MRN:SH/LKO/008042/09 Dr.H.N Tripathi Lab No.:B-/08/1488 Blood Date: 21.8.2009 RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 0.23 Total Serum Bilirubin mg/dl 0.30 - 1.20
(Method: Walter And Gerarde)
0.07 0.16
mg/dl mg/dl
9.3
IU/I
0 - 42
13.9
IU/I
0 - 42
46.8
IU/I
42 - 128
5.67
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY
Mrs. Vishi Devi IPD/ M.I.C.U Dr. M.Husain BLOOD RESULT 140.0 3.8 UNIT mmol/l mmol/l
Age/Sex: 50y/F MRN:SH/LKO/007639/08/09 Lab No.:B-/08/1489 Date: 21.8.2009 REFERENCE RANGE 135 - 145 3.5 - 5.5
Serum Potassium
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY
Name: Mr. Anoop Bansal Pt. Location: IPD/ E/W Referred By: Dr. Mufazal Ahmed Specimen: BLOOD PARAMETER RESULT Blood Urea Nitrogen 53.81
Method Urease GLDH Kinetic
6 to 20
0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
5.62
Serum Calcium
(Method: arsenazo III)
9.49
mg/dl
8.4- 10.4
Phosphorus
(Method: phosphomolybdate UV
5.76
mg/dl
2.5 - 4.5
2.5 6.8
135 - 225
17.9
mg/dl U/I
Serum LDH
Method: DGKC IFCC
1048
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Anoop Bansal Age/Sex: 43y/M
Pt. Location: IPD/ E/W MRN:SH/LKO/008002/08/09 Referred By: Dr. Mufazal Ahmed Lab No.:B-/08/1492 Specimen: BLOOD Date: 21.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 0.88 Total Serum Bilirubin mg/dl 0.30 - 1.20
(Method: Walter And Gerarde)
0.26 0.62
mg/dl mg/dl
75.8
IU/I
0 - 42
58.6
IU/I
0 - 42
80.8
IU/I
42 - 128
5.24
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Anoop Bansal Age/Sex: 43y/M
Pt. Location: IPD/ E/W Referred By: Dr. Mufazal Ahmed Specimen: BLOOD PARAMETER RESULT
UNIT
*Quantitative determination of the immunoglobulins can provide important information on the humoral immune status of the body *Decreased serum immunoglobulin concentration occur in primary immunodeficiency conditions as well as in secondary immune insufficiencies ,e.g. in advanced malignant tumors, lymphatic leukemias etc. *Increased serum immunoglobulin concentration occur due to polyclonal proliferation ,eg.in hepatic diseases (hepatitis,viral cirrhosis),acute and chronic infections as well as in cord blood of neonates with intrauterine and perinatal infections. *Monoclonal immunoglobulin proliferation are seen in Plasmacytomas,Waldenstroms disease and heavy chain
disease.
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Surender Kumar Pt. Location: IPD/ T.ICU Age/Sex: 65y/M MRN:SH/LKO/007690/08/09
Referred By: Dr. H.N Triphati Specimen: BLOOD PARAMETER Serum Uric Acid
(Method : Uricase-POD)
RESULT
UNIT mg/dl
10
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Rinku Bansal Pt. Location: IPD/ E/W Referred By: Dr. S.K Somani Age/Sex: 35y/M MRN:SH/LKO/008052/08/09 Lab No.:B-/08/1495
RESULT
UNIT
Serum Calcium
(Method: arsenazo III)
9.89
mg/dl
8.4- 10.4
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
147.0 3.4
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Santosh Sahu Pt. Location: IPD/ G/W Referred By: Dr. M.Ahmed Age/Sex: 35y/M MRN:SH/LKO/007925/08/09 Lab No.:B-/08/1496
RESULT
186.8
UNIT
g/dl
g/dl g/dl %
112 - 346
250 - 450 13 - 45
Iron is transported as Fe(111) bound to the plasma protein apotransferrin.Normally only about one third of the iron binding sites of transferrin are occupied by Fe(111).The additional amount of iron that can be bound is the unsaturated iron binding capacity (UIBC). The sum of the serum iron and UIBC represents TIBC.TIBC is a measurement for the maximum iron concentration that transferrin can bind. The serum TIBC varies in disorders of iron metabolism .In iron dediciency anemia the TIBC is elevated and the transferring saturation is lowered to 15% or less. Low serum iron associated with low TIBC is characteristic of the anemia of chronic disorders,malignant tumors,and infections. (Dr. Anju Shukla, MD) Associate Consultant
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Sanehi Sahi Pt. Location: IPD/ E/W Referred By: Dr. R.K Mishra Age/Sex: 65y/M MRN:SH/LKO/006839/08/09 Lab No.:B-/08/1501
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
128.0 6.0
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Subhash Chandra Pt. Location: IPD/ E/W Referred By: Dr. A.S Pandey Age/Sex: 51y/M MRN:SH/LKO/007928/08/09 Lab No.:B-/08/1502
RESULT 109
UNIT mg/dl
Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Rasna Devi Pt. Location: IPD/ MICU Referred By: Dr. H.N Triphati Age/Sex: 85y/F MRN:SH/LKO/006643/08/09 Lab No.:B-/08/1503
RESULT
UNIT
137.0 3.50
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Kiran Gupta Pt. Location: IPD/ E/W Referred By: Dr. H.N Triphati Age/Sex: 55y/F MRN:SH/LKO/008075/08/09 Lab No.:B-/08/1504
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
140.0 8.0
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Kiran Gupta Pt. Location: IPD/ E/W Referred By: Dr. H.N Triphati Age/Sex: 55y/F MRN:SH/LKO/008075/08/09 Lab No.:B-/08/1504
RESULT UNIT LIVER FUNCTION TEST 0.57 mg/dl 0.24 0.33 mg/dl mg/dl
12
IU/I
0 - 42
16
IU/I
0 - 42
274
IU/I
42 - 128
7.16
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Prem Bodh Pt. Location: IPD/ E/W Referred By: Dr. H.N Triphati Age/Sex: 87y/M MRN:SH/LKO/007258/08/09 Lab No.:B-/08/1507
RESULT 37 1.49
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
138.0 3.0
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Sunita Malhotra Pt. Location: IPD/ MICU Referred By: Dr. Alok Age/Sex: 54y/F MRN:SH/LKO/007253/08/09 Lab No.:B-/08/1508
RESULT
UNIT
Serum Potassium
3.70
mmol/l
3.5 - 5.5
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Mukesh Shukla Pt. Location: OPD/Dialysis Referred By: Dr. M.Ahmed Specimen: BLOOD Tr.No-20088 PARAMETER RESULT Age/Sex: 33y/M MRN:SH/LKO/006048/09 Lab No.:B-/08/1505 Date: 21.8.2009 REFERENCE RANGE
UNIT
75.73
mg/dl
6 to 20
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
5.52
mg/dl
0.70 - 1.30
Serum Calcium
(Method: arsenazo III)
8.78
mg/dl
8.4- 10.4
Phosphorus
(Method: phosphomolybdate UV
6.13
mg/dl
2.5 - 4.5
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
135.0 4.90
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
PRE HD
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Monika Mansani Pt. Location: OPD/Dialysis Referred By: Dr. M.Ahmed Specimen: BLOOD Tr.No-2408 PARAMETER RESULT Age/Sex: 41y/F MRN:SH/LKO/007976/09 Lab No.:B-/08/1506 Date: 21.8.2009 REFERENCE RANGE
UNIT
82.4
IU/I
42 - 128
Serum Albumin
(Method: Bromo Cresol Green BCG))
3.44
g/dl
3.2 - 5.0
56.21 8.94
mg/dl mg/dl
6 to 20
0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Serum Calcium
(Method: arsenazo III)
8.81
mg/dl
8.4- 10.4
Phosphorus
(Method: phosphomolybdate UV
5.15
mg/dl
2.5 - 4.5
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
133.0 4.10
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer ) PRE HD
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Monika Mansani Pt. Location: OPD/Dialysis Referred By: Dr. M.Ahmed Specimen: BLOOD Tr.No-2408 PARAMETER RESULT Age/Sex: 41y/F MRN:SH/LKO/007976/09 Lab No.:B-/08/1516 Date: 21.8.2009 REFERENCE RANGE
UNIT
32.4 3.67
mg/dl mg/dl
6 to 20
0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
129.0 4.0
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
POST HD
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mast. Aryan Mathur Pt. Location: IPD/ PICU Referred By: Dr. M.U Hasan Age/Sex: 1/1my/M MRN:SH/LKO/008076/08/09 Lab No.:B-/08/1512
RESULT UNIT LIVER FUNCTION TEST 0.23 mg/dl 0.05 0.18 mg/dl mg/dl
16.8
IU/I
0 - 42
47.5
IU/I
0 - 42
114.1
IU/I
42 - 128
8.72
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mast. Aryan Mathur Pt. Location: IPD/ PICU Referred By: Dr. M.U Hasan Age/Sex: 1/1my/M MRN:SH/LKO/008076/08/09 Lab No.:B-/08/1512
6 to 20
0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Serum Calcium
(Method: arsenazo III)
10.24
mg/dl
8.4- 10.4
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
138.0 4.3
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
C reactive protein(C.R.P)
20.4
mg/L
less than 3
*CRP is an acute phase reactant appeared in plasma during many infectious or inflammatory conditions CRP assay provides useful information for the diagnosis,therapy and monitoring of inflammatory processes and associated diseases. Increase in CRP values are non specific and should not be interpreted without a complete clinical history.
Note : above test carried out by BN ProSpec Nephlometer Automated Analyzer .
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mes.Susheela Devi Pt. Location: IPD/ G.W Referred By: Dr.Sunil Dabadghao Age/Sex: 43y/F MRN:SH/LKO/008030/08/09 Lab No.:B-/08/1514
RESULT
UNIT
Serum Complement C3
Method-Immunonephalometric assay
109
mg/dl
90 - 180
Serum Complement C4
Method-Immunonephalometric assay
27.6
mg/dl
10 - 40
NOTE : *Complement proteins are acute phase reactants and their serum levels rises in inflammatory states and fall in autoimmune conditions as in S.L.E. *In SLE low levels are found in patients with active disease. *Patients with gram negative septicemia, and pyogenic infections aften have deficiency of C3 complement *Complement also appears to be a key importance in glomerular damage in may of the glomerulonephritis,
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Susheela Devi Pt. Location: IPD/ G.W Referred By: Dr.Sunil Dabadghao Specimen: BLOOD Age/Sex: 43y/F MRN:SH/LKO/008030/08/09 Lab No.:B-/08/1514 Date: 21.8.2009
PARAMETER
C reactive protein(C.R.P)
RESULT
UNIT
REFERENCE RANGE
mg/L
less than 3
*CRP is an acute phase reactant appeared in plasma during many infectious or inflammatory conditions CRP assay provides useful information for the diagnosis,therapy and monitoring of inflammatory processes and associated diseases. Increase in CRP values are non specific and should not be interpreted without a complete clinical history.
Note : above test carried out by BN ProSpec Nephlometer Automated Analyzer .
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Susheela Devi Pt. Location: IPD/ G.W Referred By: Dr.Sunil Dabadghao Specimen: BLOOD Age/Sex: 43y/F MRN:SH/LKO/008030/08/09 Lab No.:B-/08/1514 Date: 21.8.2009
Serum Calcium
(Method: arsenazo III)
Phosphorus
(Method: phosphomolybdate UV
2.5 - 4.5
14.9
IU/I
0 - 42
20.8
IU/I
0 - 42
65.8
IU/I
42 - 128
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
1.15
mmol/l
1.12 1.32
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mast.Ankit Pt. Location: IPD/MICU Referred By: Dr.Mazhar Husain Specimen: BLOOD PARAMETER RESULT Age/Sex: 15y/M MRN:SH/LKO/007559/08/09 Lab No.:B-/08/1521 Date: 22.8.2009 REFERENCE RANGE
UNIT
135.0 4.2
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Sarswati Devi Pt. Location: IPD/MICU Referred By: Dr.H.N.Tripathi Specimen: BLOOD PARAMETER RESULT Age/Sex: 70y/F MRN:SH/LKO/008042/08/09 Lab No.:B-/08/1523 Date: 22.8.2009 REFERENCE RANGE
UNIT
Serum Urea
Methodology- Urease- GLDH, Kinetic
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Serum Calcium
(Method: arsenazo III)
Serum Albumin
(Method: Bromo Cresol Green BCG))
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Rasna Devi Pt. Location: IPD/MICU Referred By: Dr.H.N.Tripathi Specimen: BLOOD PARAMETER Age/Sex: 85y/F MRN:SH/LKO/006643/08/09 Lab No.:B-/08/1524 Date: 22.8.2009 REFERENCE RANGE
RESULT
UNIT
Serum Urea
Methodology- Urease- GLDH, Kinetic
72.9 3.16
mg/dl mg/dl
13 - 43 0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
135.0 3.1
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.A.N.Shukla Pt. Location: IPD/MICU Referred By: Dr.Alok Specimen: BLOOD PARAMETER Age/Sex: 62y/M MRN:SH/LKO/007845/08/09 Lab No.:B-/08/1525 Date: 22.8.2009 REFERENCE RANGE
RESULT
UNIT
Serum Urea
Methodology- Urease- GLDH, Kinetic
222.7 8.26
mg/dl mg/dl
13 - 43 0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
135.0 4.8
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Sunita Malhotra Pt. Location: IPD/MICU Referred By: Dr.S.K.Somani Specimen: BLOOD PARAMETER RESULT Age/Sex: 54y/F MRN:SH/LKO/007253/08/09 Lab No.:B-/08/1526 Date: 22.8.2009 REFERENCE RANGE
UNIT
126.9
mg/dl
6 to 20
0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
2.31
mg/dl
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
151.0 4.4
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Jamila Begam Pt. Location: IPD/MICU Referred By: Dr.Mazhar Husain Specimen: BLOOD PARAMETER RESULT Age/Sex: 80y/F MRN:SH/LKO/007772/08/09 Lab No.:B-/08/1527 Date: 22.8.2009 REFERENCE RANGE
UNIT
62.7
mg/dl
6 to 20
0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
1.88
mg/dl
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
155.0 3.6
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Kamlesh Kumari Pt. Location: IPD/MICU Referred By: Dr.Vaibhav Khanna Specimen: BLOOD PARAMETER RESULT Age/Sex: 35y/F MRN:SH/LKO/007860/08/09 Lab No.:B-/08/1528 Date: 22.8.2009 REFERENCE RANGE
UNIT
11.71
mg/dl
6 to 20
0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
0.49
mg/dl
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
136.0 3.9
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Ashish Mitra Pt. Location: IPD/MICU Referred By: Dr.Mazhar Husain Specimen: BLOOD PARAMETER RESULT Age/Sex: 38y/M MRN:SH/LKO/007836/08/09 Lab No.:B-/08/1530 Date: 21.8.2009 REFERENCE RANGE
UNIT
150.0 4.0
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Vishi Devi Pt. Location: IPD/ M.I.C.U Referred By: Dr. M.Husain Specimen: BLOOD PARAMETER Age/Sex: 50y/F MRN:SH/LKO/007639/08/09 Lab No.:B-/08/1531 Date: 22.8.2009 REFERENCE RANGE
RESULT
UNIT
140.0 3.5
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Ibtessam Anjum Pt. Location: IPD/ Gyne Referred By: Dr.Manjusha Specimen: BLOOD PARAMETER RESULT Blood Sugar Random 105.6 Age/Sex: 28y/F MRN:SH/LKO/004719/09 Lab No.:B-/08/1533 Date: 22.8.2009 UNIT REFERENCE RANGE mg/dl 70 - 140
(Method: - GOD-POD) (Normal 140mg/dl, Impaired glucose tolerance 140-199 mg/dl, Diabetes mellitus 200mg/dl According to Amercian diabetes association, 2004
Serum Urea
Methodology- Urease- GLDH, Kinetic
21.5 0.52
mg/dl mg/dl
13 - 43 0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
138.0 4.80
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Ibtessam Anjum Pt. Location: IPD/ Gyne Referred By: Dr.Manjusha Specimen: BLOOD PARAMETER RESULT UNIT LIVER FUNCTION TEST Age/Sex: 28y/F MRN:SH/LKO/004719/09 Lab No.:B-/08/1533 Date: 22.8.2009 REFERENCE RANGE
9.4
IU/I
0 - 42
19.5
IU/I
0 - 42
145.5
IU/I
42 - 128
7.04
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.K.K.Singh Pt. Location: IPD/ CCU Referred By: Dr. Alok Specimen: BLOOD PARAMETER Age/Sex: 58y/M MRN:SH/LKO/006015/09 Lab No.:B-/08/1534 Date: 22.8.2009 REFERENCE RANGE
RESULT
UNIT
143.0 3.0
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Mohad Farooq Pt. Location: IPD/E.W Referred By: Dr. M.Husain Specimen: BLOOD PARAMETER RESULT Age/Sex: 55y/M MRN:SH/LKO/007979/09 Lab No.:B-/08/1537 Date: 22.8.2009 REFERENCE RANGE
UNIT
132.0 5.70
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs Kamla Kapoor Pt. Location: IPD/T.Icu Referred By: Dr. H.N.Tripathi Specimen: BLOOD PARAMETER RESULT Age/Sex: 72y/F MRN:SH/LKO/007647/09 Lab No.:B-/08/1538 Date: 22.8.2009 REFERENCE RANGE
UNIT
134.0 4.10
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
41.35
mg/dl
6 to 20
0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
3.45
mg/dl
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Abhinandan Pt. Location: IPD/NICU Referred By: Dr. M.Husain Specimen: BLOOD PARAMETER Age/Sex: 67y/M MRN:SH/LKO/007651/09 Lab No.:B-/08/1539 Date: 22.8.2009 REFERENCE RANGE
RESULT
UNIT
Serum Urea
Methodology- Urease- GLDH, Kinetic
112.5 2.21
mg/dl mg/dl
13 - 43 0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
141.0 3.0
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Jagdish Pandey Pt. Location: IPD/SICU Referred By: Dr. M Ahamad Specimen: BLOOD PARAMETER RESULT Age/Sex: 72y/M MRN:SH/LKO/007761/09 Lab No.:B-/08/1540 Date: 22.8.2009 REFERENCE RANGE
UNIT
135.0 3.60
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
34.8
mg/dl
6 to 20
0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
4.03
mg/dl
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs Anita Chatterjee Pt. Location: IPD/S.Icu Referred By: Dr. V.K.Tewari Specimen: BLOOD PARAMETER RESULT Serum Sodium 125.0 Age/Sex: 70y/F MRN:SH/LKO/006912/09 Lab No.:B-/08/1541 Date: 22.8.2009 REFERENCE RANGE 135 - 145
UNIT mmol/l
Serum Potassium
2.80
mmol/l
3.5 - 5.5
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
53.3
mg/dl
6 to 20
0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
2.7
mg/dl
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs Sushma Pandey Pt. Location: IPD/S.Icu Referred By: Dr. Swadesh Specimen: BLOOD PARAMETER RESULT Age/Sex: 41y/F MRN:SH/LKO/007236/09 Lab No.:B-/08/1542 Date: 22.8.2009 REFERENCE RANGE
UNIT
125.0 2.80
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs Shakuntala Pt. Location: IPD/S.Icu Referred By: Dr. M.Ahamad Specimen: BLOOD PARAMETER Age/Sex: 86y/F MRN:SH/LKO/007538/09 Lab No.:B-/08/1543 Date: 22.8.2009 REFERENCE RANGE
RESULT
UNIT
129.0 3.70
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Ram Bodh Mishra Pt. Location: IPD/E.W Referred By: Dr.H.N.Tripathi Specimen: BLOOD PARAMETER RESULT Age/Sex: 87y/M MRN:SH/LKO/007254/09 Lab No.:B-/08/1544 Date: 22.8.2009 REFERENCE RANGE
UNIT
Serum Urea
Methodology- Urease- GLDH, Kinetic
60.8
mg/dl
13 - 43
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
2.17
mg/dl
0.70 - 1.30
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
134.0 3.50
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Bharat Lal Pt. Location: IPD/G.W Referred By: Dr.H.N.Tripathi Specimen: BLOOD PARAMETER Age/Sex: 51y/M MRN:SH/LKO/006354/09 Lab No.:B-/08/1545 Date: 22.8.2009 REFERENCE RANGE
RESULT
UNIT
100.4
mg/dl
6 to 20
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
6.59
mg/dl
0.70 - 1.30
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
123.0 4.7
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Ram Devan Yadav Pt. Location: IPD/G.W Referred By: Dr.M.Ahamad Specimen: BLOOD PARAMETER RESULT Age/Sex: 75y/M MRN:SH/LKO/006934/09 Lab No.:B-/08/1546 Date: 22.8.2009 REFERENCE RANGE
UNIT
74
mg/dl
6 to 20
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
3.33
mg/dl
0.70 - 1.30
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
133.0 5.0
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Ambarish Arora Pt. Location: IPD/G.W Referred By: Dr.Abhishek Specimen: BLOOD PARAMETER RESULT
LIPID PROFILE
Total Serum Cholesterol
(Method-CHOD-PAP 194.9 mg/dl
UNIT
(Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl) Serum Triglycerides 332 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 23.3 mg/dl
(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)
105.2
mg/dl
66.43
mg/dl
10 to 40
8.37
mg/dl
Less 4.5
4.52
mg/dl
Less 3.0
Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Jamila Begum Age/Sex: 80y/F Pt. Location: IPD/MICU MRN:SH/LKO/007772/09 Referred By: Dr. M.Husain Lab No.:B-/08/1548 Specimen: BLOOD Date: 22.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 0.31 Total Serum Bilirubin mg/dl 0.30 - 1.20
(Method: Walter And Gerarde)
0.19
mg/dl
0 - 0.20
0.12
mg/dl
0.08 - 0.75
20.7
IU/I
0 - 42
56.4
IU/I
0 - 42
37
IU/I
42 - 128
5.63
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: B/O Ibtessam Anjum Pt. Location: IPD/Gyanee Referred By: Dr. M. U Hasan Specimen: BLOOD PARAMETER RESULT C reactive protein(C.R.P) 10.5 Age/Sex: y/ MRN:SH/LKO/008070/09 Lab No.:B-/08/1549 Date: 22.8.2009 REFERENCE RANGE
UNIT
mg/L
less than 3
*CRP is an acute phase reactant appeared in plasma during many infectious or inflammatory conditions CRP assay provides useful information for the diagnosis,therapy and monitoring of inflammatory processes
and associated diseases. Increase in CRP values are non specific and should not be interpreted without a complete clinical history.
Note : above test carried out by BN ProSpec Nephlometer Automated Analyzer .
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Asha Rawat Pt. Location: IPD/E/W Referred By: Dr. Sandeep Specimen: BLOOD PARAMETER RESULT Blood Sugar Random 105 Age/Sex: 28y/F MRN:SH/LKO/007649/09 Lab No.:B-/08/1552 Date: 22.8.2009 REFERENCE RANGE 70 - 140
UNIT mg/dl
(Method: - GOD-POD) (Normal 140mg/dl, Impaired glucose tolerance 140-199 mg/dl, Diabetes mellitus 200mg/dl
Serum Urea
Methodology- Urease- GLDH, Kinetic
56 0.9
mg/dl mg/dl
13 - 43 0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Asha Rawat Age/Sex: 28y/F Pt. Location: IPD/E/W MRN:SH/LKO/007649/09 Referred By: Dr. Sandeep Lab No.:B-/08/1552 Specimen: BLOOD Date: 22.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 0.52 Total Serum Bilirubin mg/dl 0.30 - 1.20
(Method: Walter And Gerarde)
0.20
mg/dl
0 - 0.20
0.32
mg/dl
0.08 - 0.75
44
IU/I
0 - 42
30
IU/I
0 - 42
105
IU/I
42 - 128
5.98
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Balwant Singh Pt. Location: IPD/C.T Step Referred By: Dr. Abhishek Specimen: BLOOD PARAMETER RESULT Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
UNIT mg/dl
Age/Sex: 30y/M MRN:SH/LKO/005726/09 Lab No.:B-/08/1569 Date: 22.8.2009 REFERENCE RANGE 0.70 - 1.30
0.62
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
134.0 4.9
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: B/O Subharda Pt. Location: IPD/PICU Referred By: Dr. M.U Hasan Specimen: BLOOD PARAMETER Total Serum Bilirubin
(Method: Walter And Gerarde)
Age/Sex: y/ MRN:SH/LKO/07784/09 Lab No.:B-/08/7784 Date: 22.8.2009 REFERENCE RANGE 0.30 - 1.20 0 - 0.20 0.08 - 0.75
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: B/O Kusum Pt. Location: IPD/PICU Referred By: Dr. M.U Hasan Specimen: BLOOD PARAMETER Total Serum Bilirubin
(Method: Walter And Gerarde)
Age/Sex: y/ MRN:SH/LKO/07634/09 Lab No.:B-/08/1573 Date: 22.8.2009 REFERENCE RANGE 0.30 - 1.20 0 - 0.20 0.08 - 0.75
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Ubaidur Rahman Pt. Location: IPD/SICU Referred By: Dr. V.K Tiwari Specimen: BLOOD PARAMETER RESULT Serum Urea
Methodology- Urease- GLDH, Kinetic
Age/Sex: 79y/M MRN:SH/LKO/03660/09 Lab No.:B-/08/1574 Date: 22.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30
198 4.38
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
24.7
IU/I
0 - 42
31.9
IU/I
0 - 42
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Ubaidur Rahman Pt. Location: IPD/SICU Referred By: Dr. V.K Tiwari Specimen: BLOOD PARAMETER RESULT Age/Sex: 79y/M MRN:SH/LKO/03660/09 Lab No.:B-/08/1574 Date: 22.8.2009 REFERENCE RANGE
UNIT
122.0 6.5
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Kiran Gupta Pt. Location: IPD/SICU Referred By: Dr. H.N Triphati Specimen: BLOOD PARAMETER RESULT Age/Sex: 55y/F MRN:SH/LKO/08075/09 Lab No.:B-/08/1577 Date: 22.8.2009 REFERENCE RANGE
UNIT
142.0 8.3
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Amit Kushwaha Pt. Location: IPD/G/W Referred By: Dr. H.N Triphati Specimen: BLOOD PARAMETER RESULT Total Serum Bilirubin
(Method: Walter And Gerarde)
Age/Sex: 24y/M MRN:SH/LKO/06223/09 Lab No.:B-/08/1579 Date: 22.8.2009 REFERENCE RANGE 0.30 - 1.20 0 - 0.20 0.08 - 0.75
774
IU/I
0 - 42
1634
IU/I
0 - 42
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Fakkruddin Pt. Location: IPD/E/W Referred By: Dr. M.Ahmed Specimen: BLOOD PARAMETER Blood Urea Nitrogen
Method Urease GLDH Kinetic
6 to 20
0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
138.0 6.9
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Amar Jeet Singh Pt. Location: IPD/E/W Referred By: Dr. Sandeep Kapoor Specimen: BLOOD PARAMETER RESULT Serum Urea
Methodology- Urease- GLDH, Kinetic
Age/Sex: 30y/M MRN:SH/LKO/08137/09 Lab No.:B-/08/1605 Date: 22.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30
31 0.78
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
136.0 4.90
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Fakkruddin Pt. Location: IPD/E/W Referred By: Dr. M.Ahmed Specimen: BLOOD PARAMETER
Serum IRON
RESULT
44.7
UNIT
g/dl
g/dl g/dl %
112 - 346
250 - 450 13 - 45
Iron is transported as Fe(111) bound to the plasma protein apotransferrin.Normally only about one third of the iron binding sites of transferrin are occupied by Fe(111).The additional amount of iron that can be bound is the unsaturated iron binding capacity (UIBC). The sum of the serum iron and UIBC represents TIBC.TIBC is a measurement for the maximum iron concentration that transferrin can bind. The serum TIBC varies in disorders of iron metabolism .In iron dediciency anemia the TIBC is elevated and the transferring saturation is lowered to 15% or less. Low serum iron associated with low TIBC is characteristic of the anemia of chronic disorders,malignant tumors,and infections. (Dr. Anju Shukla, MD) Associate Consultant
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Dinesh Bajpai Pt. Location: IPD/G/W Referred By: Specimen: BLOOD PARAMETER RESULT Age/Sex: 60y/M MRN:SH/LKO/07336/09 Lab No.:B-/08/1592 Date: 22.8.2009 REFERENCE RANGE
UNIT
Serum Sodium
124.0
mmol/l
135 - 145
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Ketki Devi Pt. Location: IPD/MICU Referred By: Dr.S.K.Somani Specimen: Blood PARAMETER Total Serum Bilirubin
(Method: Walter And Gerarde)
Age/Sex: 47/F MRN:SH/LKO/008004/09 Lab No.:B-/08/1593 Date: 22.8.2009 REFERENCE RANGE 0.30 - 1.20 0 - 0.20 0.08 - 0.75
207.7
IU/I
42 - 128
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Ketki Devi Pt. Location: IPD/MICU Referred By: Dr.S.K.Somani Specimen: Blood PARAMETER Age/Sex: 47/F MRN:SH/LKO/008004/09 Lab No.:B-/08/1606 Date: 22.8.2009 REFERENCE RANGE
RESULT
UNIT
150.0 2.80
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Vindhya Vashini Pt. Location: IPD/E/W Referred By: Dr.S.K.Somani Specimen: Blood PARAMETER RESULT Serum Amylase Serum Lipase Serum Urea
Methodology- Urease- GLDH, Kinetic
Age/Sex: 60/F MRN:SH/LKO/008139/09 Lab No.:B-/08/1595 Date: 22.8.2009 REFERENCE RANGE 28 - 100 13 - 60 13 - 43 0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
135.0 5.20
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Vindhya Vashini Age/Sex: 60/F Pt. Location: IPD/E/W MRN:SH/LKO/008139/09 Referred By: Dr.S.K.Somani Lab No.:B-/08/1595 Specimen: Blood Date: 22.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 0.53 Total Serum Bilirubin mg/dl 0.30 - 1.20
(Method: Walter And Gerarde)
0.17 0.36
mg/dl mg/dl
13.5
IU/I
0 - 42
27.6
IU/I
0 - 42
92
IU/I
42 - 128
7.61
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Bhanumati Age/Sex: 50/F Pt. Location: IPD/E/W MRN:SH/LKO/001439/09 Referred By: Dr. Nitin Joshi Lab No.:B-/08/1596 Specimen: Blood Date: 22.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 0.71 Total Serum Bilirubin mg/dl 0.30 - 1.20
(Method: Walter And Gerarde)
0.12 0.59
mg/dl mg/dl
17
IU/I
0 - 42
28
IU/I
0 - 42
107
IU/I
42 - 128
7.14
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Bhanumati Pt. Location: IPD/E/W Referred By: Dr. Nitin Joshi Specimen: Blood PARAMETER Serum Urea
Methodology- Urease- GLDH, Kinetic
RESULT 67 1.75
Age/Sex: 50/F MRN:SH/LKO/001439/09 Lab No.:B-/08/1596 Date: 22.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Serum Sodium
139.0
mmol/l
135 - 145
Serum Potassium
4.50
mmol/l
3.5 - 5.5
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mohd Rafeeq Pt. Location: IPD/G/W Referred By: Dr. R.K Mishra Specimen: Blood PARAMETER Serum Urea
Methodology- Urease- GLDH, Kinetic
Age/Sex: 65/M MRN:SH/LKO/008127/09 Lab No.:B-/08/1597 Date: 22.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Serum Sodium
138.0
mmol/l
135 - 145
Serum Potassium
6.0
mmol/l
3.5 - 5.5
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Mamta Lal Pt. Location: IPD/E/W Referred By: Dr. Alok Specimen: Blood PARAMETER D-Dimer (Quantitative) Age/Sex: 48/F MRN:SH/LKO/005094/09 Lab No.:B-/08/1600 Date: 22.8.2009 REFERENCE RANGE
RESULT 1.11
UNIT
D-Dimer measure cross linked FDP,is a very sensitive marker for the activation of coagulation.Apart from DVT,PE,and DIC,D-Dimer may reflect other causes associated with fibrin formation such as trauma, pregnancy complication, malignant disease or vascular abnormalities.Elevated D-Dimer levels therefore have to be interpreted in the context of possible underlying diseases and clinical symptoms.
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Raj Kumar Singh Pt. Location: OPD Referred By: Dr. Sandeep Kapoor Specimen: BLOOD Tr.NoPARAMETER RESULT Blood Sugar Fasting 104.0 Age/Sex: 64y/M MRN:SH/LKO/008116/09 Lab No.:B-/08/1583 Date: 22.8.2009 REFERENCE RANGE 70 - 110
UNIT mg/dl
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
234
mg/dl
70 - 140
Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Raj Kumar Singh Pt. Location: OPD Referred By: Dr. Sandeep Kapoor Specimen: BLOOD Tr.NoPARAMETER RESULT
LIPID PROFILE
Total Serum Cholesterol
124 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)
UNIT
Serum Triglycerides 79 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 40.3 mg/dl
(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)
67.9
mg/dl
15.8
mg/dl
10 to 40
3.07
mg/dl
Less 4.5
1.68
mg/dl
Less 3.0
Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Naresh Chandra Verma Pt. Location: OPD Referred By: Dr. S. K Somani Specimen: BLOOD Tr.NoPARAMETER RESULT Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
UNIT mg/dl
Age/Sex: 68y/M MRN:SH/LKO/008103/09 Lab No.:B-/08/1568 Date: 22.8.2009 REFERENCE RANGE 0.70 - 1.30
1.44
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
136.0 5.6
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Naresh Chandra Verma Age/Sex: 68y/M Pt. Location: OPD MRN:SH/LKO/008103/09 Referred By: Dr. S. K Somani Lab No.:B-/08/1568 Specimen: BLOOD Tr.NoDate: 22.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 0.54 Total Serum Bilirubin mg/dl 0.30 - 1.20
(Method: Walter And Gerarde)
0.20 0.34
mg/dl mg/dl
37
IU/I
0 - 42
31
IU/I
0 - 42
198
IU/I
42 - 128
7.66
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. R.K Agarwal Pt. Location: OPD Referred By: Dr. S. K. Singh Specimen: BLOOD Tr.NoPARAMETER RESULT Blood Sugar Fasting 92.0 Age/Sex: 70y/M MRN:SH/LKO/008097/09 Lab No.:B-/08/1567 Date: 22.8.2009 REFERENCE RANGE 70 - 110
UNIT mg/dl
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
13.59
mg/dl
6 to 20
15
IU/I
0 - 42
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
0.93
mg/dl
0.70 - 1.30
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. R.K Agarwal Pt. Location: OPD Referred By: Dr. S. K. Singh Specimen: BLOOD Tr.NoPARAMETER RESULT
LIPID PROFILE
Total Serum Cholesterol
152.6 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)
UNIT
Serum Triglycerides 103 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 41.3 mg/dl
(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)
90.6
mg/dl
20.61
mg/dl
10 to 40
3.69
mg/dl
Less 4.5
2.19
mg/dl
Less 3.0
Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Ragini Pt. Location: OPD Referred By: Dr. Himani Negi Specimen: BLOOD PARAMETER Blood Sugar Random Age/Sex: 27y/F MRN:SH/LKO/007467/09 Lab No.:B-/08/1566 Date: 22.8.2009 REFERENCE RANGE 70 - 140
(Method: - GOD-POD) (Normal 140mg/dl, Impaired glucose tolerance 140-199 mg/dl, Diabetes mellitus 200mg/dl According to Amercian diabetes association, 2004
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Jitender Kumar Agarwal Pt. Location: OPD Referred By: Dr. Sunil Kumar Verma Specimen: BLOOD Tr.No- 21515 PARAMETER RESULT UNIT Blood Sugar Fasting 133.0 mg/dl Age/Sex: 62y/M MRN:SH/LKO/008081/09 Lab No.:B-/08/1565 Date: 22.8.2009 REFERENCE RANGE 70 - 110
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
8.6 7.7% %
A 1C
(%)
* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods
*ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Rajender Prasad Pt. Location: OPD Referred By: M.H.C Specimen: BLOOD Tr.NoPARAMETER RESULT Blood Sugar Fasting 94 Age/Sex: 47y/M MRN:SH/LKO/008093/09 Lab No.:B-/08/1553 Date: 22.8.2009 UNIT REFERENCE RANGE mg/dl 70 - 110
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
106
mg/dl
70 - 140
Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004
6 to 20
0.70 - 1.30 8.4- 10.4
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Serum Calcium
(Method: arsenazo III)
Phosphorus
(Method: phosphomolybdate UV
2.5 - 4.5
6.21
mg/dl
2.5 6.8
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
1.18
mmol/l
1.12 1.32
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Rajender Prasad Age/Sex: 47y/M Pt. Location: OPD MRN:SH/LKO/008093/09 Referred By: M.H.C Lab No.:B-/08/1553 Specimen: BLOOD Tr.NoDate: 22.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 0.44 Total Serum Bilirubin mg/dl 0.30 - 1.20
(Method: Walter And Gerarde)
0.12 0.32
mg/dl mg/dl
24
IU/I
0 - 42
21
IU/I
0 - 42
100
IU/I
42 - 128
7.62
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Rajender Prasad Pt. Location: OPD Referred By: M.H.C Specimen: BLOOD Tr.NoPARAMETER RESULT
LIPID PROFILE
Total Serum Cholesterol
152.8 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)
UNIT
Serum Triglycerides 163.4 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 24 mg/dl
(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)
95.9
mg/dl
32.68
mg/dl
10 to 40
6.35
mg/dl
Less 4.5
3.95
mg/dl
Less 3.0
Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Rajender Prasad Pt. Location: OPD Referred By: M.H.C Specimen: BLOOD Tr.NoPARAMETER RESULT Age/Sex: 47y/M MRN:SH/LKO/008093/09 Lab No.:B-/08/1553 Date: 22.8.2009 REFERENCE RANGE
UNIT
8.6 6.0% %
A 1C
(%)
* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Rajender Prasad Pt. Location: OPD Referred By: M.H.C Specimen: BLOOD Tr.NoPARAMETER RESULT
ApolipoProtein Estimation Apolipoprotein A1 (Apo-A1)
(Method :Immunonephelometric assay) 76
UNIT
Apolipoprotein B (Apo-B)
(Method :Immunonephelometric assay)
91.7
apo-A1/apo-B Ratio
0.82
( Elevation of apo B (present in chylomicrons, VLDL, HDL and LDL), decrease in apo A-1 (present mostly in HDL), and decrease in the apo A -1/apo B ratio have been associated with increased risk of CHD)
Checked by..
Associate Consultant
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. R.P Karan Pt. Location: OPD Referred By: M.H.C Specimen: BLOOD PARAMETER Blood Sugar Fasting Age/Sex: 54y/M MRN:SH/LKO/008087/09 Lab No.:B-/08/1554 Date: 22.8.2009 REFERENCE RANGE 70 - 110
Tr.NoRESULT 96
UNIT mg/dl
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
107
mg/dl
70 - 140
Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004
6 to 20
0.70 - 1.30 8.4- 10.4
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Serum Calcium
(Method: arsenazo III)
Phosphorus
(Method: phosphomolybdate UV
2.5 - 4.5
4.68
mg/dl
2.5 6.8
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
1.2
mmol/l
1.12 1.32
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. R.P Karan Age/Sex: 54y/M Pt. Location: OPD MRN:SH/LKO/008087/09 Referred By: M.H.C Lab No.:B-/08/1554 Specimen: BLOOD Tr.NoDate: 22.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 0.36 Total Serum Bilirubin mg/dl 0.30 - 1.20
(Method: Walter And Gerarde)
0.10 0.26
mg/dl mg/dl
22
IU/I
0 - 42
21
IU/I
0 - 42
72
IU/I
42 - 128
7.50
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. R.P Karan Pt. Location: OPD Referred By: M.H.C Specimen: BLOOD PARAMETER
Total Serum Cholesterol
Tr.NoRESULT
103
UNIT
mg/dl
LIPID PROFILE
(Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl) Serum Triglycerides 113.9 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 28 mg/dl
(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)
52.7
mg/dl
22.78
mg/dl
10 to 40
3.72
mg/dl
Less 4.5
1.9
mg/dl
Less 3.0
Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. R.P Karan Pt. Location: OPD Referred By: M.H.C Specimen: BLOOD PARAMETER
ApolipoProtein Estimation Apolipoprotein A1 (Apo-A1)
(Method :Immunonephelometric assay) 107
Tr.NoRESULT
UNIT
Apolipoprotein B (Apo-B)
(Method :Immunonephelometric assay)
53.3
apo-A1/apo-B Ratio
( Elevation of apo B (present in chylomicrons, VLDL, HDL and LDL), decrease in apo A-1 (present mostly in HDL), and decrease in the apo A -1/apo B ratio have been associated with increased risk of CHD)
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. R.P Karan Pt. Location: OPD Referred By: M.H.C Specimen: BLOOD PARAMETER Age/Sex: 54y/M MRN:SH/LKO/008087/09 Lab No.:B-/08/1554 Date: 22.8.2009 REFERENCE RANGE
Tr.NoRESULT
UNIT
8.6 6.1% %
A 1C
(%)
* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications
Checked by..
Associate Consultant
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Shiv Veer Kureel Pt. Location: OPD Referred By: M.H.C Specimen: BLOOD Tr.NoPARAMETER RESULT Blood Sugar Fasting 102 Age/Sex: 49y/M MRN:SH/LKO/008088/09 Lab No.:B-/08/1555 Date: 22.8.2009 REFERENCE RANGE 70 - 110
UNIT mg/dl
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
121.7
mg/dl
70 - 140
Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004
6 to 20
0.70 - 1.30 8.4- 10.4
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Serum Calcium
(Method: arsenazo III)
Phosphorus
(Method: phosphomolybdate UV
2.5 - 4.5
7.03
mg/dl
2.5 6.8
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
1.18
mmol/l
1.12 1.32
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Shiv Veer Kureel Age/Sex: 49y/M Pt. Location: OPD MRN:SH/LKO/008088/09 Referred By: M.H.C Lab No.:B-/08/1555 Specimen: BLOOD Tr.NoDate: 22.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 1.36 Total Serum Bilirubin mg/dl 0.30 - 1.20
(Method: Walter And Gerarde)
0.30 1.06
mg/dl mg/dl
72.5
IU/I
0 - 42
44.4
IU/I
0 - 42
97.6
IU/I
42 - 128
7.47
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
4.0
g/dl
3.2 - 5.0
3.47 1.15
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Shiv Veer Kureel Pt. Location: OPD Referred By: M.H.C Specimen: BLOOD Tr.NoPARAMETER RESULT
LIPID PROFILE
Total Serum Cholesterol
180.9 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)
UNIT
Serum Triglycerides 181 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 35.3 mg/dl
(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)
109.4
mg/dl
36.24
mg/dl
10 to 40
5.12
mg/dl
Less 4.5
3.1
mg/dl
Less 3.0
Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National
Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Shiv Veer Kureel Pt. Location: OPD Referred By: M.H.C Specimen: BLOOD Tr.NoPARAMETER RESULT
ApolipoProtein Estimation Apolipoprotein A1 (Apo-A1)
(Method :Immunonephelometric assay) 120
UNIT
Apolipoprotein B (Apo-B)
(Method :Immunonephelometric assay)
102
apo-A1/apo-B Ratio
1.17
( Elevation of apo B (present in chylomicrons, VLDL, HDL and LDL), decrease in apo A-1 (present mostly in HDL), and decrease in the apo A -1/apo B ratio have been associated with increased risk of CHD)
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Shiv Veer Kureel Pt. Location: OPD Referred By: M.H.C Specimen: BLOOD Tr.NoPARAMETER RESULT Age/Sex: 49y/M MRN:SH/LKO/008088/09 Lab No.:B-/08/1555 Date: 22.8.2009 REFERENCE RANGE
UNIT
8.6 6.0% %
A 1C
(%)
* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Shiv Kishore Pt. Location: OPD Referred By: M.H.C Specimen: BLOOD Tr.NoPARAMETER RESULT Blood Sugar Fasting 95 Age/Sex: 44y/M MRN:SH/LKO/008089/09 Lab No.:B-/08/1556 Date: 22.8.2009 REFERENCE RANGE 70 - 110
UNIT mg/dl
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
129
mg/dl
70 - 140
Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004
6 to 20
0.70 - 1.30 8.4- 10.4
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Serum Calcium
(Method: arsenazo III)
Phosphorus
(Method: phosphomolybdate UV
2.5 - 4.5
4.87
mg/dl
2.5 6.8
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
1.16
mmol/l
1.12 1.32
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Shiv Kishore Age/Sex: 44y/M Pt. Location: OPD MRN:SH/LKO/008089/09 Referred By: M.H.C Lab No.:B-/08/1556 Specimen: BLOOD Tr.NoDate: 22.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 1.0 Total Serum Bilirubin mg/dl 0.30 - 1.20
(Method: Walter And Gerarde)
0.32 0.68
mg/dl mg/dl
28
IU/I
0 - 42
45
IU/I
0 - 42
105
IU/I
42 - 128
8.44
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Shiv Kishore Pt. Location: OPD Referred By: M.H.C Specimen: BLOOD Tr.NoPARAMETER RESULT
LIPID PROFILE
Total Serum Cholesterol
114 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)
UNIT
Serum Triglycerides 46.4 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 35 mg/dl
(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)
70.1
mg/dl
9.29
mg/dl
10 to 40
3.27
mg/dl
Less 4.5
mg/dl
Less 3.0
Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Shiv Kishore Pt. Location: OPD Referred By: M.H.C Specimen: BLOOD Tr.NoPARAMETER RESULT
ApolipoProtein Estimation Apolipoprotein A1 (Apo-A1)
(Method :Immunonephelometric assay) 96.9
UNIT
Apolipoprotein B (Apo-B)
(Method :Immunonephelometric assay)
48.3
apo-A1/apo-B Ratio
( Elevation of apo B (present in chylomicrons, VLDL, HDL and LDL), decrease in apo A-1 (present mostly in HDL), and decrease in the apo A -1/apo B ratio have been associated with increased risk of CHD)
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Shiv Kishore Pt. Location: OPD Referred By: M.H.C Specimen: BLOOD Tr.NoPARAMETER RESULT Age/Sex: 44y/M MRN:SH/LKO/008089/09 Lab No.:B-/08/1556 Date: 22.8.2009 REFERENCE RANGE
UNIT
8.6 6.5% %
A 1C
(%)
* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. M.P Mishra Pt. Location: OPD Referred By: M.H.C Specimen: BLOOD PARAMETER Blood Sugar Fasting Age/Sex: 43y/M MRN:SH/LKO/008090/09 Lab No.:B-/08/1557 Date: 22.8.2009 REFERENCE RANGE 70 - 110
Tr.NoRESULT 88
UNIT mg/dl
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
109
mg/dl
70 - 140
Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004
6 to 20
0.70 - 1.30 8.4- 10.4
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Serum Calcium
(Method: arsenazo III)
Phosphorus
(Method: phosphomolybdate UV
2.5 - 4.5
6.9
mg/dl
2.5 6.8
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
1.21
mmol/l
1.12 1.32
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. M.P Mishra Age/Sex: 43y/M Pt. Location: OPD MRN:SH/LKO/008090/09 Referred By: M.H.C Lab No.:B-/08/1557 Specimen: BLOOD Tr.NoDate: 22.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 0.43 Total Serum Bilirubin mg/dl 0.30 - 1.20
(Method: Walter And Gerarde)
0.13 0.30
mg/dl mg/dl
56
IU/I
0 - 42
36
IU/I
0 - 42
65
IU/I
42 - 128
7.12
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. M.P Mishra Pt. Location: OPD Referred By: M.H.C Specimen: BLOOD PARAMETER
Total Serum Cholesterol
Tr.NoRESULT
UNIT
LIPID PROFILE
229 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)
Serum Triglycerides 376 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 80 mg/dl
(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)
73.4
mg/dl
75.26
mg/dl
10 to 40
2.85
mg/dl
Less 4.5
0.92
mg/dl
Less 3.0
Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. M.P Mishra Pt. Location: OPD Referred By: M.H.C Specimen: BLOOD PARAMETER
ApolipoProtein Estimation Apolipoprotein A1 (Apo-A1)
(Method :Immunonephelometric assay) 217
Tr.NoRESULT
UNIT
Apolipoprotein B (Apo-B)
(Method :Immunonephelometric assay)
83.6
apo-A1/apo-B Ratio
2.59
( Elevation of apo B (present in chylomicrons, VLDL, HDL and LDL), decrease in apo A-1 (present mostly in HDL), and decrease in the apo A -1/apo B ratio have been associated with increased risk of CHD)
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. M.P Mishra Pt. Location: OPD Referred By: M.H.C Specimen: BLOOD PARAMETER Age/Sex: 43y/M MRN:SH/LKO/008090/09 Lab No.:B-/08/1557 Date: 22.8.2009 REFERENCE RANGE
Tr.NoRESULT
UNIT
8.6 5.5% %
A 1C
(%)
* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Ashutosh Pandey Pt. Location: OPD Referred By: M.H.C Specimen: BLOOD Tr.NoPARAMETER RESULT Blood Sugar Fasting 80 Age/Sex: 16y/M MRN:SH/LKO/008079/09 Lab No.:B-/08/1558 Date: 22.8.2009 REFERENCE RANGE 70 - 110
UNIT mg/dl
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl According to Amercian diabetes association, 2004
10.47
mg/dl
6 to 20
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
0.91
mg/dl
0.70 - 1.30
Serum Calcium
(Method: arsenazo III)
9.38
mg/dl
8.4- 10.4
Phosphorus
(Method: phosphomolybdate UV
3.78
mg/dl
2.5 - 4.5
2.5 6.8
5.51
mg/dl
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
1.24
mmol/l
1.12 1.32
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Ashutosh Pandey Age/Sex: 16y/M Pt. Location: OPD MRN:SH/LKO/008079/09 Referred By: M.H.C Lab No.:B-/08/1558 Specimen: BLOOD Tr.NoDate: 22.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 0.55 Total Serum Bilirubin mg/dl 0.30 - 1.20
(Method: Walter And Gerarde)
0.15 0.40
mg/dl mg/dl
11
IU/I
0 - 42
20
IU/I
0 - 42
178
IU/I
42 - 128
8.12
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Ashutosh Pandey Pt. Location: OPD Referred By: M.H.C Specimen: BLOOD Tr.NoPARAMETER RESULT
LIPID PROFILE
Total Serum Cholesterol
107 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)
UNIT
Serum Triglycerides 82.8 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 26 mg/dl
(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)
64.8
mg/dl
16.57
mg/dl
10 to 40
4.11
mg/dl
Less 4.5
2.49
mg/dl
Less 3.0
Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Ashutosh Pandey Pt. Location: OPD Referred By: M.H.C Specimen: BLOOD Tr.NoPARAMETER RESULT
ApolipoProtein Estimation Apolipoprotein A1 (Apo-A1)
(Method :Immunonephelometric assay) 82
UNIT
Apolipoprotein B (Apo-B)
(Method :Immunonephelometric assay)
53
apo-A1/apo-B Ratio
1.54
( Elevation of apo B (present in chylomicrons, VLDL, HDL and LDL), decrease in apo A-1 (present mostly in HDL), and decrease in the apo A -1/apo B ratio have been associated with increased risk of CHD)
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Ashutosh Pandey Pt. Location: OPD Referred By: M.H.C Specimen: BLOOD Tr.NoPARAMETER RESULT Age/Sex: 16y/M MRN:SH/LKO/008079/09 Lab No.:B-/08/1558 Date: 22.8.2009 REFERENCE RANGE
UNIT
8.6 5.6% %
A 1C
(%)
* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Pramila Pandey Pt. Location: OPD Referred By: M.H.C Specimen: BLOOD Tr.NoPARAMETER RESULT Blood Sugar Fasting 85 Age/Sex: 42y/F MRN:SH/LKO/008080/09 Lab No.:B-/08/1559 Date: 22.8.2009 REFERENCE RANGE 70 - 110
UNIT mg/dl
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl According to Amercian diabetes association, 2004
9.67
mg/dl
6 to 20
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
0.67
mg/dl
0.70 - 1.30
Serum Calcium
(Method: arsenazo III)
9.1
mg/dl
8.4- 10.4
Phosphorus
(Method: phosphomolybdate UV
3.14
mg/dl
2.5 - 4.5
2.5 6.8
5.24
mg/dl
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
1.2
mmol/l
1.12 1.32
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Pramila Pandey Age/Sex: 42y/F Pt. Location: OPD MRN:SH/LKO/008080/09 Referred By: M.H.C Lab No.:B-/08/1559 Specimen: BLOOD Tr.NoDate: 22.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 0.63 Total Serum Bilirubin mg/dl 0.30 - 1.20
(Method: Walter And Gerarde)
0.16 0.47
mg/dl mg/dl
10
IU/I
0 - 42
16
IU/I
0 - 42
98
IU/I
42 - 128
8.23
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Pramila Pandey Pt. Location: OPD Referred By: M.H.C Specimen: BLOOD Tr.NoPARAMETER RESULT
LIPID PROFILE
Total Serum Cholesterol
188.8 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)
UNIT
Serum Triglycerides 106.9 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 32.2 mg/dl
(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)
135.2
mg/dl
21.38
mg/dl
10 to 40
5.86
mg/dl
Less 4.5
4.2
mg/dl
Less 3.0
Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Pramila Pandey Pt. Location: OPD Referred By: M.H.C Specimen: BLOOD Tr.NoPARAMETER RESULT
ApolipoProtein Estimation Apolipoprotein A1 (Apo-A1)
(Method :Immunonephelometric assay) 111
UNIT
Apolipoprotein B (Apo-B)
(Method :Immunonephelometric assay)
102
apo-A1/apo-B Ratio
1.08
( Elevation of apo B (present in chylomicrons, VLDL, HDL and LDL), decrease in apo A-1 (present mostly in HDL), and decrease in the apo A -1/apo B ratio have been associated with increased risk of CHD)
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Pramila Pandey Pt. Location: OPD Referred By: M.H.C Specimen: BLOOD Tr.NoPARAMETER RESULT Age/Sex: 42y/F MRN:SH/LKO/008080/09 Lab No.:B-/08/1559 Date: 22.8.2009 REFERENCE RANGE
UNIT
8.6 5.7% %
A 1C
(%)
* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications
Checked by..
SAHARA HOSPITAL
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Ahmed Khan Pt. Location: IPD/E/W Referred By: Dr. S. Agarwal Specimen: Blood PARAMETER RESULT Blood Sugar Random 79 Age/Sex: 14/M MRN:SH/LKO/008141/09 Lab No.:B-/08/1602 Date: 22.8.2009 REFERENCE RANGE 70 - 140
UNIT mg/dl
(Method: - GOD-POD) (Normal 140mg/dl, Impaired glucose tolerance 140-199 mg/dl, Diabetes mellitus 200mg/dl According to Amercian diabetes association, 2004
Checked by..
SAHARA HOSPITAL
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Ahmed Khan Age/Sex: 14/M Pt. Location: IPD/E/W MRN:SH/LKO/008141/09 Referred By: Dr. S. Agarwal Lab No.:B-/08/1602 Specimen: Blood Date: 22.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 0.55 Total Serum Bilirubin mg/dl 0.30 - 1.20
(Method: Walter And Gerarde)
0.20 0.35
mg/dl mg/dl
106
IU/I
0 - 42
212
IU/I
0 - 42
195
IU/I
42 - 128
6.10
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..
SAHARA HOSPITAL
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Shiv Murti Pt. Location: IPD/G/W Referred By: Dr. V.K Tiwari Specimen: Blood PARAMETER Blood Sugar Random Age/Sex: 65/M MRN:SH/LKO/001384/09 Lab No.:B-/08/1603 Date: 22.8.2009 REFERENCE RANGE 70 - 140
RESULT 127
UNIT mg/dl
(Method: - GOD-POD) (Normal 140mg/dl, Impaired glucose tolerance 140-199 mg/dl, Diabetes mellitus 200mg/dl According to Amercian diabetes association, 2004
Serum Urea
Methodology- Urease- GLDH, Kinetic
44 1.23
mg/dl mg/dl
13 - 43 0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
118.0 4.40
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Shiv Balak Singh Pt. Location: IPD/G/W Referred By: Dr. Alok Specimen: Blood PARAMETER RESULT Serum Urea
Methodology- Urease- GLDH, Kinetic
Age/Sex: 66/M MRN:SH/LKO/008138/09 Lab No.:B-/08/1604 Date: 22.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30
66 1.39
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
132.0 5.70
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Shiv Balak Singh Pt. Location: IPD/G/W Referred By: Dr. Alok Specimen: Blood PARAMETER RESULT Age/Sex: 66/M MRN:SH/LKO/008138/09 Lab No.:B-/08/1604 Date: 22.8.2009 REFERENCE RANGE
UNIT
12
IU/I
0 - 42
48
IU/I
0 - 42
356
IU/I
42 - 128
6.88
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..
SAHARA HOSPITAL
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Shiv Balak Singh Pt. Location: IPD/G/W Referred By: Dr. Alok Specimen: Blood PARAMETER RESULT Age/Sex: 66/M MRN:SH/LKO/008138/09 Lab No.:B-/08/1604 Date: 22.8.2009 REFERENCE RANGE
UNIT
8.6 10.4% %
A 1C
(%)
* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications
Checked by..
SAHARA HOSPITAL
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Prahalad Rai Pt. Location: IPD/E/W Referred By: Dr. M.Ahmed Specimen: Blood PARAMETER RESULT Blood Urea Nitrogen
Method Urease GLDH Kinetic
UNIT mg/dl
39.04
6 to 20
0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
4.4
mg/dl
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Prahalad Rai Age/Sex: 70/M Pt. Location: IPD/E/W MRN:SH/LKO/001386/09 Referred By: Dr. M.Ahmed Lab No.:B-/08/1607 Specimen: Blood Date: 22.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 0.98 Total Serum Bilirubin mg/dl 0.30 - 1.20
(Method: Walter And Gerarde)
0.47 0.51
mg/dl mg/dl
50.7
IU/I
0 - 42
110.1
IU/I
0 - 42
60.9
IU/I
42 - 128
6.48
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Prahalad Rai Pt. Location: IPD/E/W Referred By: Dr. M.Ahmed Specimen: Blood PARAMETER RESULT
Serum IRON 30.8
UNIT
g/dl
g/dl g/dl %
112 - 346
250 - 450 13 - 45
Iron is transported as Fe(111) bound to the plasma protein apotransferrin.Normally only about one third of the iron binding sites of transferrin are occupied by Fe(111).The additional amount of iron that can be bound is the unsaturated iron binding capacity (UIBC). The sum of the serum iron and UIBC represents TIBC.TIBC is a measurement for the maximum iron concentration that transferrin can bind. The serum TIBC varies in disorders of iron metabolism .In iron dediciency anemia the TIBC is elevated and the transferring saturation is lowered to 15% or less. Low serum iron associated with low TIBC is characteristic of the anemia of chronic disorders,malignant tumors,and infections. (Dr. Anju Shukla, MD) Associate Consultant
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Hon'ble Mata Ji (Smt.Chhabi Roy) Pt. Location: OPD Referred By: Dr.H.P.Kumar, MD Specimen: Blood
PARAMETER RESULT 0.76 0.23 0.53 UNIT mg/dl mg/dl mg/dl
15.1
IU/I
0 - 41
27.8
IU/I
0 - 40
142.7
IU/I
40 - 129
7.77
g/dl
6.6 - 8.7
Serum Albumin
(Method: Bromo Cresol Green BCG))
g/dl
3.97 - 4.95
NOTE : Above test carried out by Cobas Integra 400 plus automated biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Hon'ble Mata Ji (Smt.Chhabi Roy) Pt. Location: OPD Referred By: Dr.H.P.Kumar, MD Specimen: Blood
PARAMETER RESULT LIPID PROFILE UNIT
174.6 mg/dl (Method-CHOD-PAP) (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)
Serum Triglycerides 92.3 mg/dl (Method-GPO-PAP) (Desirabl <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : (Low <40 mg/dl ;High 60 mg/dl) 69.1 mg/dl
18.46
mg/dl
10 to 40
2.53
mg/dl
Less 4.5
1.56
mg/dl
Less 3.0
Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Hon'ble Mata Ji (Smt.Chhabi Roy) Pt. Location: OPD Referred By: Dr.H.P.Kumar, MD Specimen: Blood
PARAMETER RESULT UNIT
192
mg/dl
70 - 110
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl According to Amercian diabetes association, 2004
Serum Urea
Methodology- Urease- GLDH, Kinetic
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Serum Calcium
(Method: arsenazo III)
Phosphorus
(Method: phosphomolybdate UV
2.5 - 4.5
2.5 6.8
8.44
mg/dl
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
mmol/l mmol/l
mmol/l
1.12 1.32
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Hon'ble Mata Ji (Smt.Chhabi Roy) Pt. Location: OPD Referred By: Dr.H.P.Kumar, MD Specimen: Blood
PARAMETER RESULT UNIT
7.6%
A 1C
(%)
* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Hon'ble Mata Ji (Smt.Chhabi Roy) Age/Sex: 80Y/F
15.1
IU/I
0 - 41
27.8
IU/I
0 - 40
142.7
IU/I
40 - 129
7.77
g/dl
6.6 - 8.7
Serum Albumin
(Method: Bromo Cresol Green BCG))
g/dl
3.97 - 4.95
NOTE : Above test carried out by Cobas Integra 400 plus automated biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Hon'ble Mata Ji (Smt.Chhabi Roy) Age/Sex: 80Y/F
mg/dl
(Method-CHOD-PAP) (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl) Serum Triglycerides 92.3 mg/dl (Method-GPO-PAP) (Desirabl <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : (Low <40 mg/dl ;High 60 mg/dl) 69.1 mg/dl
18.46
mg/dl
10 to 40
2.53
mg/dl
Less 4.5
1.56
mg/dl
Less 3.0
Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Hon'ble Mata Ji (Smt.Chhabi Roy) Age/Sex: 80Y/F
192
mg/dl
70 - 110
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl According to Amercian diabetes association, 2004
Serum Urea
Methodology- Urease- GLDH, Kinetic
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Serum Calcium
(Method: arsenazo III)
Phosphorus
(Method: phosphomolybdate UV
2.5 - 4.5
2.5 6.8
8.44
mg/dl
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
mmol/l mmol/l
mmol/l
1.12 1.32
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Hon'ble Mata Ji (Smt.Chhabi Roy) Pt. Location: OPD Referred By: Dr.H.P.Kumar, MD Specimen: Blood
PARAMETER RESULT UNIT
7.6%
A 1C
(%)
* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.S.U.Siddiqui Age/Sex: 63Y/M
204.0
mg/dl
70 - 110
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
230
mg/dl
70 - 140
Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
1.21
mg/dl
0.70 - 1.30
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
138.0 4.60
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.S.U.Siddiqui Pt. Location: OPD Age/Sex: 63Y/M MRN:7992
Dr.M.Husain Blood
RESULT UNIT
22.8
IU/I
0 - 42
23.2
IU/I
0 - 42
38.5
IU/I
42 - 128
7.4
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs.Sushma Agarwal Pt. Location: MHC Age/Sex: 54Y/F MRN: 0
SELF Blood
RESULT UNIT
101
mg/dl
70 - 110
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl According to Amercian diabetes association, 2004
Serum Urea
Methodology- Urease- GLDH, Kinetic
43
mg/dl
13 - 43
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
1.0
mg/dl
0.70 - 1.30
7.3
mg/dl U/I
2.5 6.8
135 - 225
Serum LDH
Method: DGKC IFCC
187
CK-MB
Method- Immunoinhibition
12.2 68.6
U/L U/L
0-25 38 - 174
CPK
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs.Sushma Agarwal Pt. Location: MHC Age/Sex: 54Y/F MRN: 0
SELF Blood
RESULT UNIT
36
IU/I
0 - 42
33
IU/I
0 - 42
77
IU/I
42 - 128
8.45
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs.Sushma Agarwal Pt. Location: MHC Age/Sex: 54Y/F MRN: 0
SELF Blood
RESULT LIPID PROFILE UNIT
245 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)
Serum Triglycerides 93.8 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 51.8 mg/dl
(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)
174.9
mg/dl
18.75
mg/dl
10 to 40
4.74
mg/dl
Less 4.5
3.38
mg/dl
Less 3.0
Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Ram Devan Yadav Age/Sex: 75y/M
RESULT
UNIT
9299.6
*MINIMAL proteinuria (<1.0g/day) present in postural proteinuria and transient proteinuria.It is also
seen with inactive phase of glomerular disease ,nephrosclerosis,chronic interstitial nephritis,congenital diseases such as polycystic disease and medullary cystic disease ,and renal tubular diseases. *Moderate proteinuria (1.0-4.0 g/day) found in vast majority of renal diseases ,as well as nephrosclerosis,multiple myeloma,toxic nephropathies along with degenerative,malignant and inflammatory conditions of lower urinary tract. *Heavy proteinuria(>4 g/day) characteristically seen with the nephritic syndrome.
URINARY CREATININE(24 Hrs) Urinary Creatinine (24 Hrs) 417.3 mg/day M :- 1000-2000 mg/day F :- 800-1800 mg/day
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Shiv Balak Singh Age/Sex: 66/M
Pt. Location: IPD/G/W Referred By: Dr. Alok Specimen: Pleural Fluid PARAMETER
Pleural fluid Protein Pleural fluid Glucose Pleural fluid lactate dehydrogenase(LDH)
RESULT
4.53 162
UNIT
g/dl mg/dl
1465
U/L
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Ram Dularey Verma Age/Sex: 70y/M
Pt. Location: IPD/E.W Referred By: Dr.Puneet Gupta Specimen: BLOOD PARAMETER Serum Urea
Methodology- Urease- GLDH, Kinetic
MRN:SH/LKO/008142/09 Lab No.:B-/08/1601 Date: 22.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30 28 - 100 13 - 60 1.7 - 2.5 8.4- 10.4
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Ram Dularey Verma Age/Sex: 70y/M
Pt. Location: IPD/E.W MRN:SH/LKO/008142/09 Referred By: Dr.Puneet Gupta Lab No.:B-/08/1601 Specimen: BLOOD Date: 22.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 0.10 Total Serum Bilirubin mg/dl 0.30 - 1.20
(Method: Walter And Gerarde)
0.50 0.60
mg/dl mg/dl
32
IU/I
0 - 42
72
IU/I
0 - 42
61
IU/I
42 - 128
6.25
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Mohd Shadab Age/Sex: 6y/M
Pt. Location: IPD/SICU Referred By: Dr.Mazhar Husain Specimen: BLOOD PARAMETER RESULT Blood Sugar Random 467
UNIT mg/dl
(Method: - GOD-POD) (Normal 140mg/dl, Impaired glucose tolerance 140-199 mg/dl, Diabetes mellitus 200mg/dl According to Amercian diabetes association, 2004
Serum Urea
Methodology- Urease- GLDH, Kinetic
452.9 3.31
mg/dl mg/dl
13 - 43 0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
188.0 4.9
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Mohd Shadab Age/Sex: 6y/M
Pt. Location: IPD/SICU MRN:SH/LKO/008142/09 Referred By: Dr.Mazhar Husain Lab No.:B-/08/1613 Specimen: BLOOD Date: 22.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 0.23 Total Serum Bilirubin mg/dl 0.30 - 1.20
(Method: Walter And Gerarde)
0.07 0.16
mg/dl mg/dl
240.5
IU/I
0 - 42
454
IU/I
0 - 42
223.2
IU/I
42 - 128
8.01
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.R.K.Bajpai Age/Sex: 63y/M
Pt. Location: IPD/E.W Referred By: Dr.Abhishek Specimen: BLOOD PARAMETER Serum Urea
Methodology- Urease- GLDH, Kinetic
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
132.0 3.9
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.R.K.Bajpai Pt. Location: IPD/E.W Age/Sex: 63y/M MRN:SH/LKO/008144/09
Referred By: Dr.Abhishek Lab No.:B-/08/1614 Specimen: BLOOD Date: 23.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 0.53 Total Serum Bilirubin mg/dl 0.30 - 1.20
(Method: Walter And Gerarde)
0.13 0.40
mg/dl mg/dl
29.2
IU/I
0 - 42
27.3
IU/I
0 - 42
77.6
IU/I
42 - 128
7.55
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Malti Devi Pt. Location: IPD/CCU Age/Sex: 57y/F MRN:SH/LKO/007664/09
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Vishi Devi Pt. Location: IPD/ M.I.C.U Age/Sex: 50y/F MRN:SH/LKO/007639/08/09
RESULT
UNIT
143.0 3.5
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Ashish Mitra Pt. Location: IPD/MICU Age/Sex: 38y/M MRN:SH/LKO/007836/08/09
Referred By: Dr.Mazhar Husain Specimen: BLOOD PARAMETER RESULT Serum Urea
Methodology- Urease- GLDH, Kinetic
107.9 2.54
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
147.0 3.7
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Ketki Devi Pt. Location: IPD/NICU Age/Sex: 47/F MRN:SH/LKO/008004/09
RESULT
UNIT
151.0 5.9
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail:saharahospitals.com
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mast Ankit Age/Sex: 15y/M
RESULT
UNIT
137.0 3.8
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Hari Shanker Shukla Pt. Location: IPD/MICU Age/Sex: 70y/M MRN:SH/LKO/007921/08/09
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
140.0 3.6
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.A.N.Shukla Age/Sex: 62y/M
RESULT
UNIT
132.0 4.5
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Sunita Malhotra Pt. Location: IPD/ MICU Age/Sex: 51y/F MRN:SH/LKO/007253/08/09
Referred By: Dr. S.K Somani Specimen: BLOOD PARAMETER Blood Urea Nitrogen
Method Urease GLDH Kinetic
6 to 20
0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
150.0 3.8
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Saraswati Devi Pt. Location: IPD/MICU Age/Sex:70/F MRN:SH/LKO/008042/09
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
139.0 2.7
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Kamlesh Kumari Pt. Location: IPD/ MICU Age/Sex: 35y/F MRN:SH/LKO/007860/08/09
RESULT
UNIT
135.0 3.5
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Jamila Begam Pt. Location: IPD/N.ICU Age/Sex: 80y/F MRN:SH/LKO/007772/08/09
Referred By: Dr.Mazhar Husain Specimen: BLOOD PARAMETER RESULT Blood Urea Nitrogen
Method Urease GLDH Kinetic
UNIT mg/dl
41.7
6 to 20
0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
1.64
mg/dl
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
150.0 3.0
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Sushma Pandey Pt. Location: IPD/SICU Age/Sex: 41y/F MRN:SH/LKO/007236/08/09
Referred By: Dr.Swadesh Singh Specimen: BLOOD PARAMETER RESULT Serum Albumin
(Method: Bromo Cresol Green BCG))
UNIT g/dl
2.2
Serum Urea
Methodology- Urease- GLDH, Kinetic
43.2 1.21
mg/dl mg/dl
13 - 43 0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Mohad Farooq Pt. Location: IPD/S.ICU Age/Sex: 55y/M MRN:SH/LKO/007979/09
Referred By: Dr. Mufazal Ahmad Specimen: BLOOD PARAMETER RESULT Blood Urea Nitrogen
Method Urease GLDH Kinetic
UNIT mg/dl
144.7
6 to 20
0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
10.96
mg/dl
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
128.0 5.5
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Mohad Farooq Pt. Location: IPD/S.ICU Age/Sex: 55y/M MRN:SH/LKO/007979/09
UNIT
8.6 6.7% %
A 1C
(%)
* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Shakuntla Pt. Location: IPD/SICU Age/Sex: 85y/F MRN:SH/LKO/007538/08/09
Referred By: Dr.Mufazal Ahmad Specimen: BLOOD PARAMETER RESULT Serum Urea
Methodology- Urease- GLDH, Kinetic
67.4 1.43
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
130.0 3.6
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Kiran Gupta Pt. Location: IPD/SICU Age/Sex: 55y/F MRN:SH/LKO/008075/08/09
RESULT
UNIT
139.0 5.5
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Ubaidur Rahman Pt. Location: IPD/SICU Age/Sex: 79y/M MRN:SH/LKO/03660/09
RESULT
UNIT
119.0 5.5
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Jagdish Pandey Pt. Location: IPD/SICU Age/Sex: 72y/M MRN:SH/LKO/007761/09
UNIT
133.0 3.0
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
40.95
mg/dl
6 to 20
0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
4.42
mg/dl
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Malti Srivastava Pt. Location: IPD/Ct.step Age/Sex: 59y/F MRN:SH/LKO/004852/09
Referred By: Dr.Mazhar Husain Specimen: BLOOD PARAMETER RESULT Blood Sugar Fasting 75.7
UNIT mg/dl
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
88
mg/dl
70 - 140
Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail:saharahospitals.com
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Abhinandan Swaroop Pt. Location: IPD/Ct.step Age/Sex: 67y/M MRN:SH/LKO/007651/09
Referred By: Dr.Mazhar Husain Specimen: Blood PARAMETER RESULT Blood Urea Nitrogen
Method Urease GLDH Kinetic
44.94 96 1.69
6 to 20
13 - 43 0.70 - 1.30
Serum Urea
Methodology- Urease- GLDH, Kinetic
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
139.0 2.6
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs Kamla Kapoor Pt. Location: IPD/T.Icu Referred By: Dr. H.N.Tripathi Age/Sex: 72y/F MRN:SH/LKO/007647/09 Lab No.:B-/08/1637
RESULT
UNIT
132.0 3.8
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Fakkruddin Pt. Location: IPD/E/W Referred By: Dr. Mufazal Ahmad Age/Sex: 72y/M MRN:SH/LKO/07589/09 Lab No.:B-/08/1638
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Bharat Lal Pt. Location: IPD/G/W Referred By: Dr. H.N Triphati Age/Sex: 51/M MRN:SH/LKO/006354/08/09 Lab No.:B-/08/1639
6 to 20
0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
125.0 4.6
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Avadesh Narain Pt. Location: IPD/SICU Referred By: Dr.Mufazal Ahmad Age/Sex: 56y/M MRN:SH/LKO/007658/08/09 Lab No.:B-/08/1640
6 to 20
0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
135.0 4.0
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mohd Rafeeq Pt. Location: IPD/G/W Referred By: Dr. R.K Mishra Age/Sex: 65/M MRN:SH/LKO/008127/09 Lab No.:B-/08/1641
RESULT 81.0
UNIT mg/dl
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail:saharahospitals.com
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Asha Rawat Pt. Location: IPD/E.W Referred By: Dr.Sandeep Age/Sex: 28y/F MRN:SH/LKO/007649/09 Lab No.:B-/08/1643
RESULT 8.95
UNIT mg/dl
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
142.0 4.10
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Anoop Bansal Pt. Location: IPD/ G/W Referred By: Dr.Sunil Dabadghao Specimen: BLOOD Age/Sex: 43y/M MRN:SH/LKO/008002/08/09 Lab No.:B-/08/1644 Date: 23.8.2009
RESULT
11.64
Serum Urea
Methodology- Urease- GLDH, Kinetic
93 4.45
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
136.0 4.2
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Kunwar Chand Pt. Location: IPD/ G/W Referred By: Dr.V.K.Tiwari Specimen: BLOOD PARAMETER RESULT Age/Sex: 57y/M MRN:SH/LKO/001428/08/09 Lab No.:B-/08/1645 Date: 23.8.2009 REFERENCE RANGE
UNIT
Serum Urea
Methodology- Urease- GLDH, Kinetic
23 1.0
mg/dl mg/dl
13 - 43 0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
134.0 4.10
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Bhanu Mati Verma Pt. Location: IPD/ E/W Referred By: Dr.Nitin Joshi Specimen: BLOOD PARAMETER RESULT Age/Sex: 58y/F MRN:SH/LKO/001439/08/09 Lab No.:B-/08/1646 Date: 23.8.2009 REFERENCE RANGE
UNIT
Serum Urea
Methodology- Urease- GLDH, Kinetic
40 1.1
mg/dl mg/dl
13 - 43 0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
140.0 3.6
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Shyama Kumari Pt. Location: IPD/ G/W Referred By: Dr.Sandeep Agarwal Specimen: BLOOD PARAMETER RESULT Age/Sex: 60y/F MRN:SH/LKO/008146/08/09 Lab No.:B-/08/1647 Date: 23.8.2009 REFERENCE RANGE
UNIT
Serum Urea
Methodology- Urease- GLDH, Kinetic
49 1.0
mg/dl mg/dl
13 - 43 0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Shyama Kumari Pt. Location: IPD/ G/W Referred By: Dr.Sandeep Agarwal Specimen: BLOOD PARAMETER RESULT UNIT LIVER FUNCTION TEST Age/Sex: 60y/F MRN:SH/LKO/008146/08/09 Lab No.:B-/08/1647 Date: 23.8.2009 REFERENCE RANGE
25
IU/I
0 - 42
23
IU/I
0 - 42
66
IU/I
42 - 128
7.40
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Sunita Malhotra Pt. Location: IPD/ MICU Referred By: Dr. S.K Somani Specimen: BLOOD PARAMETER RESULT Age/Sex: 51y/F MRN:SH/LKO/007253/08/09 Lab No.:B-/08/1648 Date: 23.8.2009 REFERENCE RANGE
UNIT
Serum Calcium
(Method: arsenazo III)
8.1
mg/dl
8.4- 10.4
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
1.08
mmol/l
1.12 1.32
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail:saharahospitals.com
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Dinesh Bajpai Pt. Location: IPD/G.W Referred By: Dr.Swadesh Singh Specimen: Blood PARAMETER RESULT Age/Sex: 65y/M MRN:SH/LKO/007336/09 Lab No.:B-/08/1649 Date: 23.8.2009 REFERENCE RANGE
UNIT
Serum Sodium
133.0
mmol/l
135 - 145
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Mohd Shadab Pt. Location: IPD/SICU Referred By: Dr.Mazhar Husain Specimen: BLOOD PARAMETER RESULT Serum Urea 333 Age/Sex: 6y/M MRN:SH/LKO/008142/09 Lab No.:B-/08/1651 Date: 23.8.2009 REFERENCE RANGE 13 - 43
UNIT mg/dl
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
1.84
mg/dl
0.70 - 1.30
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
172.0 4.1
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.C.L.Jaiswal Pt. Location: IPD/E.W Referred By: Dr.H.N.Tripathi Specimen: BLOOD PARAMETER Total Serum Bilirubin Age/Sex: 57y/M MRN:SH/LKO/0088145/09 Lab No.:B-/08/1652 Date: 23.8.2009 REFERENCE RANGE 0.30 - 1.20
RESULT 5.48
UNIT mg/dl
4.52 0.97
mg/dl mg/dl
14
IU/I
0 - 42
15
IU/I
0 - 42
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Shaheeda Raza Pt. Location: IPD/G.W Referred By: Dr.V.K.Tiwari Specimen: BLOOD PARAMETER RESULT Blood Sugar Random 104 Age/Sex: 40y/F MRN:SH/LKO/006819/09 Lab No.:B-/08/1657 Date: 23.8.2009 REFERENCE RANGE 70 - 140
UNIT mg/dl
(Method: - GOD-POD) (Normal 140mg/dl, Impaired glucose tolerance 140-199 mg/dl, Diabetes mellitus 200mg/dl According to Amercian diabetes association, 2004
Serum Urea
Methodology- Urease- GLDH, Kinetic
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
CK-MB
Method- Immunoinhibition
CPK
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
TROPONIN T (Qualitative
NEGATIVE
A positive result means that the concentration of troponin T in the sample is above the tests threshold value of 0.1ng/ml .This is evidence of cell damage to the myocardium. *Test performed by Troponin T Rapid test from Roche Diagnostics GmbH.
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Sunita Malhotra Pt. Location: IPD/ MICU Referred By: Dr. S.K Somani Specimen: BLOOD PARAMETER RESULT Age/Sex: 51y/F MRN:SH/LKO/007253/08/09 Lab No.:B-/08/11659 Date: 23.8.2009 UNIT REFERENCE RANGE
Ammonia
(Method: Enzymatic)
83.3
mol/l
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Prahalad Rai Pt. Location: IPD/MICU Referred By: Dr. Mufazal Ahmad Specimen: Blood PARAMETER RESULT Serum Urea 99
Methodology- Urease- GLDH, Kinetic
Age/Sex: 70/M MRN:SH/LKO/001386/09 Lab No.:B-/08/1660 Date: 23.8.2009 UNIT REFERENCE RANGE mg/dl 13 - 43
46.3 4.75
mg/dl mg/dl
6 to 20
0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
137.0 4.6
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Chanchal Singh Pt. Location: IPD/N.ICU Referred By: Dr. Mazhar Husain Specimen: Blood PARAMETER RESULT Serum Urea 21.5 Age/Sex: 25/M MRN:SH/LKO/005975/09 Lab No.:B-/08/1661 Date: 23.8.2009 REFERENCE RANGE 13 - 43
UNIT mg/dl
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
0.7
mg/dl
0.70 - 1.30
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
142.0 3.9
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Chanchal Singh Age/Sex: 25/M Pt. Location: IPD/N.ICU MRN:SH/LKO/005975/09 Referred By: Dr. Mazhar Husain Lab No.:B-/08/1661 Specimen: Blood Date: 23.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 0.17 Total Serum Bilirubin mg/dl 0.30 - 1.20
(Method: Walter And Gerarde)
0.03 0.14
mg/dl mg/dl
25.3
IU/I
0 - 42
16.9
IU/I
0 - 42
108
IU/I
42 - 128
7.73
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Mohd Shadab Pt. Location: IPD/SICU Referred By: Dr.Mazhar Husain Specimen: BLOOD PARAMETER RESULT Age/Sex: 6y/M MRN:SH/LKO/008142/09 Lab No.:B-/08/1662 Date: 23.8.2009 REFERENCE RANGE
UNIT
Serum Sodium
181.0
mmol/l
135 - 145
Serum Potassium
4.0
mmol/l
3.5 - 5.5
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Virendra Kumar Pt. Location: IPD/Pvt.6 Referred By: Dr.(Col) S.Sablok Specimen: BLOOD PARAMETER RESULT Serum Urea
Methodology- Urease- GLDH, Kinetic
UNIT mg/dl
21
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
1.25
mg/dl
0.70 - 1.30
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
135.0 3.5
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.A.N.Shukla Pt. Location: IPD/MICU Referred By: Dr.Alok Specimen: BLOOD PARAMETER Serum Urea
Methodology- Urease- GLDH, Kinetic
Age/Sex: 62y/M MRN:SH/LKO/007845/08/09 Lab No.:B-/08/1665 Date: 23.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30
Serum Creatinine
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
131.0 4.6
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.S.N.Lal Pt. Location: IPD/E.W Referred By: Dr.Alok Specimen: BLOOD PARAMETER Serum Urea
Methodology- Urease- GLDH, Kinetic
Age/Sex: 58y/M MRN:SH/LKO/008150/08/09 Lab No.:B-/08/1666 Date: 23.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
136.0 3.1
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.S.N.Lal Pt. Location: IPD/E.W Referred By: Dr.Alok Specimen: BLOOD PARAMETER Total Serum Bilirubin
(Method: Walter And Gerarde)
Age/Sex: 58y/M MRN:SH/LKO/008150/08/09 Lab No.:B-/08/1666 Date: 23.8.2009 REFERENCE RANGE 0.30 - 1.20 0 - 0.20
1.01
mg/dl
0.08 - 0.75
59.9
IU/I
0 - 42
220.4
IU/I
0 - 42
1188.8
IU/I
42 - 128
6.14
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Mohd Shadab Pt. Location: IPD/NICU Referred By: Dr.Mazhar Husain Specimen: BLOOD PARAMETER RESULT Age/Sex: 6y/M MRN:SH/LKO/008142/09 Lab No.:B-/08/1669 Date: 23.8.2009 REFERENCE RANGE
at.9;15pm
UNIT
180.0 4.4
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Papia Mukherjee Pt. Location: IPD/E/W Referred By: Dr. H.N Triphati Specimen: BLOOD PARAMETER RESULT Total Serum Bilirubin
(Method: Walter And Gerarde)
Age/Sex: 46y/F MRN:SH/LKO/004797/09 Lab No.:B-/08/1670 Date: 23.8.2009 REFERENCE RANGE 0.30 - 1.20 0 - 0.20 0.08 - 0.75
45.2
IU/I
0 - 42
36.4
IU/I
0 - 42
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
0.89
mg/dl
0.70 - 1.30
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
129.0 3.3
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Saraswati Devi Pt. Location: IPD/M.I.C.U Referred By: Dr.H.N Tripathi Specimen: Blood PARAMETER RESULT Serum Urea
Methodology- Urease- GLDH, Kinetic
Age/Sex:70/F MRN:SH/LKO/008042/09 Lab No.:B-/08/1672 Date: 23.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30
60.6 2.81
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
139.0 3.6
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Vishi Devi Pt. Location: IPD/ M.I.C.U Referred By: Dr. M.Husain Specimen: BLOOD PARAMETER Age/Sex: 50y/F MRN:SH/LKO/007639/08/09 Lab No.:B-/08/1677 Date: 24.8.2009 REFERENCE RANGE
RESULT
UNIT
140.0 4.0
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Kamlesh Kumari Pt. Location: IPD/MICU Referred By: Dr. V.Khanna Specimen: Blood PARAMETER RESULT Age/Sex: 35y/F MRN:SH/LKO/007840/09 Lab No.:B-/08/1680 Date: 24.8.2009 REFERENCE RANGE
UNIT
136.0 4.0
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mast Ankit Pt. Location: IPD/MICU Referred By: Dr.M..Husain. Specimen: Blood PARAMETER Age/Sex: 15y/M MRN:SH/LKO/007559/09 Lab No.:B-/08/1679 Date: 24.8.2009 REFERENCE RANGE
RESULT
UNIT
135.0 4.0
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Sunita Malhotra Pt. Location: IPD/ MICU Referred By: Dr. S.K Somani Specimen: BLOOD PARAMETER RESULT Serum Urea
Methodology- Urease- GLDH, Kinetic
Age/Sex: 51y/F MRN:SH/LKO/007253/08/09 Lab No.:B-/08/1674 Date: 24.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30
316.5 2.49
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
152.0 3.5
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Prahalad Rai Pt. Location: IPD/MICU Referred By: Dr. M.Ahmed Specimen: Blood PARAMETER RESULT Blood Urea Nitrogen
Method Urease GLDH Kinetic
52.26 5.14
6 to 20
0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
134.0 4.7
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Ashish Mital Pt. Location: IPD/MICU Referred By: Dr. Specimen: Blood PARAMETER RESULT Serum Urea
Methodology- Urease- GLDH, Kinetic
Age/Sex: 38/M MRN:SH/LKO/004836/09 Lab No.:B-/08/1676 Date: 24.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30
131.2 2.36
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
151.0 3.9
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.A.N.Shukla Pt. Location: IPD/MICU Referred By: Dr.Alok Specimen: BLOOD PARAMETER Serum Urea
Methodology- Urease- GLDH, Kinetic
Age/Sex: 62y/M MRN:SH/LKO/007845/08/09 Lab No.:B-/08/1678 Date: 24.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
129.0 4.8
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Hari Shanker Shukla Pt. Location: IPD/MICU Referred By: Dr.H.N.Tripathi Specimen: BLOOD PARAMETER RESULT Serum Urea
Methodology- Urease- GLDH, Kinetic
Age/Sex: 70y/M MRN:SH/LKO/007921/08/09 Lab No.:B-/08/1681 Date: 24.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30
153.5 3.97
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
141.0 3.9
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Sarswati Devi Pt. Location: IPD/MICU Referred By: Dr.H.N.Tripathi Specimen: BLOOD PARAMETER RESULT Serum Urea
Methodology- Urease- GLDH, Kinetic
Age/Sex: 70y/M MRN:SH/LKO/008042/08/09 Lab No.:B-/08/1682 Date: 24.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30
66.8 3.2
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
137.0 4.0
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Ram Dularey Verma Pt. Location: IPD/E.W Referred By: Dr.Mufazal Ahmad Specimen: BLOOD PARAMETER RESULT Blood Urea Nitrogen
Method Urease GLDH Kinetic
107.76 3.29
6 to 20
0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
139.0 4.1
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Mohad Farooq Pt. Location: IPD/SICU Referred By: Dr.Mufazal Ahmad Specimen: BLOOD PARAMETER RESULT Blood Urea Nitrogen
Method Urease GLDH Kinetic
94.2 8.27
6 to 20
0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
126.0 4.9
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Jagdish Pandey Pt. Location: IPD/SICU Referred By: Dr. M Ahamad Specimen: BLOOD PARAMETER RESULT Blood Urea Nitrogen
Method Urease GLDH Kinetic
44.14 4.8
6 to 20
0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
132.0 3.1
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Ubaidur Rahman Pt. Location: IPD/SICU Referred By: Dr. V.K Tiwari Specimen: BLOOD PARAMETER RESULT Age/Sex: 79y/M MRN:SH/LKO/03660/09 Lab No.:B-/08/1688 Date: 24.8.2009 REFERENCE RANGE
UNIT
121.0 5.3
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Kiran Gupta Pt. Location: IPD/SICU Referred By: Dr. H.N Triphati Specimen: BLOOD PARAMETER RESULT Blood Urea Nitrogen
Method Urease GLDH Kinetic
22.61 2.27
6 to 20
0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
141.0 4.4
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.R.K.Bajpai Pt. Location: IPD/SICU Referred By: Dr.Abhishek Specimen: BLOOD PARAMETER Age/Sex: 63y/M MRN:SH/LKO/008144/09 Lab No.:B-/08/1690 Date: 24.8.2009 REFERENCE RANGE
RESULT
UNIT
129.0 3.8
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Shakuntla Pt. Location: IPD/MICU Referred By: Dr.Mufazal Ahmad Specimen: BLOOD PARAMETER RESULT Blood Urea Nitrogen
Method Urease GLDH Kinetic
75.2 2.13
6 to 20
0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
128.0 5.0
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mast.Mohd Sadab Pt. Location: IPD/NICU Referred By: Dr.Mazhar Husain Specimen: BLOOD PARAMETER RESULT Age/Sex: 6y/M MRN:SH/LKO/008143/09 Lab No.:B-/08/1692 Date: 24.8.2009 REFERENCE RANGE
UNIT
179.0 4.7
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Ibtessam Anjum Pt. Location: IPD/Gyane Referred By: Dr.Manjusha Specimen: BLOOD PARAMETER RESULT Blood Sugar Fasting 88.4 Age/Sex: 28y/F MRN:SH/LKO/007953/09 Lab No.:B-/08/1693 Date: 24.8.2009 UNIT REFERENCE RANGE mg/dl 70 - 110
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Ram Devan Yadav Pt. Location: IPD/G.W Referred By: Dr.M.Ahamad Specimen: BLOOD PARAMETER RESULT Age/Sex: 75y/M MRN:SH/LKO/006934/09 Lab No.:B-/08/1546 Date: 22.8.2009 REFERENCE RANGE
UNIT
74 3.33
mg/dl mg/dl
6 to 20
0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Serum Sodium
133.0
mmol/l
135 - 145
Serum Potassium
5.0
mmol/l
3.5 - 5.5
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Dr.H.P.Kumar Pt. Location: OPD Referred By: Dr.Self Specimen: BLOOD PARAMETER Blood Sugar Fasting Age/Sex: 64y/M MRN:SH/LKO/002049/09 Lab No.:B-/08/1714 Date: 24.8.2009 REFERENCE RANGE 70 - 110
UNIT mg/dl
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
Serum Urea
Methodology- Urease- GLDH, Kinetic
22.5 0.9
4.58
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Dr.H.P.Kumar Age/Sex: 64y/M Pt. Location: OPD MRN:SH/LKO/002049/09 Referred By: Dr.Self Lab No.:B-/08/1714 Specimen: BLOOD Tr. No.7461 Date: 24.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 1.05 Total Serum Bilirubin mg/dl 0.30 - 1.20
(Method: Walter And Gerarde)
0.37 0.68
mg/dl mg/dl
38.2
IU/I
0 - 42
28.7
IU/I
0 - 42
77.5
IU/I
42 - 128
7.20
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Dr.H.P.Kumar Pt. Location: OPD Referred By: Dr.Self Specimen: BLOOD PARAMETER
Total Serum Cholesterol
UNIT
LIPID PROFILE
95 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)
Serum Triglycerides 87.2 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 33 mg/dl
(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)
44.5
mg/dl
(Method-Direct enzymaticCHE&CO) (<100 optimal, 100 129 near optimal/ above optimal; 130 -159 mg/dl Border line High; 160 -189 mg/dl High, 190= very high)
17.44
mg/dl
10 to 40
2.87
mg/dl
Less 4.5
1.35
mg/dl
Less 3.0
Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Asha Kumar Pt. Location: OPD Referred By: Dr.H.P.Kumar MD Specimen: BLOOD Tr. No.7460 PARAMETER RESULT Blood Sugar Fasting 118.0 Age/Sex: 55y/F MRN:SH/LKO/001542/09 Lab No.:B-/08/1715 Date: 24.8.2009 REFERENCE RANGE 70 - 110
UNIT mg/dl
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
Serum Urea
Methodology- Urease- GLDH, Kinetic
21.8 0.69
4.13
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
139.0 5.0
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Asha Kumar Pt. Location: OPD Referred By: Dr.H.P.Kumar MD Specimen: BLOOD Tr. No.7460 PARAMETER RESULT
LIPID PROFILE
Total Serum Cholesterol
216.9 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)
UNIT
Serum Triglycerides 331.8 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 38.8 mg/dl
(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)
111.7
mg/dl
66.37
mg/dl
10 to 40
5.59
mg/dl
Less 4.5
2.88
mg/dl
Less 3.0
Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Asha Kumar Pt. Location: OPD Referred By: Dr.H.P.Kumar MD Specimen: BLOOD Tr. No.7460 PARAMETER RESULT Age/Sex: 55y/F MRN:SH/LKO/001542/09 Lab No.:B-/08/1715 Date: 24.8.2009 REFERENCE RANGE
UNIT
8.6 7.6% %
A 1C
(%)
* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment
goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Gunjan Kumar Pt. Location: OPD Referred By: Dr.H.P.Kumar MD Specimen: BLOOD Tr. No.6461 PARAMETER RESULT Blood Sugar Fasting 81.4 Age/Sex: 55y/F MRN:SH/LKO/002049/09 Lab No.B-08/1716 Date: 24-8-2009 REFERENCE RANGE 70 - 110
UNIT mg/dl
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
Serum Urea
Methodology- Urease- GLDH, Kinetic
21.4 0.87
4.49
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Gunjan Kumar Pt. Location: OPD Referred By: Dr.H.P.Kumar MD Specimen: BLOOD Tr. No.7461 PARAMETER RESULT UNIT LIVER FUNCTION TEST 0.49 Total Serum Bilirubin mg/dl
(Method: Walter And Gerarde)
Age/Sex: 55y/F MRN:SH/LKO/002049/09 Lab No.B-08/1716 Date: 24-8-2009 REFERENCE RANGE 0.30 - 1.20 0 - 0.20 0.08 - 0.75
0.10 0.39
mg/dl mg/dl
35.1
IU/I
0 - 42
27.3
IU/I
0 - 42
84.4
IU/I
42 - 128
7.36
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Gunjan Kumar Pt. Location: OPD Referred By: Dr.H.P.Kumar MD Specimen: BLOOD Tr. No.7461 PARAMETER RESULT
LIPID PROFILE
Total Serum Cholesterol
168.6 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)
UNIT
Serum Triglycerides 114 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 31.5 mg/dl
(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)
114.22
mg/dl
22.88
mg/dl
10 to 40
5.35
mg/dl
Less 4.5
3.62
mg/dl
Less 3.0
Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Rahmatullah Pt. Location: OPD Referred By: Dr.Manoj Mishra Specimen: BLOOD Tr. No.20602 PARAMETER RESULT Blood Sugar Random 84 Age/Sex: 62y/M MRN:SH/LKO/008171/09 Lab No.B-08/1742 Date: 24-8-2009 REFERENCE RANGE 70 - 140
UNIT mg/dl
(Method: - GOD-POD) (Normal 140mg/dl, Impaired glucose tolerance 140-199 mg/dl, Diabetes mellitus 200mg/dl According to Amercian diabetes association, 2004
Serum Urea
Methodology- Urease- GLDH, Kinetic
27.7 1.24
mg/dl mg/dl
13 - 43 0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Manish Singh Pt. Location: OPD Referred By: Dr.P.K.Samshrey Specimen: BLOOD Tr. No.20547 PARAMETER RESULT Blood Sugar Random 61.3 Age/Sex: 25y/M MRN:SH/LKO/008075/09 Lab No.B-08/1741 Date: 24-8-2009 REFERENCE RANGE 70 - 140
UNIT mg/dl
(Method: - GOD-POD) (Normal 140mg/dl, Impaired glucose tolerance 140-199 mg/dl, Diabetes mellitus 200mg/dl According to Amercian diabetes association, 2004
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
1.32
mg/dl
0.70 - 1.30
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Surender Kumar Pt. Location: IPD/ T.ICU Referred By: Dr. H.N Triphati Specimen: BLOOD PARAMETER RESULT Serum Uric Acid
(Method : Uricase-POD)
UNIT mg/dl
Age/Sex: 65y/M MRN:SH/LKO/007690/08/09 Lab No.:B-/08/1700 Date: 24.8.2009 REFERENCE RANGE 2.5 6.8
7.34
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Bharat Lal Pt. Location: IPD/G/W Referred By: Dr. H.N Tripathi MD Specimen: BLOOD PARAMETER RESULT Blood Urea Nitrogen
Method Urease GLDH Kinetic
82.69 5.8
6 to 20
0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
127.0 4.3
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Amit Kushwaha Pt. Location: IPD/G/W Referred By: Dr. H.N Tripathi MD Specimen: BLOOD PARAMETER RESULT Total Serum Bilirubin
(Method: Walter And Gerarde)
Age/Sex: 24y/M MRN:SH/LKO/06223/09 Lab No.:B-/08/1703 Date: 24.8.2009 REFERENCE RANGE 0.30 - 1.20 0 - 0.20 0.08 - 0.75
811.6
IU/I
0 - 42
555.4
IU/I
0 - 42
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Girija Shankar Pt. Location: OPD Referred By: M.H.C Specimen: BLOOD Tr. No.78 PARAMETER RESULT Blood Sugar Fasting 125 Age/Sex: 54y/M MRN:SH/LKO/008160/09 Lab No.B-08/1720 Date: 24-8-2009 REFERENCE RANGE 70 - 110
UNIT mg/dl
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
157.3
mg/dl
70 - 140
Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004
6 to 20
0.70 - 1.30 8.4- 10.4
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Serum Calcium
(Method: arsenazo III)
Phosphorus
(Method: phosphomolybdate UV
2.5 - 4.5
6.36
mg/dl
2.5 6.8
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
1.2
mmol/l
1.12 1.32
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Girija Shankar Pt. Location: OPD Referred By: M.H.C Specimen: BLOOD Tr. No.78 PARAMETER RESULT UNIT LIVER FUNCTION TEST 0.70 Total Serum Bilirubin mg/dl
(Method: Walter And Gerarde)
Age/Sex: 54y/M MRN:SH/LKO/008160/09 Lab No.B-08/1720 Date: 24-8-2009 REFERENCE RANGE 0.30 - 1.20 0 - 0.20 0.08 - 0.75
0.18 0.52
mg/dl mg/dl
15.7
IU/I
0 - 42
19.4
IU/I
0 - 42
124.2
IU/I
42 - 128
8.18
g/dl
6.0 - 8.3
(Method: Biuret)
Serum Albumin
(Method: Bromo Cresol Green BCG))
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Girija Shankar Pt. Location: OPD Referred By: M.H.C Specimen: BLOOD Tr. No.78 PARAMETER RESULT
LIPID PROFILE
Total Serum Cholesterol
168.9 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)
UNIT
Serum Triglycerides 86.4 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 41 mg/dl
(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)
110.6
mg/dl
17.28
mg/dl
10 to 40
4.12
mg/dl
Less 4.5
2.7
mg/dl
Less 3.0
Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Girija Shankar Pt. Location: OPD Referred By: M.H.C Specimen: BLOOD Tr. No.78 PARAMETER RESULT
ApolipoProtein Estimation Apolipoprotein A1 (Apo-A1)
(Method :Immunonephelometric assay) 121
UNIT
Apolipoprotein B (Apo-B)
(Method :Immunonephelometric assay)
93.9
apo-A1/apo-B Ratio
1.28
( Elevation of apo B (present in chylomicrons, VLDL, HDL and LDL), decrease in apo A-1 (present mostly in HDL), and decrease in the apo A -1/apo B ratio have been associated with increased risk of CHD)
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Girija Shankar Pt. Location: OPD Referred By: M.H.C Specimen: BLOOD Tr. No.78 PARAMETER RESULT Age/Sex: 54y/M MRN:SH/LKO/008160/09 Lab No.B-08/1720 Date: 24-8-2009 REFERENCE RANGE
UNIT
8.6 7.4% %
A 1C
(%)
* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Moti Lal Pt. Location: OPD Referred By: M.H.C Specimen: BLOOD PARAMETER Blood Sugar Fasting Age/Sex: 51y/M MRN:SH/LKO/008159/09 Lab No.B-08/1721 Date: 24-8-2009 REFERENCE RANGE 70 - 110
UNIT mg/dl
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
195
mg/dl
70 - 140
Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004
6 to 20
0.70 - 1.30 8.4- 10.4
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Serum Calcium
(Method: arsenazo III)
Phosphorus
(Method: phosphomolybdate UV
2.5 - 4.5
6.58
mg/dl
2.5 6.8
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
1.21
mmol/l
1.12 1.32
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Moti Lal Pt. Location: OPD Referred By: M.H.C Specimen: BLOOD Tr. No. PARAMETER RESULT UNIT LIVER FUNCTION TEST 0.35 Total Serum Bilirubin mg/dl
(Method: Walter And Gerarde)
Age/Sex: 51y/M MRN:SH/LKO/008159/09 Lab No.B-08/1721 Date: 24-8-2009 REFERENCE RANGE 0.30 - 1.20 0 - 0.20 0.08 - 0.75
0.10 0.25
mg/dl mg/dl
41
IU/I
0 - 42
21
IU/I
0 - 42
100
IU/I
42 - 128
7.39
g/dl
6.0 - 8.3
Serum Albumin
4.20
g/dl
3.2 - 5.0
3.19 1.31
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Moti Lal Pt. Location: OPD Referred By: M.H.C Specimen: BLOOD PARAMETER
Total Serum Cholesterol
UNIT
LIPID PROFILE
198 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)
Serum Triglycerides 424 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 29.2 mg/dl
(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)
84.2
mg/dl
84.8
mg/dl
10 to 40
6.78
mg/dl
Less 4.5
2.88
mg/dl
Less 3.0
Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Moti Lal Pt. Location: OPD Referred By: M.H.C Specimen: BLOOD PARAMETER
ApolipoProtein Estimation Apolipoprotein A1 (Apo-A1)
(Method :Immunonephelometric assay) 136
UNIT
Apolipoprotein B (Apo-B)
(Method :Immunonephelometric assay)
100
apo-A1/apo-B Ratio
1.36
( Elevation of apo B (present in chylomicrons, VLDL, HDL and LDL), decrease in apo A-1 (present mostly in HDL), and decrease in the apo A -1/apo B ratio have been associated with increased risk of CHD)
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Moti Lal Pt. Location: OPD Referred By: M.H.C Specimen: BLOOD PARAMETER Age/Sex: 51y/M MRN:SH/LKO/008159/09 Lab No.B-08/1721 Date: 24-8-2009 REFERENCE RANGE
UNIT
8.6 8.9% %
A 1C
(%)
* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. G.K Kumar Pt. Location: OPD Referred By: Dr. V.K Tiwari Specimen: BLOOD PARAMETER Serum Urea
Methodology- Urease- GLDH, Kinetic
Age/Sex: 59y/M MRN:SH/LKO/007561/09 Lab No.B-08/1726 Date: 24-8-2009 REFERENCE RANGE 13 - 43 0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
124.0 5.0
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Ms. Anjali Maurya Pt. Location: OPD Referred By: Dr. Mufazal Ahmed Specimen: BLOOD Tr. No. 20543 PARAMETER RESULT UNIT Age/Sex: 12y/F MRN:SH/LKO/005403/09 Lab No.B-08/1735 Date: 24-8-2009 REFERENCE RANGE
Serum Albumin
(Method: Bromo Cresol Green BCG))
3.6
g/dl
3.2 - 5.0
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
0.69
mg/dl
0.70 - 1.30
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Kiran Lata Pt. Location: OPD Referred By: Dr. Mufazal Ahmed Specimen: BLOOD Tr. No. 20569 PARAMETER RESULT UNIT Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Age/Sex: 49y/F MRN:SH/LKO/008177/09 Lab No.B-08/1736 Date: 24-8-2009 REFERENCE RANGE 0.70 - 1.30 8.4- 10.4
Serum Calcium
(Method: arsenazo III)
Phosphorus
(Method: phosphomolybdate UV
2.5 - 4.5
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
144.0 4.2
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Anil Kumar Jaishwal Pt. Location: OPD Referred By: Dr. H.N Triphati Specimen: BLOOD Tr. No. 8194 PARAMETER RESULT Age/Sex: 33y/M MRN:SH/LKO/008194/09 Lab No.B-08/1731 Date: 24-8-2009 REFERENCE RANGE
UNIT
8.6 6.4% %
A 1C
(%)
* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. A. K Singh Pt. Location: OPD Referred By: Dr. Abhishek Specimen: BLOOD PARAMETER CPK Serum Alkaline Phosphatase
(Method: ALP - AMP)
Tr. No. 20548 RESULT UNIT 47.9 439.6 1.77 U/L IU/I mg/dl
Age/Sex: 51y/M MRN:SH/LKO/008186/09 Lab No.B-08/1737 Date: 24-8-2009 REFERENCE RANGE 38 - 174 42 - 128
Phosphorus
(Method: phosphomolybdate UV
1.17
mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Atul Kumar Pandey Pt. Location: OPD Referred By: Dr. Abhishek Specimen: BLOOD Tr. No. PARAMETER RESULT Serum Glutamic Pyruvic Transminase(SGPT/ALT)
(Method: IFCC Without Pyridoxal Phosphate))
UNIT
17.1
IU/I
0 - 42
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
0.9
mg/dl
0.70 - 1.30
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
136.0 4.3
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. R.K Chanda Pt. Location: OPD Referred By: Dr. S.K Singh Specimen: BLOOD PARAMETER Serum Amylase Serum Lipase Age/Sex: 60y/M MRN:SH/LKO/008200/09 Lab No.B-08/1739 Date: 24-8-2009 REFERENCE RANGE 28 - 100 13 - 60
Serum Urea
Methodology- Urease- GLDH, Kinetic
19.6 1.1
mg/dl mg/dl
13 - 43 0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Manisha Singh Pt. Location: OPD Referred By: Dr. I. Tyagi Specimen: BLOOD Tr. No. 20562 PARAMETER RESULT UNIT Blood Sugar Random 91 mg/dl Age/Sex: 18y/F MRN:SH/LKO/008185/09 Lab No.B-08/1740 Date: 24-8-2009 REFERENCE RANGE 70 - 140
(Method: - GOD-POD) (Normal 140mg/dl, Impaired glucose tolerance 140-199 mg/dl, Diabetes mellitus 200mg/dl According to Amercian diabetes association, 2004
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Ms. Hellan Kabla Cheti Pt. Location: OPD Referred By: Dr. Vaibh Khanna Specimen: BLOOD Tr. No. PARAMETER RESULT Blood Sugar Random 104 Age/Sex: 33y/F MRN:SH/LKO/001825/09 Lab No.B-08/1748 Date: 24-8-2009 REFERENCE RANGE 70 - 140
UNIT mg/dl
(Method: - GOD-POD) (Normal 140mg/dl, Impaired glucose tolerance 140-199 mg/dl, Diabetes mellitus 200mg/dl According to Amercian diabetes association, 2004
Serum Urea
Methodology- Urease- GLDH, Kinetic
28 0.88
mg/dl mg/dl
13 - 43 0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Shakuntla Pandey Pt. Location: OPD Referred By: Dr. M.Ahmed Specimen: BLOOD Tr. No. PARAMETER RESULT Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
UNIT mg/dl
Age/Sex: 55y/F MRN:SH/LKO/005188/09 Lab No.B-08/1749 Date: 24-8-2009 REFERENCE RANGE 0.70 - 1.30
1.44
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
136.0 5.60
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. R.B Gupta Pt. Location: IPD/G/W Referred By: Dr. P.Gupta Specimen: Blood PARAMETER Blood Sugar Random Age/Sex: 28/M MRN:SH/LKO/008099/09 Lab No.:B-/08/1745 Date: 24.8.2009 REFERENCE RANGE 70 - 140
RESULT 85
UNIT mg/dl
(Method: - GOD-POD) (Normal 140mg/dl, Impaired glucose tolerance 140-199 mg/dl, Diabetes mellitus 200mg/dl According to Amercian diabetes association, 2004
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Bhullar Prasad Pt. Location: IPD/G/W Referred By: Dr. Sablok Specimen: Blood PARAMETER RESULT Blood Sugar Random 176 Age/Sex: 62/M MRN:SH/LKO/008207/09 Lab No.:B-/08/1746 Date: 24.8.2009 REFERENCE RANGE 70 - 140
UNIT mg/dl
(Method: - GOD-POD) (Normal 140mg/dl, Impaired glucose tolerance 140-199 mg/dl, Diabetes mellitus 200mg/dl According to Amercian diabetes association, 2004
Serum Urea
Methodology- Urease- GLDH, Kinetic
35.6 1.17
mg/dl mg/dl
13 - 43 0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Bhullar Prasad Pt. Location: IPD/G/W Referred By: Dr. Sablok Specimen: Blood PARAMETER RESULT Age/Sex: 62/M MRN:SH/LKO/008207/09 Lab No.:B-/08/1746 Date: 24.8.2009 REFERENCE RANGE
UNIT
8.6 5.8% %
A 1C
(%)
* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Bhullar Prasad Age/Sex: 62/M Pt. Location: IPD/G/W MRN:SH/LKO/008207/09 Referred By: Dr. Sablok Lab No.:B-/08/1746 Specimen: Blood Date: 24.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 0.37 Total Serum Bilirubin mg/dl 0.30 - 1.20
(Method: Walter And Gerarde)
0.10 0.27
mg/dl mg/dl
63
IU/I
0 - 42
51
IU/I
0 - 42
285
IU/I
42 - 128
7.11
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. G.C Mehta Pt. Location: IPD/Neuro Referred By: Dr. M.Husain Specimen: Blood PARAMETER Blood Sugar Random Age/Sex: 80y/M MRN:SH/LKO/007405/09 Lab No.:B-/08/1743 Date: 24.8.2009 REFERENCE RANGE 70 - 140
RESULT 95
UNIT mg/dl
(Method: - GOD-POD) (Normal 140mg/dl, Impaired glucose tolerance 140-199 mg/dl, Diabetes mellitus 200mg/dl According to Amercian diabetes association, 2004
Serum Urea
Methodology- Urease- GLDH, Kinetic
38 0.62
mg/dl mg/dl
13 - 43 0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
127.0 5.5
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. C.L Jaishwal Pt. Location: IPD/G/W Referred By: Dr.H.N Triphati Specimen: Blood PARAMETER RESULT Serum Urea
Methodology- Urease- GLDH, Kinetic
Age/Sex: 57y/M MRN:SH/LKO/008145/09 Lab No.:B-/08/1729 Date: 24.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30
58 1.55
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Dr. Manish Tomar Pt. Location: IPD/E/W Referred By: Dr.H.N Triphati Specimen: Blood PARAMETER RESULT Age/Sex: y/M MRN:SH/LKO/008184/09 Lab No.:B-/08/1730 Date: 24.8.2009 REFERENCE RANGE
UNIT
8.6 8.8% %
A 1C
(%)
* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Dr. Manish Tomar Pt. Location: IPD/E/W Referred By: Dr.H.N Triphati Specimen: Blood PARAMETER RESULT Serum Urea
Methodology- Urease- GLDH, Kinetic
Age/Sex: y/M MRN:SH/LKO/008184/09 Lab No.:B-/08/1730 Date: 24.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30
67.8 0.72
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
113.0 4.0
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Shiv Balak Singh Pt. Location: IPD/G/W Referred By: Dr. Alok Specimen: Urine PARAMETER RESULT Urine microalbumin Urine Microalbumin 8.17 mg/ L <20mg/L Age/Sex: 60y/M MRN:SH/LKO/008138/09 Lab No.:B-/08/1732 Date: 24.8.2009 REFERENCE RANGE
UNIT
Microalbuminuria is the presence of albumin in the urine above the normal levels bu below the detectable range of conventional methods. Urine albumin levels from 20-200 mg/L are an indicator of early or possibly reversible glomerular damage.In diabetic patients ,microalbulinemia is associated with a four to six fold increase in cardiovascular mortality,and an independent risk factor for renal mortality.It is also more prevelant in hypertensive subjects Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Shiv Balak Singh Pt. Location: IPD/G/W Referred By: Dr. Alok Specimen: Blood PARAMETER RESULT Blood Sugar Post Prandial 257.6 Age/Sex: 60y/M MRN:SH/LKO/008138/09 Lab No.:B-/08/1732 Date: 24.8.2009 REFERENCE RANGE 70 - 140
UNIT mg/dl
Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Karuna Srivastava Pt. Location: IPD/G/W Referred By: Dr. Specimen: Blood PARAMETER RESULT
Serum IRON 151
UNIT
g/dl
170.4 321.5 47
g/dl g/dl %
112 - 346
250 - 450 13 - 45
Iron is transported as Fe(111) bound to the plasma protein apotransferrin.Normally only about one third of the iron binding sites of transferrin are occupied by Fe(111).The additional amount of iron that can be bound is the unsaturated iron binding capacity (UIBC). The sum of the serum iron and UIBC represents TIBC.TIBC is a measurement for the maximum iron concentration that transferrin can bind. The serum TIBC varies in disorders of iron metabolism .In iron dediciency anemia the TIBC is elevated and the transferring saturation is lowered to 15% or less. Low serum iron associated with low TIBC is characteristic of the anemia of chronic disorders,malignant tumors,and infections. (Dr. Anju Shukla, MD) Associate Consultant
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mast. Aleem Pt. Location: IPD/PICU Referred By: Dr. M.U Hasan Specimen: Blood PARAMETER Age/Sex: 6y/M MRN:SH/LKO/008084/09 Lab No.:B-/08/1723 Date: 24.8.2009 REFERENCE RANGE
RESULT 5.92
UNIT mg/dl
Phosphorus
(Method: phosphomolybdate UV
2.5 - 4.5
263.6
IU/I
1.14
mmol/l
C reactive protein(C.R.P)
11
mg/L
less than 3
*CRP is an acute phase reactant appeared in plasma during many infectious or inflammatory conditions CRP assay provides useful information for the diagnosis,therapy and monitoring of inflammatory processes and associated diseases. Increase in CRP values are non specific and should not be interpreted without a complete clinical history.
Note : above test carried out by BN ProSpec Nephlometer Automated Analyzer .
Checked by..
SAHARA HOSPITAL
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: B/O Mamta Pt. Location: IPD/PICU Referred By: Dr. M.U Hasan Specimen: Blood PARAMETER Age/Sex: NB/ MRN:SH/LKO/007034/09 Lab No.:B-/08/1725 Date: 24.8.2009 REFERENCE RANGE
RESULT
UNIT
6 to 20
0.70 - 1.30 1.12 1.32
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
C reactive protein(C.R.P)
< 3.08
mg/L
less than 3
*CRP is an acute phase reactant appeared in plasma during many infectious or inflammatory conditions CRP assay provides useful information for the diagnosis,therapy and monitoring of inflammatory processes and associated diseases. Increase in CRP values are non specific and should not be interpreted without a complete clinical history.
Note : above test carried out by BN ProSpec Nephlometer Automated Analyzer .
Checked by..
SAHARA HOSPITAL
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: B/O Mamta Age/Sex: NB/ Pt. Location: IPD/PICU MRN:SH/LKO/007034/09 Referred By: Dr. M.U Hasan Lab No.:B-/08/1725 Specimen: Blood Date: 24.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 0.49 Total Serum Bilirubin mg/dl 0.30 - 1.20
(Method: Walter And Gerarde)
0.11 0.38
mg/dl mg/dl
79.2
IU/I
0 - 42
207.3
IU/I
0 - 42
209
IU/I
42 - 128
5.62
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..
SAHARA HOSPITAL
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Ubaidur Rehman Pt. Location: IPD/SICU Referred By: Dr. V.K Tiwari Specimen: Blood PARAMETER RESULT Serum Urea
Methodology- Urease- GLDH, Kinetic
Age/Sex: 79/M MRN:SH/LKO/003660/09 Lab No.:B-/08/1727 Date: 24.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30
149 3.58
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
SAHARA HOSPITAL
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Laxmi Singh Pt. Location: IPD/G/W Referred By: Dr. S.Dabadghao Specimen: Blood PARAMETER RESULT Serum Urea
Methodology- Urease- GLDH, Kinetic
Age/Sex: 54/F MRN:SH/LKO/008000/09 Lab No.:B-/08/1747 Date: 24.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30
18.7 0.61
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
SAHARA HOSPITAL
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Laxmi Singh Age/Sex: 54/F Pt. Location: IPD/G/W MRN:SH/LKO/008000/09 Referred By: Dr. S.Dabadghao Lab No.:B-/08/1747 Specimen: Blood Date: 24.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 0.30 Total Serum Bilirubin mg/dl 0.30 - 1.20
(Method: Walter And Gerarde)
0.10 0.20
mg/dl mg/dl
17
IU/I
0 - 42
16
IU/I
0 - 42
54
IU/I
42 - 128
6.8
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..
SAHARA HOSPITAL
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Jagdamba Prasad Pt. Location: IPD/E/W Referred By: Dr. M.Husain Specimen: Blood PARAMETER RESULT Serum Urea
Methodology- Urease- GLDH, Kinetic
Age/Sex: 57/M MRN:SH/LKO/008226/09 Lab No.:B-/08/1764 Date: 24.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30
45.3 1.02
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
146.0 3.3
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Jagdamba Prasad Age/Sex: 57/M Pt. Location: IPD/E/W MRN:SH/LKO/008226/09 Referred By: Dr. M.Husain Lab No.:B-/08/1764 Specimen: Blood Date: 24.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 0.73 Total Serum Bilirubin mg/dl 0.30 - 1.20
(Method: Walter And Gerarde)
0.17 0.56
mg/dl mg/dl
41.3
IU/I
0 - 42
63.4
IU/I
0 - 42
130.1
IU/I
42 - 128
6.73
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..
SAHARA HOSPITAL
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Ram Dularey Verma Pt. Location: IPD/E.W Referred By: Dr.Puneet Gupta Specimen: BLOOD PARAMETER RESULT Age/Sex: 70y/M MRN:SH/LKO/008142/09 Lab No.:B-/08/1752 Date: 24.8.2009 REFERENCE RANGE
UNIT
140.0 4.10
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Aditya Gupta Pt. Location: IPD/G.W Referred By: Dr. Ramesh Kohli Specimen: BLOOD PARAMETER RESULT Age/Sex: 30y/M MRN:SH/LKO/006569/09 Lab No.:B-/08/1757 Date: 24.8.2009 REFERENCE RANGE
UNIT
141.0 4.10
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Ahmer Khan Pt. Location: IPD/G.W Referred By: Dr. S. Agarwal Specimen: c.s.f PARAMETER RESULT C.S.F C.S.F Protein Glucose 33 93 Age/Sex: y/M MRN:SH/LKO/008141/09 Lab No.:B-/08/1758 Date: 24.8.2009 REFERENCE RANGE 15 - 45 40 - 80
Checked by..
SAHARA HOSPITAL
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mast.Mohd Sadab Pt. Location: IPD/PICU Referred By: Dr.Mazhar Husain Specimen: BLOOD PARAMETER RESULT Serum Urea
Methodology- Urease- GLDH, Kinetic
Age/Sex: 6y/M MRN:SH/LKO/008143/09 Lab No.:B-/08/1759 Date: 24.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30
130.6 0.76
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
182.0 4.5
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. J.P Srivastava Pt. Location: IPD/E/W Referred By: Dr. S.Agarwal Specimen: BLOOD PARAMETER RESULT Serum Urea
Methodology- Urease- GLDH, Kinetic
Age/Sex: 59y/M MRN:SH/LKO/008223/09 Lab No.:B-/08/1760 Date: 24.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30
47.4 1.11
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
133.0 4.8
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. J.P Srivastava Age/Sex: 59y/M Pt. Location: IPD/E/W MRN:SH/LKO/008223/09 Referred By: Dr. S.Agarwal Lab No.:B-/08/1760 Specimen: BLOOD Date: 24.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 0.65 Total Serum Bilirubin mg/dl 0.30 - 1.20
(Method: Walter And Gerarde)
0.20 0.45
mg/dl mg/dl
21.3
IU/I
0 - 42
23.6
IU/I
0 - 42
72.3
IU/I
42 - 128
8.32
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..
SAHARA HOSPITAL
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Manish Pt. Location: IPD/M.I.C.U Referred By: Dr. R.Kohli Specimen: BLOOD PARAMETER Serum Urea
Methodology- Urease- GLDH, Kinetic
Age/Sex: 45y/M MRN:SH/LKO/008184/09 Lab No.:B-/08/1762 Date: 24.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
115.0 3.7
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Manish Tomar Pt. Location: IPD/M.I.C.U Referred By: Dr. R.Kohli Specimen: BLOOD PARAMETER RESULT Total Serum Bilirubin
(Method: Walter And Gerarde)
Age/Sex: 45y/M MRN:SH/LKO/008184/09 Lab No.:B-/08/1763 Date: 24.8.2009 REFERENCE RANGE 0.30 - 1.20 0 - 0.20 0.08 - 0.75
20.4
IU/I
0 - 42
43.5
IU/I
0 - 42
CK-MB
Method- Immunoinhibition
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant
Checked by..
SAHARA HOSPITAL
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Kuldeep Kumar Pt. Location: IPD/C.T Step Referred By: Dr. M.Husain Specimen: BLOOD PARAMETER RESULT Blood Sugar Random 110 Age/Sex: 37y/M MRN:SH/LKO/008187/09 Lab No.:B-/08/1750 Date: 24.8.2009 REFERENCE RANGE 70 - 140
UNIT mg/dl
(Method: - GOD-POD) (Normal 140mg/dl, Impaired glucose tolerance 140-199 mg/dl, Diabetes mellitus 200mg/dl According to Amercian diabetes association, 2004
Serum Urea
Methodology- Urease- GLDH, Kinetic
37 0.65
mg/dl mg/dl
13 - 43 0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
137.0 3.80
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Kuldeep Kumar Age/Sex: 37y/M Pt. Location: IPD/C.T Step MRN:SH/LKO/008187/09 Referred By: Dr. M.Husain Lab No.:B-/08/1750 Specimen: BLOOD Date: 24.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 0.30 Total Serum Bilirubin mg/dl 0.30 - 1.20
(Method: Walter And Gerarde)
0.10 0.20
mg/dl mg/dl
83.9
IU/I
0 - 42
28.2
IU/I
0 - 42
80
IU/I
42 - 128
5.78
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..
SAHARA HOSPITAL
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Bharat Lal Awasthi Pt. Location: IPD/G/W Referred By: Dr. H.N Triphati Specimen: Urine PARAMETER RESULT Spot Urine Protein Spot Urine Creatinine 5.5 22.5 Age/Sex: 51y/M MRN:SH/LKO/006354/09 Lab No.:B-/08/1751 Date: 24.8.2009 REFERENCE RANGE
0.24
Ratio
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Raghuveer Kaur Pt. Location: IPD/Neuro Referred By: Dr. M.Husain Specimen: Blood PARAMETER RESULT Serum Calcium
(Method: arsenazo III)
UNIT mg/dl
Age/Sex: 55y/M MRN:SH/LKO/008155/09 Lab No.:B-/08/1744 Date: 24.8.2009 REFERENCE RANGE 8.4- 10.4
8.72
8.6 10.1% %
A 1C
(%)
* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Raghuveer Kaur Pt. Location: IPD/Neuro Referred By: Dr. M.Husain Specimen: Blood PARAMETER RESULT Blood Sugar Fasting 174.1 Age/Sex: 55y/F MRN:SH/LKO/008155/09 Lab No.:B-/08/1777 Date: 25.8.2009 REFERENCE RANGE 70 - 110
UNIT mg/dl
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl According to Amercian diabetes association, 2004
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Ram Dularey Verma Pt. Location: IPD/E.W Referred By: Dr.Puneet Gupta Specimen: BLOOD PARAMETER RESULT Serum Urea
Methodology- Urease- GLDH, Kinetic
Age/Sex: 70y/M MRN:SH/LKO/008142/09 Lab No.:B-/08/1778 Date: 22.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30
222.6 2.8
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
104
mg/dl
6 to 20
Serum Albumin
(Method: Bromo Cresol Green BCG))
2.6
g/dl
3.2 - 5.0
193.5
mg/dl
70 - 110
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl According to Amercian diabetes association, 2004
141.0 3.7
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Ubaidur Rahman Pt. Location: IPD/SICU Referred By: Dr. V.K Tiwari Specimen: BLOOD PARAMETER RESULT Serum Sodium Serum Potassium 126.0 4.3 Age/Sex: 79y/M MRN:SH/LKO/03660/09 Lab No.:B-/08/1776 Date: 25.8.2009 REFERENCE RANGE 135 - 145 3.5 - 5.5
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Kiran Gupta Pt. Location: IPD/S.I.C.U Referred By: Dr. H.N Triphati Specimen: BLOOD PARAMETER RESULT Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
UNIT mg/dl
Age/Sex: 55y/F MRN:SH/LKO/008075/08/09 Lab No.:B-/08/1775 Date: 25.8.2009 REFERENCE RANGE 0.70 - 1.30
2.4
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
140.0 4.2
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Prahalad Rai Pt. Location: IPD/M.I.C.U Referred By: Dr. M.Ahmed Specimen: Blood PARAMETER RESULT Serum Urea
Methodology- Urease- GLDH, Kinetic
Age/Sex: 70/M MRN:SH/LKO/001386/09 Lab No.:B-/08/1765 Date: 25.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30
104 4.6
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
129.0 4.1
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Ashish Mitra Pt. Location: IPD/MICU Referred By: Dr.Mazhar Husain Specimen: BLOOD PARAMETER RESULT Age/Sex: 38y/M MRN:SH/LKO/007836/08/09 Lab No.:B-/08/1767 Date: 25.8.2009 REFERENCE RANGE
UNIT
144.0 3.5
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Saraswati Devi Pt. Location: IPD/ M.I.C.U Referred By: Dr.H.N Tripathi Specimen: Blood PARAMETER RESULT Serum Urea
Methodology- Urease- GLDH, Kinetic
Age/Sex:70/F MRN:SH/LKO/008042/09 Lab No.:B-/08/1768 Date: 25.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30
99.4 4.12
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
134.0 4.4
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Hari Shanker Shukla Pt. Location: IPD/MICU Referred By: Dr.H.N.Tripathi Specimen: BLOOD PARAMETER RESULT Blood Urea Nitrogen
Method Urease GLDH Kinetic
UNIT mg/dl
87.15
6 to 20
0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
4.12
mg/dl
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
142.0 3.4
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.A.N.Shukla Pt. Location: IPD/MICU Referred By: Dr.Alok Specimen: BLOOD PARAMETER Serum Urea
Methodology- Urease- GLDH, Kinetic
Age/Sex: 62y/M MRN:SH/LKO/007845/08/09 Lab No.:B-/08/1770 Date: 25.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
124.0 4.7
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Manish Tomar Pt. Location: IPD/M.I.C.U Referred By: Dr. R.Kohli Specimen: BLOOD PARAMETER RESULT TROPONIN T (Qualitative NEGATIVE Age/Sex: 45y/M MRN:SH/LKO/008184/09 Lab No.:B-/08/1763 Date: 24.8.2009 REFERENCE RANGE
UNIT
A positive result means that the concentration of troponin T in the sample is above the tests threshold value of 0.1ng/ml .This is evidence of cell damage to the myocardium. *Test performed by Troponin T Rapid test from Roche Diagnostics GmbH.
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Sunita Malhotra Pt. Location: IPD/ MICU Referred By: Dr. S.K Somani Specimen: BLOOD PARAMETER RESULT Serum Urea
Methodology- Urease- GLDH, Kinetic
Age/Sex: 51y/F MRN:SH/LKO/007253/08/09 Lab No.:B-/08/1771 Date: 25.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30
344.7 3.06
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
141.0 4.4
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Dr. Manish Tomar Pt. Location: IPD/M.I.C.U Referred By: Specimen: Blood PARAMETER RESULT Serum Urea
Methodology- Urease- GLDH, Kinetic
Age/Sex: y/M MRN:SH/LKO/008184/09 Lab No.:B-/08/1772 Date: 25.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30
77.6 0.86
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
116.0 4.5
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Jagdish Pandey Pt. Location: IPD/SICU Referred By: Dr. M Ahamad Specimen: BLOOD PARAMETER RESULT Blood Urea Nitrogen
Method Urease GLDH Kinetic
UNIT mg/dl
48.23
6 to 20
0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
4.91
mg/dl
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
131.0 2.9
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Mohd Farooq Pt. Location: IPD/SICU Referred By: Dr. Ravi Dubey Specimen: BLOOD PARAMETER RESULT Blood Urea Nitrogen
Method Urease GLDH Kinetic
UNIT mg/dl
99.59
6 to 20
0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
8.81
mg/dl
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
126.0 4.8
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY
Mrs. Hero Rani Rastogi OPD Dr. S.K Singh BLOOD Tr. No. 20488 RESULT UNIT 115.0 mg/dl
Age/Sex: y/F MRN:SH/LKO/008162/09 Lab No.B-08/1722 Date: 24-8-2009 REFERENCE RANGE 70 - 110
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
201.9
mg/dl
70 - 140
Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
0.71
mg/dl
0.70 - 1.30
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Hero Rani Rastogi Age/Sex: y/F
Pt. Location: OPD Referred By: Dr. S.K Singh Specimen: BLOOD PARAMETER
LIPID PROFILE
Total Serum Cholesterol
80.1 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)
Serum Triglycerides 52.6 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 28.4 mg/dl
(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)
40.9
mg/dl
10.52
mg/dl
10 to 40
2.81
mg/dl
Less 4.5
1.44
mg/dl
Less 3.0
Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Ashish Mitra Pt. Location: IPD/MICU Referred By: Dr.Mazhar Husain Specimen: BLOOD PARAMETER RESULT Serum Urea
Methodology- Urease- GLDH, Kinetic
Age/Sex: 38y/M MRN:SH/LKO/007836/08/09 Lab No.:B-/08/1779 Date: 25.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30
112.4 1.92
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY
Mr.Bharat Lal IPD/G/W Dr. H.N Triphati BLOOD RESULT 74.6 UNIT mg/dl
6 to 20
0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
5.4
mg/dl
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
130.0 4.2
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY
Mr. Bhullar Prasad IPD/G/W Dr. Sablok Blood RESULT 127.0 UNIT mg/dl
Age/Sex: 62/M MRN:SH/LKO/008207/09 Lab No.:B-/08/1781 Date: 25.8.2009 REFERENCE RANGE 70 - 110
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY
8.6 %
A 1C
(%)
* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Fakkruddin Age/Sex: 72y/F
Pt. Location: IPD/E/W Referred By: Dr. Mufazal Ahmad Specimen: BLOOD PARAMETER RESULT Blood Urea Nitrogen
Method Urease GLDH Kinetic
67.48 5.95
6 to 20
0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
135.0 4.4
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Shiv Balak Singh Age/Sex: 66/M
Pt. Location: IPD/G/W Referred By: Dr. Alok Specimen: Blood PARAMETER Blood Sugar Fasting
RESULT 185.2
UNIT mg/dl
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Anoop Bansal Age/Sex: 43y/M
Pt. Location: IPD/ E/W Referred By: Dr. Mufazal Ahmed Specimen: BLOOD PARAMETER RESULT Serum Uric Acid
(Method : Uricase-POD)
MRN:SH/LKO/008002/08/09 Lab No.:B-/08/1784 Date: 25.8.2009 REFERENCE RANGE 2.5 6.8 0.70 - 1.30
10.61
4.85
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
137.0 3.4
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mast.Mohd Sadab Age/Sex: 6y/M
Pt. Location: IPD/NICU Referred By: Dr.Mazhar Husain Specimen: BLOOD PARAMETER RESULT
UNIT
168.0 4.5
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Maneesh Kumar Pt. Location: OPD Referred By: Dr. Self Age/Sex: 38 y/M MRN:SH/LKO/008230/09 Lab No.B-08/1788
UNIT
LIPID PROFILE
Total Serum Cholesterol
203.6 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)
Serum Triglycerides 166.2 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 43.8 mg/dl
(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)
126.6
mg/dl
33.24
mg/dl
10 to 40
4.65
mg/dl
Less 4.5
2.89
mg/dl
Less 3.0
Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Maneesh Kumar Pt. Location: OPD Referred By: Dr. Self Specimen: BLOOD Tr. No. Age/Sex: 38 y/M MRN:SH/LKO/008230/09 Lab No.B-08/1788 Date: 25-8-2009
RESULT 101.1
UNIT mg/dl
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl According to Amercian diabetes association, 2004
86.4
IU/I
0 - 42
17.08 0.91
mg/dl mg/dl
6 to 20
0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Justic O.P Srivastava Pt. Location: OPD Referred By: Dr. Mahesh Chandra Specimen: BLOOD Tr. No. PARAMETER RESULT Age/Sex: 65 y/M MRN:SH/LKO/008228/09 Lab No.B-08/1789 Date: 25-8-2009 REFERENCE RANGE
UNIT
100.0
mg/dl
70 - 110
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl According to Amercian diabetes association, 2004
15.7
IU/I
0 - 42
12.31 0.88
mg/dl mg/dl
6 to 20
0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Justic O.P Srivastava Pt. Location: OPD Referred By: Dr. Mahesh Chandra Specimen: BLOOD Tr. No. PARAMETER RESULT
LIPID PROFILE
UNIT
213.8 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)
Serum Triglycerides 176.1 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 66.9 mg/dl
(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)
111.8
mg/dl
35.21
mg/dl
10 to 40
3.2
mg/dl
Less 4.5
1.67
mg/dl
Less 3.0
Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Vaibhav Kumar Pt. Location: OPD Referred By: Dr. H.N Triphati Specimen: BLOOD Tr. No. 22065 PARAMETER RESULT UNIT Age/Sex: 31 y/M MRN:SH/LKO/004815/09 Lab No.B-08/1790 Date: 25-8-2009 REFERENCE RANGE
7.08
mg/dl
2.5 6.8
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Paras Ram Agarwal Pt. Location: OPD Referred By: Dr. H.N Triphati Specimen: BLOOD Tr. No. 22067 PARAMETER RESULT UNIT Blood Sugar Fasting 110.0 mg/dl Age/Sex: 65y/M MRN:SH/LKO/00820/09 Lab No.B-08/1791 Date: 25-8-2009 REFERENCE RANGE 70 - 110
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
185
mg/dl
70 - 140
Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Kaushlya Devi Pt. Location: OPD Referred By: Dr. H.N Triphati Specimen: BLOOD Tr. No. 20714 PARAMETER RESULT UNIT Blood Sugar Fasting
(Method: - GOD-POD)
Age/Sex: 64y/F MRN:SH/LKO/008219/09 Lab No.B-08/1792 Date: 25-8-2009 REFERENCE RANGE 70 - 110
167.5
mg/dl
(Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
264
mg/dl
70 - 140
Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004
Serum Urea
Methodology- Urease- GLDH, Kinetic
33.9 0.78
mg/dl mg/dl
13 - 43 0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Kaushlya Devi Pt. Location: OPD Referred By: Dr. H.N Triphati Specimen: BLOOD Tr. No. 20714 PARAMETER RESULT UNIT LIVER FUNCTION TEST 0.48 Total Serum Bilirubin mg/dl Age/Sex: 64y/F MRN:SH/LKO/008219/09 Lab No.B-08/1792 Date: 25-8-2009 REFERENCE RANGE 0.30 - 1.20
0.13 0.32
mg/dl mg/dl
16.6
IU/I
0 - 42
14.2
IU/I
0 - 42
81
IU/I
42 - 128
7.24
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Surender Kumar Age/Sex: 65y/M Pt. Location: IPD/ T.ICU MRN:SH/LKO/007690/08/09 Referred By: Dr. H.N Triphati Lab No.:B-/08/1815 Specimen: BLOOD Date: 25.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 0.55 Total Serum Bilirubin mg/dl 0.30 - 1.20
0.20 0.35
mg/dl mg/dl
64
IU/I
0 - 42
45
IU/I
0 - 42
92
IU/I
42 - 128
5.37
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Sabir Khan Pt. Location: OPD Referred By: Dr.S.K.Singh Specimen: BLOOD PARAMETER
Total Serum Cholesterol
LIPID PROFILE
190.8 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)
Serum Triglycerides 243.8 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 28.6 mg/dl
(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)
113.4
mg/dl
48.76
mg/dl
10 to 40
6.68
mg/dl
Less 4.5
3.97
mg/dl
Less 3.0
Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Sunil Agarwal Pt. Location: OPD Referred By: Dr.S.K.Singh Specimen: BLOOD Tr. No. 072 PARAMETER RESULT Blood Sugar Fasting 65.8 Age/Sex: 56y/M MRN:SH/LKO/008083/09 Lab No.B-08/1835 Date: 22-8-2009 REFERENCE RANGE 70 - 110
UNIT mg/dl
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl According to Amercian diabetes association, 2004
28.3
mg/dl
6 to 20
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
1.02
mg/dl
0.70 - 1.30
Serum Calcium
(Method: arsenazo III)
9.59
mg/dl mg/dl
5.4
CK-MB
Method- Immunoinhibition
18 39.6 137
0-25 38 - 174
135 - 225
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Sunil Agarwal Pt. Location: OPD Referred By: Dr.S.K.Singh Specimen: BLOOD Tr. No. 072 PARAMETER RESULT UNIT LIVER FUNCTION TEST 0.30 Total Serum Bilirubin mg/dl
(Method: Walter And Gerarde)
Age/Sex: 56y/M MRN:SH/LKO/008083/09 Lab No.B-08/1835 Date: 22-8-2009 REFERENCE RANGE 0.30 - 1.20 0 - 0.20 0.08 - 0.75
0.13 0.17
mg/dl mg/dl
25.5
IU/I
0 - 42
18.7
IU/I
0 - 42
56.7
IU/I
42 - 128
6.95
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Sunil Agarwal Pt. Location: OPD Referred By: Dr.S.K.Singh Specimen: BLOOD Tr. No. 072 PARAMETER RESULT
LIPID PROFILE
Total Serum Cholesterol
130.7 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)
UNIT
Serum Triglycerides 83.6 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl)
43.8
mg/dl
(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)
70.2
mg/dl
16.71
mg/dl
10 to 40
2.98
mg/dl
Less 4.5
1.6
mg/dl
Less 3.0
Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Alok Swaroop Pt. Location: OPD Referred By: Dr.H.N.Tripathi Specimen: BLOOD PARAMETER RESULT Blood Sugar Post Prandial 353.7 Age/Sex: 44y/M MRN:SH/LKO/008269/09 Lab No.B-08/1828 Date: 25-8-2009 REFERENCE RANGE 70 - 140
UNIT mg/dl
Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Rajesh Kumar Agarwal Pt. Location: OPD Referred By: Dr.H.N.Tripathi Specimen: BLOOD Tr.No.20298 PARAMETER RESULT Blood Sugar Post Prandial 81.4 Age/Sex: 43y/M MRN:SH/LKO/008260/09 Lab No.B-08/1822 Date: 25-8-2009 REFERENCE RANGE 70 - 140
UNIT mg/dl
Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Manish Singh Pt. Location: OPD Referred By: Dr.Farah Arshad Specimen: BLOOD Tr.No.20802 PARAMETER RESULT UNIT LIVER FUNCTION TEST 1.10 Total Serum Bilirubin mg/dl
(Method: Walter And Gerarde)
Age/Sex: 25y/M MRN:SH/LKO/008015/08/09 Lab No.B-08/1823 Date: 25-8-2009 REFERENCE RANGE 0.30 - 1.20 0 - 0.20 0.08 - 0.75
0.29 0.81
mg/dl mg/dl
16
IU/I
0 - 42
18.8
IU/I
0 - 42
56.2
IU/I
42 - 128
7.29
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Syed Aliwahid Zaidi Pt. Location: OPD Referred By: Dr.H.N.Tripathi Specimen: BLOOD Tr.No.20 PARAMETER RESULT UNIT LIVER FUNCTION TEST 0.40 Total Serum Bilirubin mg/dl
(Method: Walter And Gerarde)
Age/Sex: 54y/M MRN:SH/LKO/008259/08/09 Lab No.B-08/1827 Date: 25-8-2009 REFERENCE RANGE 0.30 - 1.20 0 - 0.20 0.08 - 0.75
0.16 0.25
mg/dl mg/dl
14.7
IU/I
0 - 42
28
IU/I
0 - 42
135.3
IU/I
42 - 128
6.56
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.John Christophar Pt. Location: OPD Referred By: Dr.P.K.Samshrey Specimen: BLOOD PARAMETER RESULT Serum Uric Acid
(Method : Uricase-POD)
UNIT mg/dl
Age/Sex: 27y/M MRN:SH/LKO/00/08/09 Lab No.B-08/1831 Date: 25-8-2009 REFERENCE RANGE 2.5 6.8
10.51
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. C reactive protein(C.R.P)
<3.08
mg/L
less than 3
*CRP is an acute phase reactant appeared in plasma during many infectious or inflammatory conditions CRP assay provides useful information for the diagnosis,therapy and monitoring of inflammatory processes and associated diseases.
Increase in CRP values are non specific and should not be interpreted without a complete clinical history.
Note : above test carried out by BN ProSpec Nephlometer Automated Analyzer .
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Sonal Agarwal Pt. Location: OPD Referred By: Dr. Specimen: BLOOD Tr.No.881 PARAMETER RESULT Blood Sugar Random 72.3 Age/Sex: 29y/F MRN:SH/LKO/00138/08/09 Lab No.B-08/1831 Date: 25-8-2009 REFERENCE RANGE 70 - 140
UNIT mg/dl
(Method: - GOD-POD) (Normal 140mg/dl, Impaired glucose tolerance 140-199 mg/dl, Diabetes mellitus 200mg/dl According to Amercian diabetes association, 2004
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Tek Narayan Pt. Location: OPD Referred By: Dr.P.K.Samshrey Specimen: BLOOD Tr.No.20 PARAMETER RESULT
C reactive protein(C.R.P)
UNIT
94.2
mg/L
less than 3
*CRP is an acute phase reactant appeared in plasma during many infectious or inflammatory conditions CRP assay provides useful information for the diagnosis,therapy and monitoring of inflammatory processes and associated diseases. Increase in CRP values are non specific and should not be interpreted without a complete clinical history.
Note : above test carried out by BN ProSpec Nephlometer Automated Analyzer .
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Tek Narayan Pt. Location: OPD Referred By: Dr.P.K.Samshrey Specimen: Fluid Tr.No.20 PARAMETER RESULT Age/Sex: 47y/M MRN:SH/LKO/00138/08/09 Lab No.B-08/1829 Date: 25-8-2009 REFERENCE RANGE
UNIT
4.2
mg/dl
79.6 6.71
mg/dl g/dl
Interpretation of SF glucose values requires comparision with serum levels,preceded by 8 hours to allow glucose to equilibrate across the synovial membrane.The serum - synovial differential is less than 10 mg/dl in normal and many non inflammatory conditions.In septic arthritis,this difference ranges from 20-
60 mg/dl. Measurement of SF protein is non specific:the sensitivity is about 52% and the specificity 56% for inflammatory conditions.
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Mohd Qasim Pt. Location: OPD Referred By: Dr. H,N,Tripathi Specimen: BLOOD PARAMETER Blood Sugar Fasting Age/Sex: 49y/M MRN:SH/LKO/008262/08/09 Lab No.B-08/1826 Date: 25-8-2009 REFERENCE RANGE 70 - 110
UNIT mg/dl
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
Serum Urea
Methodology- Urease- GLDH, Kinetic
37.7 1.3
mg/dl mg/dl
13 - 43 0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Mohd Qasim Pt. Location: OPD Referred By: Dr. H,N,Tripathi Specimen: BLOOD PARAMETER
Total Serum Cholesterol
Tr.No.20832 RESULT
UNIT
LIPID PROFILE
206 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)
Serum Triglycerides 184.6 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 35.6 mg/dl
(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)
133.6
mg/dl
(Method-Direct enzymaticCHE&CO) (<100 optimal, 100 129 near optimal/ above optimal; 130 -159 mg/dl Border line High; 160 -189 mg/dl High, 190= very high)
36.91
mg/dl
10 to 40
5.8
mg/dl
Less 4.5
3.76
mg/dl
Less 3.0
Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Mohd Qasim Pt. Location: OPD Referred By: Dr. H,N,Tripathi Specimen: URINE PARAMETER Age/Sex: 49y/M MRN:SH/LKO/008262/08/09 Lab No.B-08/1826 Date: 25-8-2009 REFERENCE RANGE
Tr.No.20832 RESULT
UNIT
Microalbuminuria is the presence of albumin in the urine above the normal levels bu below the detectable range of conventional methods. Urine albumin levels from 20-200 mg/L are an indicator of early or possibly reversible glomerular damage.In diabetic patients ,microalbulinemia is associated with a four to six fold increase in cardiovascular mortality,and an independent risk factor for renal mortality.It is also more prevelant in hypertensive subjects Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mast.Mohd Sadab Pt. Location: IPD/PICU Referred By: Dr.M.U.Hasan Specimen: BLOOD PARAMETER RESULT
C reactive protein(C.R.P)
UNIT
<3.08
mg/L
less than 3
*CRP is an acute phase reactant appeared in plasma during many infectious or inflammatory conditions CRP assay provides useful information for the diagnosis,therapy and monitoring of inflammatory processes and associated diseases. Increase in CRP values are non specific and should not be interpreted without a complete clinical history.
Note : above test carried out by BN ProSpec Nephlometer Automated Analyzer .
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Bhullar Prasad Pt. Location: IPD/G/W Referred By: Dr. Sablok Specimen: Blood PARAMETER RESULT Blood Sugar Post Prandial 232.2 Age/Sex: 62/M MRN:SH/LKO/008207/09 Lab No.:B-/08/1820 Date: 25.8.2009 REFERENCE RANGE 70 - 140
UNIT mg/dl
Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Bharti Lal Pt. Location: OPD Referred By: M.H.C Specimen: URINE PARAMETER Blood Sugar Fasting Age/Sex: 42y/F MRN:SH/LKO/008279/08/09 Lab No.B-08/1832 Date: 25-8-2009 REFERENCE RANGE 70 - 110
UNIT mg/dl
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
6 to 20
0.70 - 1.30 8.4- 10.4
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Serum Calcium
(Method: arsenazo III)
Phosphorus
(Method: phosphomolybdate UV
2.5 - 4.5
5.23
mg/dl
2.5 6.8
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
1.21
mmol/l
1.12 1.32
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Bharti Lal Pt. Location: OPD Referred By: M.H.C Specimen: URINE Tr.No.93 PARAMETER RESULT UNIT LIVER FUNCTION TEST 0.41 Total Serum Bilirubin mg/dl
(Method: Walter And Gerarde)
0.10. 0.32
mg/dl mg/dl
34
IU/I
0 - 42
26.7
IU/I
0 - 42
82.2
IU/I
42 - 128
7.48
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Bharti Lal Pt. Location: OPD Referred By: M.H.C Specimen: URINE PARAMETER
Total Serum Cholesterol
Tr.No.93 RESULT
UNIT
189.3 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)
Serum Triglycerides 186.9 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 30.6 mg/dl
(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)
121.3
mg/dl
37.37
mg/dl
10 to 40
6.19
mg/dl
Less 4.5
3.97
mg/dl
Less 3.0
Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Bharti Lal Pt. Location: OPD Referred By: M.H.C Specimen: URINE PARAMETER
ApolipoProtein Estimation Apolipoprotein A1 (Apo-A1)
(Method :Immunonephelometric assay) 119
Tr.No.93 RESULT
UNIT
Apolipoprotein B (Apo-B)
(Method :Immunonephelometric assay)
99
apo-A1/apo-B Ratio
1.2
( Elevation of apo B (present in chylomicrons, VLDL, HDL and LDL), decrease in apo A-1 (present mostly in HDL), and decrease in the apo A -1/apo B ratio have been associated with increased risk of CHD)
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Bharti Lal Pt. Location: OPD Referred By: M.H.C Specimen: URINE PARAMETER Age/Sex: 42y/F MRN:SH/LKO/008279/08/09 Lab No.B-08/1832 Date: 25-8-2009 REFERENCE RANGE
Tr.No.93 RESULT
UNIT
6.2%
A 1C
(%)
* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended.
* Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.A.B.Lal Pt. Location: OPD Referred By: M.H.C Specimen: URINE PARAMETER Blood Sugar Fasting Age/Sex: 47y/M MRN:SH/LKO/008275/08/09 Lab No.B-08/1833 Date: 25-8-2009 REFERENCE RANGE 70 - 110
UNIT mg/dl
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
6 to 20
0.70 - 1.30 8.4- 10.4
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Serum Calcium
(Method: arsenazo III)
Phosphorus
(Method: phosphomolybdate UV
2.5 - 4.5
8.42
mg/dl
2.5 6.8
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
1.14
mmol/l
1.12 1.32
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.A.B.Lal Pt. Location: OPD Referred By: M.H.C Specimen: URINE PARAMETER Total Serum Bilirubin
(Method: Walter And Gerarde)
49.2
IU/I
0 - 42
23
IU/I
0 - 42
98
IU/I
42 - 128
7.24
g/dl
6.0 - 8.3
(Method: Biuret)
Serum Albumin
(Method: Bromo Cresol Green BCG))
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.A.B.Lal Pt. Location: OPD Referred By: M.H.C Specimen: URINE PARAMETER
Total Serum Cholesterol
Tr.No.92 RESULT
UNIT
142.3 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)
Serum Triglycerides 155.8 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 28.3 mg/dl
(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)
82.8
mg/dl
31.16
mg/dl
10 to 40
5.03
mg/dl
Less 4.5
2.93
mg/dl
Less 3.0
Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.A.B.Lal Pt. Location: OPD Referred By: M.H.C Specimen: URINE PARAMETER
ApolipoProtein Estimation Apolipoprotein A1 (Apo-A1)
(Method :Immunonephelometric assay) 104
Tr.No.92 RESULT
UNIT
Apolipoprotein B (Apo-B)
(Method :Immunonephelometric assay)
76.5
apo-A1/apo-B Ratio
1.35
( Elevation of apo B (present in chylomicrons, VLDL, HDL and LDL), decrease in apo A-1 (present mostly in HDL), and decrease in the apo A -1/apo B ratio have been associated with increased risk of CHD)
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.A.B.Lal Pt. Location: OPD Referred By: M.H.C Specimen: URINE PARAMETER Age/Sex: 47y/M MRN:SH/LKO/008275/08/09 Lab No.B-08/1833 Date: 25-8-2009 REFERENCE RANGE
Tr.No.92 RESULT
UNIT
7.0%
A 1C
(%)
* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Shiv Balak Singh Pt. Location: IPD/G/W Referred By: Dr.Alok Specimen: Blood PARAMETER RESULT Age/Sex: 66/M MRN:SH/LKO/008138/09 Lab No.:B-/08/1842 Date: 25.8.2009 REFERENCE RANGE
UNIT
12.3
IU/I
0 - 42
19.2
IU/I
0 - 42
265.7
IU/I
42 - 128
6.38
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: B/O.Salma Pt. Location: IPD/PICU Referred By: Dr.M.U.Hasan Specimen: Blood PARAMETER Total Serum Bilirubin
(Method: Walter And Gerarde)
RESULT
22.38 1.27 21.11
UNIT
mg/dl mg/dl mg/dl
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Nidhi Sharma Pt. Location: IPD/E.W Referred By: Dr.Swadesh Specimen: Blood PARAMETER RESULT Serum Urea
Methodology- Urease- GLDH, Kinetic
Age/Sex: 20y/F MRN:SH/LKO/003293/09 Lab No.:B-/08/1848 Date: 25.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
138.0 4.3
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Jeet Bahadur Verma Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT UNIT
110.7
mg/dl
70 - 110
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
127
mg/dl
70 - 140
Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004
6 to 20
0.70 - 1.30 8.4- 10.4
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Serum Calcium
(Method: arsenazo III)
Phosphorus
(Method: phosphomolybdate UV
2.5 - 4.5
6.1
mg/dl
2.5 6.8
(Method : Uricase-POD)
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
1.21
mmol/l
1.12 1.32
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Jeet Bahadur Verma Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT 0.43 0.12 0.3 UNIT mg/dl mg/dl mg/dl
27.2
IU/I
0 - 42
18
IU/I
0 - 42
95.8
IU/I
42 - 128
8.08
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
3.8
g/dl
3.2 - 5.0
4.28 0.88
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Jeet Bahadur Verma Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT LIPID PROFILE UNIT
165.8 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)
Serum Triglycerides 121.2 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 33.4 mg/dl
(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)
90
mg/dl
42.44
mg/dl
10 to 40
4.97
mg/dl
Less 4.5
2.7
mg/dl
Less 3.0
Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Jeet Bahadur Verma Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT UNIT
Apolipoprotein B (Apo-B)
(Method :Immunonephelometric assay)
92
apo-A1/apo-B Ratio
1.34
( Elevation of apo B (present in chylomicrons, VLDL, HDL and LDL), decrease in apo A-1 (present mostly in HDL), and decrease in the apo A -1/apo B ratio have been associated with increased risk of CHD)
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Jeet Bahadur Verma Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT UNIT
6.9%
A 1C
(%)
* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Ashok Kumar Dixit Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT UNIT
117
mg/dl
70 - 110
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
156.2
mg/dl
70 - 140
Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004
6 to 20
0.70 - 1.30 8.4- 10.4
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Serum Calcium
(Method: arsenazo III)
Phosphorus
(Method: phosphomolybdate UV
2.5 - 4.5
4.48
mg/dl
2.5 6.8
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
1.24
mmol/l
1.12 1.32
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Ashok Kumar Dixit Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT 0.37 0.11 0.27 UNIT mg/dl mg/dl mg/dl
36.8
IU/I
0 - 42
31.4
IU/I
0 - 42
58.7
IU/I
42 - 128
7.78
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
4 3.48 1.14
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Ashok Kumar Dixit Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT LIPID PROFILE UNIT
220.2 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)
Serum Triglycerides 214.6 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 39.9 mg/dl
(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)
137.4
mg/dl
42.92
mg/dl
10 to 40
5.51
mg/dl
Less 4.5
3.44
mg/dl
Less 3.0
Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002)
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Ashok Kumar Dixit Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT UNIT
Apolipoprotein B (Apo-B)
(Method :Immunonephelometric assay)
116
apo-A1/apo-B Ratio
1.1
( Elevation of apo B (present in chylomicrons, VLDL, HDL and LDL), decrease in apo A-1 (present mostly in HDL), and decrease in the apo A -1/apo B ratio have been associated with increased risk of CHD)
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Ashok Kumar Dixit Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT UNIT
8.3%
A 1C
(%)
* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Chhote Lal Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT UNIT
83
mg/dl
70 - 110
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
104
mg/dl
70 - 140
Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004
6 to 20
0.70 - 1.30 8.4- 10.4
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Serum Calcium
(Method: arsenazo III)
Phosphorus
(Method: phosphomolybdate UV
2.5 - 4.5
4.9
mg/dl
2.5 6.8
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
1.23
mmol/l
1.12 1.32
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Chhote Lal Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT 0.55 0.15 0.4 UNIT mg/dl mg/dl mg/dl
59.9
IU/I
0 - 42
44.9
IU/I
0 - 42
79
IU/I
42 - 128
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
4 4 1
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Chhote Lal Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT LIPID PROFILE UNIT
177.4 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)
Serum Triglycerides 125.4 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 40.2 mg/dl
(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)
112
mg/dl
25.08
mg/dl
10 to 40
4.41
mg/dl
Less 4.5
2.79
mg/dl
Less 3.0
Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Chhote Lal Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT UNIT
Apolipoprotein B (Apo-B)
(Method :Immunonephelometric assay)
91.1
apo-A1/apo-B Ratio
1.33
( Elevation of apo B (present in chylomicrons, VLDL, HDL and LDL), decrease in apo A-1 (present mostly in HDL), and decrease in the apo A -1/apo B ratio have been associated with increased risk of CHD)
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Chhote Lal Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT UNIT
5.8%
A 1C
(%)
* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Laxmi Narayan Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT UNIT
160
mg/dl
70 - 110
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
178.5
mg/dl
70 - 140
Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004
6 to 20
0.70 - 1.30 8.4- 10.4
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Serum Calcium
(Method: arsenazo III)
Phosphorus
(Method: phosphomolybdate UV
2.5 - 4.5
4.6
mg/dl
2.5 6.8
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
1.23
mmol/l
1.12 1.32
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Laxmi Narayan Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT 0.68 0.17 0.51 UNIT mg/dl mg/dl mg/dl
22.8
IU/I
0 - 42
19
IU/I
0 - 42
108
IU/I
42 - 128
8.18
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
4.1 4.08 1
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD)
Checked by..
Associate Consultant
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Laxmi Narayan Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT LIPID PROFILE UNIT
215 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)
Serum Triglycerides 127.9 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 46 mg/dl
(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)
143.3
mg/dl
25.58
mg/dl
10 to 40
4.66
mg/dl
Less 4.5
3.11
mg/dl
Less 3.0
Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Laxmi Narayan Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT UNIT
Apolipoprotein B (Apo-B)
(Method :Immunonephelometric assay)
114
apo-A1/apo-B Ratio
1.13
( Elevation of apo B (present in chylomicrons, VLDL, HDL and LDL), decrease in apo A-1 (present mostly in HDL), and decrease in the apo A -1/apo B ratio have been associated with increased risk of CHD)
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Laxmi Narayan Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT UNIT
9.9%
A 1C
(%)
* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.H.R.Verma Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT UNIT
83.4
mg/dl
70 - 110
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
105.8
mg/dl
70 - 140
Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004
6 to 20
0.70 - 1.30 8.4- 10.4
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Serum Calcium
(Method: arsenazo III)
Phosphorus
(Method: phosphomolybdate UV
2.5 - 4.5
7.15
mg/dl
2.5 6.8
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
1.24
mmol/l
1.12 1.32
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
Associate Consultant
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.H.R.Verma Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT 0.55 0.13 0.42 UNIT mg/dl mg/dl mg/dl
80.9
IU/I
0 - 42
47.6
IU/I
0 - 42
104.5
IU/I
42 - 128
7.47
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
4 3.47 1.15
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.H.R.Verma Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT LIPID PROFILE UNIT
165.2 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)
Serum Triglycerides 167.1 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 29.5 mg/dl
(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)
102.2
mg/dl
33.41
mg/dl
10 to 40
5.59
mg/dl
Less 4.5
3.46
mg/dl
Less 3.0
Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.H.R.Verma Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT UNIT
Apolipoprotein B (Apo-B)
(Method :Immunonephelometric assay)
97.3
apo-A1/apo-B Ratio
1.17
( Elevation of apo B (present in chylomicrons, VLDL, HDL and LDL), decrease in apo A-1 (present mostly in HDL), and decrease in the apo A -1/apo B ratio have been associated with increased risk of CHD)
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.H.R.Verma Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT UNIT
6.1%
A 1C
(%)
* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Mahipal Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT UNIT
88.5
mg/dl
70 - 110
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
106.5
mg/dl
70 - 140
Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004
6 to 20
0.70 - 1.30 8.4- 10.4
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Serum Calcium
(Method: arsenazo III)
Phosphorus
(Method: phosphomolybdate UV
2.5 - 4.5
6.14
mg/dl
2.5 6.8
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
1.15
mmol/l
1.12 1.32
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Mahipal Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT 0.35 0.06 0.29 UNIT mg/dl mg/dl mg/dl
26.4
IU/I
0 - 42
25.6
IU/I
0 - 42
98.5
IU/I
42 - 128
7.02
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Mahipal Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT LIPID PROFILE UNIT
184.6 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)
Serum Triglycerides 206.8 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 38.2 mg/dl
(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)
105.1
mg/dl
41.37
mg/dl
10 to 40
4.83
mg/dl
Less 4.5
2.75
mg/dl
Less 3.0
Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Mahipal Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT UNIT
Apolipoprotein B (Apo-B)
(Method :Immunonephelometric assay)
92
apo-A1/apo-B Ratio
1.38
( Elevation of apo B (present in chylomicrons, VLDL, HDL and LDL), decrease in apo A-1 (present mostly in HDL), and decrease in the apo A -1/apo B ratio have been associated with increased risk of CHD)
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Mahipal Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT UNIT
5.8%
A 1C
(%)
* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.R.N.Thakur Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT UNIT
85.1
mg/dl
70 - 110
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
109
mg/dl
70 - 140
Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004
6 to 20
0.70 - 1.30 8.4- 10.4
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Serum Calcium
(Method: arsenazo III)
Phosphorus
(Method: phosphomolybdate UV
2.5 - 4.5
6.02
mg/dl
2.5 6.8
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
1.24
mmol/l
1.12 1.32
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.R.N.Thakur Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT 0.45 0.12 0.33 UNIT mg/dl mg/dl mg/dl
25.7
IU/I
0 - 42
23.7
IU/I
0 - 42
73
IU/I
42 - 128
7.79
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.R.N.Thakur Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT LIPID PROFILE
137.9
mg/dl
(Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl) Serum Triglycerides 124.7 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 24.6 mg/dl
(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)
88.3
mg/dl
24.95
mg/dl
10 to 40
5.66
mg/dl
Less 4.5
3.58
mg/dl
Less 3.0
Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.R.N.Thakur Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT UNIT
Apolipoprotein B (Apo-B)
(Method :Immunonephelometric assay)
80.2
apo-A1/apo-B Ratio
1.2
( Elevation of apo B (present in chylomicrons, VLDL, HDL and LDL), decrease in apo A-1 (present mostly in HDL), and decrease in the apo A -1/apo B ratio have been associated with increased risk of CHD)
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.R.N.Thakur Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT UNIT
5.6%
A 1C
(%)
* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Rajesh Kumar Agarwal Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT UNIT
94
mg/dl
70 - 110
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
17.4
mg/dl
6 to 20
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Serum Calcium
(Method: arsenazo III)
Phosphorus
(Method: phosphomolybdate UV
2.5 - 4.5
8.44
mg/dl
2.5 6.8
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
1.21
mmol/l
1.12 1.32
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Rajesh Kumar Agarwal Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT 0.54 0.16 0.38 UNIT mg/dl mg/dl mg/dl
16.6
IU/I
0 - 42
23.1
IU/I
0 - 42
72.3
IU/I
42 - 128
7.25
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Rajesh Kumar Agarwal Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT LIPID PROFILE UNIT
139 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)
Serum Triglycerides 92.8 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 45.8 mg/dl
(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)
74.6
mg/dl
18.56
mg/dl
10 to 40
3.03
mg/dl
Less 4.5
1.63
mg/dl
Less 3.0
Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Rajesh Kumar Agarwal Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT UNIT
Apolipoprotein B (Apo-B)
(Method :Immunonephelometric assay)
62.2
apo-A1/apo-B Ratio
2.34
( Elevation of apo B (present in chylomicrons, VLDL, HDL and LDL), decrease in apo A-1 (present mostly in HDL), and decrease in the apo A -1/apo B ratio have been associated with increased risk of CHD)
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Rajesh Kumar Agarwal Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT UNIT
6.0%
A 1C
(%)
* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs.Madhu Agarwal Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT UNIT
88.3
mg/dl
70 - 110
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
15.54
mg/dl
6 to 20
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Serum Calcium
(Method: arsenazo III)
Phosphorus
(Method: phosphomolybdate UV
2.5 - 4.5
5.41
mg/dl
2.5 6.8
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
1.22
mmol/l
1.12 1.32
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs.Madhu Agarwal Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT 0.28 0.06 0.22 UNIT mg/dl mg/dl mg/dl
14.4
IU/I
0 - 42
18.1
IU/I
0 - 42
78.2
IU/I
42 - 128
7.43
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs.Madhu Agarwal Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT LIPID PROFILE UNIT
292.6 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)
Serum Triglycerides 234.1 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 53.3 mg/dl
(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)
192.4
mg/dl
46.81
mg/dl
10 to 40
5.49
mg/dl
Less 4.5
3.61
mg/dl
Less 3.0
Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs.Madhu Agarwal Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT UNIT
Apolipoprotein B (Apo-B)
(Method :Immunonephelometric assay)
158
apo-A1/apo-B Ratio
( Elevation of apo B (present in chylomicrons, VLDL, HDL and LDL), decrease in apo A-1 (present mostly in HDL), and decrease in the apo A -1/apo B ratio have been associated with increased risk of CHD)
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs.Madhu Agarwal Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT UNIT
6.1%
A 1C
(%)
* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs.Pushpa Bansal Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT UNIT
77.2
mg/dl
70 - 110
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
10.35
mg/dl
6 to 20
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Serum Calcium
(Method: arsenazo III)
Phosphorus
(Method: phosphomolybdate UV
2.5 - 4.5
3.4
mg/dl
2.5 6.8
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
1.21
mmol/l
1.12 1.32
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs.Pushpa Bansal Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT 0.66 0.16 0.5 UNIT mg/dl mg/dl mg/dl
11.9
IU/I
0 - 42
15.6
IU/I
0 - 42
81.8
IU/I
42 - 128
7.66
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs.Pushpa Bansal Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT LIPID PROFILE UNIT
206.7 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)
Serum Triglycerides 122.9 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 45.6 mg/dl
(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)
136.6
mg/dl
24.59
mg/dl
10 to 40
4.54
mg/dl
Less 4.5
3.0
mg/dl
Less 3.0
Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry
Apolipoprotein B (Apo-B)
(Method :Immunonephelometric assay)
100
apo-A1/apo-B Ratio
1.38
( Elevation of apo B (present in chylomicrons, VLDL, HDL and LDL), decrease in apo A-1 (present mostly in HDL), and decrease in the apo A -1/apo B ratio have been associated with increased risk of CHD)
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry
5.7%
A 1C
(%)
* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs.Anju Bansal Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT UNIT
91.1
mg/dl
70 - 110
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
11.63
mg/dl
6 to 20
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Serum Calcium
(Method: arsenazo III)
Phosphorus
(Method: phosphomolybdate UV
2.5 - 4.5
4.13
mg/dl
2.5 6.8
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
1.22
mmol/l
1.12 1.32
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry
15.2
IU/I
0 - 42
16.6
IU/I
0 - 42
59
IU/I
42 - 128
7.58
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry
186.4 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)
Serum Triglycerides 88 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 51 mg/dl
(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)
117.9
mg/dl
17.59
mg/dl
10 to 40
3.66
mg/dl
Less 4.5
2.31
mg/dl
Less 3.0
Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs.Anju Bansal Age/Sex: 32y/F
Apolipoprotein B (Apo-B)
(Method :Immunonephelometric assay)
87
apo-A1/apo-B Ratio
1.68
( Elevation of apo B (present in chylomicrons, VLDL, HDL and LDL), decrease in apo A-1 (present mostly in HDL), and decrease in the apo A -1/apo B ratio have been associated with increased risk of CHD)
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs.Anju Bansal Age/Sex: 32y/F
5.3%
A 1C
(%)
* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Manish Pt. Location: IPD/MICU Referred By: Dr. R.Kohli Specimen: Blood PARAMETER Serum Sodium Serum Potassium
Age/Sex: 45/M MRN:SH/LKO/008184/09 Lab No.:B-/08/1851 Date: 24.8.2009 REFERENCE RANGE 135 - 145 3.5 - 5.5
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Ashish Mitra Pt. Location: IPD/MICU Referred By: Dr. M.Husain Specimen: Blood PARAMETER Serum Sodium Serum Potassium
Age/Sex: 38/M MRN:SH/LKO/007836/09 Lab No.:B-/08/1852 Date: 25.8.2009 REFERENCE RANGE 135 - 145 3.5 - 5.5
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Prahlad Rai Pt. Location: IPD/MICU Referred By: Dr. M.Husain Specimen: Blood PARAMETER Serum Sodium Serum Potassium
Age/Sex: 70/M MRN:SH/LKO/001386/09 Lab No.:B-/08/1855 Date: 25.8.2009 REFERENCE RANGE 135 - 145 3.5 - 5.5
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Kailashi Devi Pt. Location: IPD/E.W Referred By: Dr. H.N.Tripathi Specimen: Blood PARAMETER RESULT Serum Calcium
(Method: arsenazo III)
UNIT mg/dl
Age/Sex: 58/F MRN:SH/LKO/008295/09 Lab No.:B-/08/1854 Date: 25.8.2009 REFERENCE RANGE 8.4- 10.4
8.38
Serum Urea
Methodology- Urease- GLDH, Kinetic
42.1 0.78
mg/dl mg/dl
13 - 43 0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
130.0 4.30
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Kailashi Devi Pt. Location: IPD/E.W Referred By: Dr. H.N.Tripathi Specimen: Blood PARAMETER RESULT
UNIT
56
IU/I
0 - 42
47.7
IU/I
0 - 42
148
IU/I
42 - 128
7.52
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Dr. Manish Tomar Pt. Location: IPD/MICU Referred By: Dr.Vaibhav Khanna Specimen: Blood PARAMETER RESULT Serum Urea
Methodology- Urease- GLDH, Kinetic
Age/Sex: 45y/M MRN:SH/LKO/008184/09 Lab No.:B-/08/1870 Date: 26.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30
97 0.89
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
125.0 3.7
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Nidhi Mishra Pt. Location: IPD/G.W Referred By: Dr.Swadesh Singh Specimen: Blood PARAMETER RESULT
SERUM IRON 245
UNIT
g/dl
10
g/dl g/dl %
96.07
Iron is transported as Fe(111) bound to the plasma protein apotransferrin.Normally only about one third of the iron binding sites of transferrin are occupied by Fe(111).The additional amount of iron that can be bound is the unsaturated iron binding capacity (UIBC). The sum of the serum iron and UIBC represents TIBC.TIBC is a measurement for the maximum iron concentration that transferrin can bind. The serum TIBC varies in disorders of iron metabolism .In iron dediciency anemia the TIBC is elevated and the transferring saturation is lowered to 15% or less. Low serum iron associated with low TIBC is characteristic of the anemia of chronic disorders,malignant tumors,and infections. Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant
Checked by..
SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Anoop Bansal Pt. Location: IPD/ G/W Referred By: Dr.Sunil Dabadghao Specimen: BLOOD PARAMETER RESULT Blood Urea Nitrogen 57.05
Method Urease GLDH Kinetic
6 to 20
0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
5.11 9.02
Phosphorus
(Method: phosphomolybdate UV
2.5 - 4.5
2.5 6.8
10.53
mg/dl
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
137.0 3.10
mmol/l mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Hon'ble Mata Ji (Smt.Chhabi Roy) Age/Sex: 80Y/F
mg/dl
(Method-CHOD-PAP) (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl) Serum Triglycerides 107 mg/dl (Method-GPO-PAP) (Desirabl <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : (Low <40 mg/dl ;High 60 mg/dl) 62.5 mg/dl
21.4
mg/dl
10 to 40
2.36
mg/dl
Less 4.5
1.02
mg/dl
Less 3.0
Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Hon'ble Mata Ji (Smt.Chhabi Roy) Age/Sex: 80Y/F
13.7
IU/I
0 - 42
27.6
IU/I
0 - 42
125.7
IU/I
42 - 128
7.62
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Hon'ble Mata Ji (Smt.Chhabi Roy) Age/Sex: 80Y/F
160
mg/dl
70 - 140
(Method: - GOD-POD) (Normal 140mg/dl, Impaired glucose tolerance 140-199 mg/dl, Diabetes mellitus 200mg/dl According to Amercian diabetes association, 2004
Serum Urea
Methodology- Urease- GLDH, Kinetic
135.5 63.3
mg/dl mg/dl
13 - 43
6 to 20
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Serum Calcium
(Method: arsenazo III)
Phosphorus
(Method: phosphomolybdate UV
2.5 - 4.5
2.5 6.8
8.97
mg/dl
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Hon'ble Mata Ji (Smt.Chhabi Roy) Pt. Location: OPD Age/Sex: 80Y/F MRN:Ex.001498
Dr.H.P.Kumar, MD Blood
RESULT UNIT
mmol/l mmol/l
mmol/l
1.12 1.32
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs.Lakshmi Pt. Location: OPD Age/Sex: 70Y/F MRN:SH/LKO/008268/08/09
Dr.R.K.Mishra MD Blood
RESULT
Tr.No.20973 UNIT
226.4
mg/dl
70 - 110
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
Serum Urea
Methodology- Urease- GLDH, Kinetic
77
mg/dl
13 - 43
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs.Lakshmi Pt. Location: OPD Referred By: Dr.R.K.Mishra MD Specimen: Blood
PARAMETER RESULT LIPID PROFILE
Tr.No.20973 UNIT
284 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)
Serum Triglycerides 153 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 49.4 mg/dl
(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)
204
mg/dl
30.61
mg/dl
10 to 40
5.75
mg/dl
Less 4.5
4.13
mg/dl
Less 3.0
Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs.Rani Seth Age/Sex: 52Y/F
mg/dl
(Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl) Serum Triglycerides 91 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 44.5 mg/dl
(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)
87.49
mg/dl
18.23
mg/dl
10 to 40
3.38
mg/dl
Less 4.5
1.97
mg/dl
Less 3.0
Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs.Rani Seth Pt. Location: OPD Age/Sex: 52Y/F MRN:SH/LKO/010671/09
MHC Blood
RESULT UNIT
131.0
mg/dl
70 - 110
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
238
mg/dl
70 - 140
Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004
8.51
mg/dl
6 to 20
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
0.67
mg/dl
0.70 - 1.30
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs.Rani Seth Pt. Location: OPD Referred By: MHC Age/Sex: 52Y/F MRN:SH/LKO/010671/09 Lab No.:B-0/08/1880
Specimen:
PARAMETER
Blood
RESULT UNIT
Date:
10/14/2009
REFERENCE RANGE
8.8 %
A 1C
(%)
* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr. Kamini Singh Pt. Location: OPD Age/Sex: y/F52 MRN:11002616/11
143.0 3.0
mmol/l mmol/l
15.48
mg/dl
6 to 20
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
2.17
mg/dl
0.70 - 1.30
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs. Sanno Srivastava Pt. Location: OPD Referred By: Dr. G.Swaroop Age/Sex: y/F MRN:11003011/11 Lab No.:B-0/08/1809
Specimen:
PARAMETER
Blood
RESULT UNIT
REFERENCE RANGE
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
279
mg/dl
70 - 140
(Method: - GOD-POD) (Normal 140mg/dl, Impaired glucose tolerance 140-199 mg/dl, Diabetes mellitus 200mg/dl According to Amercian diabetes association, 2004
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs. Trisha Neogi Pt. Location: OPD Referred By: Dr. Neelam Vinay Specimen: Blood Age/Sex: 35y/F MRN:11009379/11 Lab No.:B-0/08/905 Date: 11/4/2011
PARAMETER
RESULT
UNIT
REFERENCE RANGE
ORAL GLUCOSE TOLERANACE TEST G.T.T (after 75 gram of glucose) Fasting plasma glucose 1 hour plasma glucose 2 hour plasma glucose 86 106 176 mg/dl mg/dl mg/dl 95 180 155
*Gestational diabetes mellitus diagnosed if 2 plasma glucose levels are exceeded (American Diabetes Association ,2004b).
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.C.P.Shukla Age/Sex: 41y/M
395
mg/dl
70 - 140
Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs.Nirmala Pt. Location: OPD Referred By: Specimen: Blood
PARAMETER RESULT UNIT
Age/Sex:
65Y/F
98.0
mg/dl
70 - 110
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
Serum Urea
Methodology- Urease- GLDH, Kinetic
24 0.7
mg/dl mg/dl
13 - 43 0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs.Mona Mishra Pt. Location: OPD Referred By: Specimen: Blood
PARAMETER RESULT UNIT
Age/Sex:
34Y/F
82.0
mg/dl
70 - 110
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
118
mg/dl
70 - 140
Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004
Homocysteine (HCY)
29.5
mol/L
5-15 mol/L
Homocysteine is an amino acid derived from methionine ,requiring ,vitamin B6 ,vitamin B12 and folic acid for further metabolizing.Mutation of the gene coding for homocysteine metabolism ,e.g.MTHFR ,result in hyperhomocysteinemia.Deficiency of folic acid ,vitamin B6,vitamin B12 are associated with increased plasma levels of homocysteine. Hyperhomocysteinemia is found to be associated with an increased risk for ischemic heart disease,stroke,peripherial arterial disease, and deep vein thrombosis,as well as neural tube defect and preeclampsia of pregnancy.An increased frequency of hyperhomocysteinemia is observed especially in elderly,smokers,patients with renal disease,diabetes ,or on a strict vegetarian diet
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Ashok Gupta Pt. Location: OPD Referred By: MHC Specimen: Blood
PARAMETER RESULT UNIT
313.0
mg/dl
70 - 110
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
0.77
mg/dl
0.70 - 1.30
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Ashok Gupta Pt. Location: OPD Referred By: MHC Specimen: Blood
PARAMETER RESULT UNIT
10.9 %
A 1C
(%)
* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Ashok Gupta Pt. Location: OPD Referred By: MHC Specimen: Blood
PARAMETER RESULT UNIT
273
mg/dl
70 - 140
Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr. Ram Dutt Dwivedi Pt. Location: OPD Referred By: Specimen: Blood
PARAMETER RESULT LIPID PROFILE
Total Serum Cholesterol
(Method-CHOD-PAP 186 mg/dl
Age/Sex:
67Y/
(Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl) Serum Triglycerides 135 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 42 mg/dl
(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)
117
mg/dl
27
mg/dl
10 to 40
4.42
mg/dl
Less 4.5
2.78
mg/dl
Less 3.0
Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr. Ram Dutt Dwivedi Pt. Location: OPD Referred By: Specimen: Blood
PARAMETER RESULT UNIT
Age/Sex:
67Y/
86.0
mg/dl
70 - 110
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
7.4
mg/dl
2.5 6.8
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
0.86 8.96
mg/dl mg/dl
Serum Calcium
(Method: arsenazo III)
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr. Ram Dutt Dwivedi Pt. Location: OPD Referred By: Specimen: Blood
PARAMETER C reactive protein(C.R.P) RESULT UNIT
Age/Sex:
67Y/
2.9
mg/L
less than 3
*CRP is an acute phase reactant appeared in plasma during many infectious or inflammatory conditions
CRP assay provides useful information for the diagnosis,therapy and monitoring of inflammatory processes and associated diseases. Increase in CRP values are non specific and should not be interpreted without a complete clinical history.
Note : above test carried out by BN ProSpec Nephlometer Automated Analyzer .
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr. S.C.Somani Pt. Location: OPD Referred By: Self Specimen: Blood
PARAMETER RESULT LIPID PROFILE
Total Serum Cholesterol
137 mg/dl
Age/Sex:
Y/
(Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)
Serum Triglycerides 132 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 39.7 mg/dl
(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)
70.61
mg/dl
26.46
mg/dl
10 to 40
3.45
mg/dl
Less 4.5
1.78
mg/dl
Less 3.0
Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr. S.C.Somani Pt. Location: OPD Referred By: Self Specimen: Blood
PARAMETER RESULT UNIT
Age/Sex:
Y/
Serum Urea
Methodology- Urease- GLDH, Kinetic
22 0.88
mg/dl mg/dl
13 - 43 0.70 - 1.30
Serum Creatinine
118.0
mg/dl
70 - 110
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
4.8
mg/dl
2.5 6.8
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr. S.C.Somani Pt. Location: OPD Referred By: Self Specimen: Blood
PARAMETER RESULT UNIT
Age/Sex:
Y/
A 1C
(%)
* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr. Pandey Pt. Location: OPD Referred By: Self Specimen: Blood
PARAMETER RESULT UNIT
Age/Sex: 70 Yrs/M
1/18/2012 70 - 140
REFERENCE RANGE
(Method: - GOD-POD) (Normal 140mg/dl, Impaired glucose tolerance 140-199 mg/dl, Diabetes mellitus 200mg/dl According to Amercian diabetes association, 2004
Serum Urea
Methodology- Urease- GLDH, Kinetic
30 1.03
mg/dl mg/dl
13 - 43 0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
29.0
IU/I
0 - 42
26.0
IU/I
0 - 42
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs. Rukhsar Husain Pt. Location: OPD Referred By: Dr .M.Ahmad Specimen: P.D.Fluid
PARAMETER RESULT UNIT
1552
mg/dl
Serum Urea
Methodology- Urease- GLDH, Kinetic
8 0.91
mg/dl mg/dl
13 - 43 0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs. Rukhsar Husain Pt. Location: OPD Referred By: Dr .M.Ahmad Specimen: P.D.Fluid
PARAMETER RESULT UNIT
1332
mg/dl
Serum Urea
Methodology- Urease- GLDH, Kinetic
43 3.53
mg/dl mg/dl
13 - 43 0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs. Rukhsar Husain Pt. Location: OPD Referred By: Dr .M.Ahmad Specimen: P.D.Fluid
PARAMETER RESULT UNIT
962
mg/dl
Serum Urea
Methodology- Urease- GLDH, Kinetic
66 5.5
mg/dl mg/dl
13 - 43 0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs. Preeti Sabarwal Pt. Location: OPD Referred By: Self Specimen: Blood
PARAMETER RESULT LIPID PROFILE UNIT
185 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl) 138 mg/dl
Serum Triglycerides
(Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 34.1 mg/dl
(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)
123.29
mg/dl
27.67
mg/dl
10 to 40
Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Santosh Sharma Pt. Location: OPD Referred By: Self Specimen: Blood
PARAMETER RESULT UNIT
Age/Sex: 37 Yrs/M
REFERENCE RANGE
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
4.35
mg/dl
2.5 6.8
Phosphorus
(Method: phosphomolybdate UV
4.35 9.12 37
Serum Calcium
(Method: arsenazo III)
Serum Urea
Methodology- Urease- GLDH, Kinetic
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs. Preeti Sabarwal Pt. Location: OPD Referred By: Self Specimen: Blood
PARAMETER RESULT UNIT
16
IU/I
0 - 42
20
IU/I
0 - 42
148
IU/I
42 - 128
6.8 3.8
6.0 - 8.3 3.2 - 5.0 g/dl 2.0 - 3.5 2.0- 3.5 ratio >1
Serum Albumin
(Method: Bromo Cresol Green BCG))
3.0 1.2:1
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr. Sidhart Dixit Pt. Location: OPD Referred By: Self Specimen: Blood
PARAMETER RESULT UNIT
Age/Sex: 23 Yrs/M
Date:
1/28/2012
REFERENCE RANGE
0.56
mg/dl
0.08 - 0.75
210.0
IU/I
0 - 42
58.0
IU/I
0 - 42
263.0
IU/I
42 - 128
6.75
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr. S.N. Pandey Pt. Location: OPD Referred By: Self Specimen: Blood
PARAMETER RESULT UNIT
Age/Sex: 76 Yrs/M
Date:
1/28/2012
REFERENCE RANGE
73.3
IU/I
0 - 42
53.0
IU/I
0 - 42
431.0
IU/I
42 - 128
6.0 - 8.3 3.2 - 5.0 g/dl 2.0 - 3.5 2.0- 3.5 ratio >1
Serum Albumin
(Method: Bromo Cresol Green BCG))
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr. S.N. Pandey Pt. Location: OPD Referred By: Self Specimen: Blood
PARAMETER RESULT UNIT
Age/Sex: 76 Yrs/M
REFERENCE RANGE
Serum Urea
Methodology- Urease- GLDH, Kinetic
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr. O.P. Bansal Pt. Location: OPD Referred By: Dr .M.Ahmad Specimen: P.D.Fluid
PARAMETER RESULT UNIT
2137 10
mg/dl mg/dl 13 - 43
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
0.62
mg/dl
0.70 - 1.30
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr. O.P. Bansal Pt. Location: OPD Referred By: Dr .M.Ahmad Specimen: P.D.Fluid
PARAMETER RESULT UNIT
1228 77
mg/dl mg/dl 13 - 43
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
2.92
mg/dl
0.70 - 1.30
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr. O.P. Bansal Pt. Location: OPD Referred By: Dr .M.Ahmad Specimen: P.D.Fluid
PARAMETER RESULT UNIT
2129 10
mg/dl mg/dl 13 - 43
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
0.62
mg/dl
0.70 - 1.30
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr. Rajendra Shukla Pt. Location: OPD Referred By: Self Specimen: Blood
PARAMETER RESULT UNIT
Age/Sex: 53 Yrs/M
14.02.2012 70 - 110
REFERENCE RANGE
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. GLYCOSYLATED HAEMOGLOBIN ESTIMATION BY (HPLC)
7.7 %
A 1C
(%)
* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs. Anjum Khatoon Pt. Location: OPD Referred By: Dr.S.Verma Specimen: Blood
PARAMETER RESULT LIPID PROFILE UNIT
258 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)
Serum Triglycerides 165 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 50.8 mg/dl
(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)
174.2
mg/dl
32.9
mg/dl
10 to 40
5.08
mg/dl
Less 4.5
3.43
mg/dl
Less 3.0
Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs. Simranjeet Kaur Pt. Location: OPD Referred By: Dr.M.Ahamad Specimen: Blood
PARAMETER RESULT UNIT
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
0.66
mg/dl
0.70 - 1.30
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr. Rajendra Singh Pt. Location: OPD Referred By: Dr.M.Ahamad Specimen: Blood
PARAMETER RESULT UNIT
4.06
mg/dl
2.5 6.8
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr. Mahaveer Prasad Agrawal Pt. Location: OPD Referred By: Dr.Naveen Jamwal Specimen: Blood
PARAMETER RESULT UNIT
20
IU/I
0 - 42
27
IU/I
0 - 42
64
IU/I
42 - 128
5.97
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs. Amita Pt. Location: OPD Referred By: Specimen: Blood
PARAMETER RESULT UNIT
Serum Urea
Methodology- Urease- GLDH, Kinetic
24.0 0.65
mg/dl mg/dl
13 - 43 0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
80.0
mg/dl
70 - 140
(Normal 140mg/dl, Impaired glucose tolerance 140-199 mg/dl, Diabetes mellitus 200mg/dl According to Amercian diabetes association, 2004
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs. Amita Pt. Location: OPD Referred By: Specimen: Blood
PARAMETER RESULT UNIT
20.4
IU/I
0 - 42
26.0
IU/I
0 - 42
231.0
IU/I
42 - 128
6.0
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr. Pt. Location: OPD Referred By: Dr. Specimen: Blood
PARAMETER RESULT UNIT
Serum Urea
Methodology- Urease- GLDH, Kinetic
47.8 4.16
mg/dl mg/dl
13 - 43 0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Raj Narayan Singh Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT UNIT
132.0
mg/dl
70 - 110
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
141
mg/dl
70 - 140
Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004
10.5
mg/dl
6 to 20
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
0.8
mg/dl
0.70 - 1.30
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Raj Narayan Singh Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT UNIT
7.6 %
A 1C
(%)
* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months.
* Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Raj Narayan Singh Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT LIPID PROFILE
122
mg/dl
(Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl) Serum Triglycerides 74 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 52.8 mg/dl
(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)
54.66
mg/dl
14.88
mg/dl
10 to 40
2.32
mg/dl
Less 4.5
1.04
mg/dl
Less 3.0
Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Bhupendra Nath Singh Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT UNIT
127.0
mg/dl
70 - 110
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
148
mg/dl
70 - 140
Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004
29.64
mg/dl
6 to 20
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
1.59
mg/dl
0.70 - 1.30
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Bhupendra Nath Singh Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT UNIT
A 1C
(%)
* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months.
* Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Bhupendra Nath Singh Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT LIPID PROFILE UNIT
86 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)
Serum Triglycerides 82 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 36.8 mg/dl
(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)
32.47
mg/dl
16.42
mg/dl
10 to 40
2.33
mg/dl
Less 4.5
0.88
mg/dl
Less 3.0
Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Ram Bujharat Pt. Location: OPD Referred By: Dr.Alok Srivastava Specimen: Blood
PARAMETER RESULT UNIT
73
mg/dl
70 - 140
(Method: - GOD-POD) (Normal 140mg/dl, Impaired glucose tolerance 140-199 mg/dl, Diabetes mellitus 200mg/dl
Serum Urea
Methodology- Urease- GLDH, Kinetic
43 0.77
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
5.2
63 26
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Ram Bujharat Pt. Location: OPD Referred By: Dr.Alok Srivastava Specimen: Blood
PARAMETER RESULT UNIT
0.36
mg/dl
0.08 - 0.75
31
IU/I
0 - 42
26
IU/I
0 - 42
195
IU/I
42 - 128
6.60
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Ram Bujharat Pt. Location: OPD Referred By: Dr.Alok Srivastava Specimen: Blood
PARAMETER RESULT UNIT
1.1
mmol/l
1.12 1.32
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Serum Sodium
132.0
mmol/l
135 - 145
Serum Potassium
4.1
mmol/l
3.5 - 5.5
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs. Shahida Khatoon Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT UNIT
224.0
mg/dl
70 - 110
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
287
mg/dl
70 - 140
Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004
9.85 0.59
mg/dl mg/dl
6 to 20
0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs. Shahida Khatoon Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT UNIT
A 1C
(%)
* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs. Shahida Khatoon Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT UNIT
Microalbuminuria is the presence of albumin in the urine above the normal levels bu below the detectable range of conventional methods. Urine albumin levels from 20-200 mg/L are an indicator of early or possibly reversible glomerular damage.In diabetic patients ,microalbulinemia is associated with a four to six fold increase in cardiovascular mortality,and an independent risk factor for renal mortality.It is also more prevelant in hypertensive subjects Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs. Shalini Manchanda Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT UNIT
103.0
mg/dl
70 - 110
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
202
mg/dl
70 - 140
Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004
11.19 0.55
mg/dl mg/dl
6 to 20
0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs. Shalini Manchanda Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT LIPID PROFILE
Total Serum Cholesterol
(Method-CHOD-PAP 121 mg/dl
(Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl) Serum Triglycerides 145 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 38.8 mg/dl
(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)
53.28
mg/dl
29.09
mg/dl
10 to 40
3.12
mg/dl
Less 4.5
1.37
mg/dl
Less 3.0
Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs. Shalini Manchanda Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT UNIT
A 1C
(%)
* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr. Girish Chandra Manchanda Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT UNIT
108.0
mg/dl
70 - 110
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
155
mg/dl
70 - 140
Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004
11.03 0.56
mg/dl mg/dl
6 to 20
0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr. Girish Chandra Manchanda Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT LIPID PROFILE
Total Serum Cholesterol
(Method-CHOD-PAP 156 mg/dl
(Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl) Serum Triglycerides 127 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 40.5 mg/dl
(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)
89.7
mg/dl
25.31
mg/dl
10 to 40
3.84
mg/dl
Less 4.5
2.22
mg/dl
Less 3.0
Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr. Girish Chandra Manchanda Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT UNIT
A 1C
(%)
* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr. Vishnu Vijay Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT UNIT
302.0
mg/dl
70 - 110
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
399
mg/dl
70 - 140
Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
0.69
mg/dl
0.70 - 1.30
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr. Vishnu Vijay Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT UNIT
A 1C
(%)
* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Jitendra Srivastava Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT UNIT
161.0
mg/dl
70 - 110
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
199
mg/dl
70 - 140
Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
0.68
mg/dl
0.70 - 1.30
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Jitendra Srivastava Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT UNIT
A 1C
(%)
* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Rajendra Kumar Agrahari Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT UNIT
124.0
mg/dl
70 - 110
(Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
214
mg/dl
70 - 140
Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
1.02
mg/dl
0.70 - 1.30
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Rajendra Kumar Agrahari Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT UNIT
A 1C
(%)
* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr. Babu Ram Yadav Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT UNIT
157.0
mg/dl
70 - 110
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
214
mg/dl
70 - 140
Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
0.63
mg/dl
0.70 - 1.30
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr. Babu Ram Yadav Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT UNIT
A 1C
(%)
* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs.Deepshikha Pt. Location: OPD Referred By: Self Specimen: Blood
PARAMETER RESULT UNIT
22.9
IU/I
0 - 42
27
IU/I
0 - 42
125
IU/I
42 - 128
7.61
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs.Deepshikha Pt. Location: OPD Referred By: Self Specimen: Blood
PARAMETER RESULT UNIT
Serum Urea
Methodology- Urease- GLDH, Kinetic
16 0.57
mg/dl mg/dl
13 - 43 0.50 - 1.20
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Subroto Roy Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT UNIT
138.0
mg/dl
70 - 110
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
13.49
mg/dl
6 to 20
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
0.83
mg/dl
0.70 - 1.30
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Subroto Roy Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT UNIT
A 1C
(%)
* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Subroto Roy Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT LIPID PROFILE UNIT
236 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)
Serum Triglycerides 118 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 66.2 mg/dl
(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)
146.43
mg/dl
23.6
mg/dl
10 to 40
3.57
mg/dl
Less 4.5
2.21
mg/dl
Less 3.0
Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Vishnu Vijay Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT UNIT
A 1C
(%)
* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Vishnu Vijay Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT UNIT
6 to 20
0.70 - 1.30 70 - 110
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
256
mg/dl
70 - 140
Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Vishnu Vijay Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT UNIT
Urine Microalbumin
65.7
mg/ L
<20mg/L
Microalbuminuria is the presence of albumin in the urine above the normal levels bu below the detectable range of conventional methods. Urine albumin levels from 20-200 mg/L are an indicator of early or possibly reversible glomerular damage.In diabetic patients ,microalbulinemia is associated with a four to six fold increase in cardiovascular mortality,and an independent risk factor for renal mortality.It is also more prevelant in hypertensive subjects Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr. Ram Jas Agarwal Pt. Location: MHC Referred By: Dr. Specimen: Blood Age/Sex: 56Yrs/M MRN-12004319 Lab No.-05 Date: 5/14/2012
PARAMETER
RESULT
UNIT
REFERENCE RANGE
127.0
mg/dl
70 - 110
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
189
mg/dl
70 - 140
Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
0.94
mg/dl
0.70 - 1.30
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr. Ram Jas Agarwal Pt. Location: MHC Referred By: Dr. Specimen: Blood Age/Sex: 56Yrs/M MRN-12004319 Lab No.-05 Date: 5/14/2012
PARAMETER
RESULT
UNIT
REFERENCE RANGE
A 1C
(%)
* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr. Krishna Agarwal Pt. Location: MHC Referred By: Dr. Specimen: Blood Age/Sex: 58Yrs/M MRN-11016777 Lab No.-05 Date: 5/16/2012
PARAMETER
RESULT
UNIT
REFERENCE RANGE
A 1C
(%)
* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications
Checked by..
13800
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.S.P.Pathak Pt. Location: OPD Referred By: Self Specimen: Blood Age/Sex: 79 Yrs/M MRN1 Lab No.-1 Date: 5/21/2012
PARAMETER
RESULT
UNIT
REFERENCE RANGE
6 to 20
0.70 - 1.30 70 - 110
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
Serum Calcium
(Method: arsenazo III)
9.0 3.1
mg/dl mg/dl
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.S.P.Pathak Pt. Location: OPD Referred By: Self Specimen: Blood Age/Sex: 79 Yrs/M MRN1 Lab No.-1 Date: 5/21/2012
PARAMETER
RESULT
UNIT
REFERENCE RANGE
13.3
IU/I
0 - 42
21.8
IU/I
0 - 42
83
IU/I
42 - 128
6.49
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.S.P.Pathak Pt. Location: OPD Referred By: Self Specimen: Blood Age/Sex: 79 Yrs/M MRN1 Lab No.-1 Date: 5/21/2012
PARAMETER
RESULT
UNIT
REFERENCE RANGE
5.6
A 1C
(%)
* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Shri Prakash Mishra Pt. Location: OPD Referred By: Self Specimen: Blood Age/Sex: 54 Yrs/M MRN:12001747 Lab No.-4760 Date: 5/21/2012
PARAMETER
RESULT
UNIT
REFERENCE RANGE
7.2
A 1C
(%)
* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Shri Prakash Mishra Pt. Location: OPD Referred By: Self Specimen: Blood Age/Sex: 54 Yrs/M MRN:12001747 Lab No.-4760 Date: 5/21/2012
PARAMETER
RESULT
UNIT
REFERENCE RANGE
147.0
mg/dl
70 - 110
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
315.0
mg/dl
70 - 140
Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs. Shamida khatoon Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT UNIT
LIPID PROFILE
Total Serum Cholesterol
231 mg/dl
(Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl) Serum Triglycerides 191 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 45.8 mg/dl
(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)
146.78
mg/dl
38.28
mg/dl
10 to 40
5.04
mg/dl
Less 4.5
3.21
mg/dl
Less 3.0
Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs. Shamida khatoon Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT UNIT
A 1C
(%)
* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs. Shamida khatoon Pt. Location: MHC Referred By: Dr. Specimen: Blood Age/Sex: 55 Yrs/F MRN-100815 Lab No.-1 Date: 6/12/2012
PARAMETER
RESULT
UNIT
REFERENCE RANGE
6 to 20
0.70 - 1.30 70 - 110
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
221
mg/dl
70 - 140
Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr. Babu Ram Yadav Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT UNIT
163.0
mg/dl
70 - 110
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
245.0
mg/dl
70 - 140
Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004
15.81 1.09
mg/dl mg/dl
6 to 20
0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr. Babu Ram Yadav Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT UNIT
A 1C
(%)
* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr. Babu Ram Yadav Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT UNIT
Microalbuminuria is the presence of albumin in the urine above the normal levels bu below the detectable range of conventional methods. Urine albumin levels from 20-200 mg/L are an indicator of early or possibly reversible glomerular damage.In diabetic patients ,microalbulinemia is associated with a four to six fold increase in cardiovascular mortality,and an independent risk factor for renal mortality.It is also more prevelant in hypertensive subjects Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr. M.A.Khan Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT UNIT
127.0
mg/dl
70 - 110
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
10.61 0.77
mg/dl mg/dl
6 to 20
0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr. M.A.Khan Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT UNIT
A 1C
(%)
* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr. Brijesh Singh Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT UNIT
147.0
mg/dl
70 - 110
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
242
mg/dl
70 - 140
Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
0.67
mg/dl
0.70 - 1.30
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr. Brijesh Singh Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT UNIT
A 1C
(%)
* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Shri Prakash Mishra Pt. Location: OPD Referred By: Self Specimen: Blood Age/Sex: 54 Yrs/M MRN:12001747 Lab No.-1 Date: 8/3/2012
PARAMETER
RESULT
UNIT
REFERENCE RANGE
8.1
A 1C
(%)
* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Shri Prakash Mishra Pt. Location: OPD Referred By: Self Specimen: Blood Age/Sex: 54 Yrs/M MRN:12001747 Lab No.-1 Date: 8/3/2012
PARAMETER
RESULT
UNIT
REFERENCE RANGE
153.0
mg/dl
70 - 110
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
243.0
mg/dl
70 - 140
Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004
6.08 0.59
mg/dl mg/dl
6 to 20
0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Shri Prakash Mishra Pt. Location: OPD Referred By: Self Specimen: Blood
PARAMETER RESULT UNIT
Microalbuminuria is the presence of albumin in the urine above the normal levels bu below the detectable range of conventional methods. Urine albumin levels from 20-200 mg/L are an indicator of early or possibly reversible glomerular damage.In diabetic patients ,microalbulinemia is associated with a four to six fold increase in cardiovascular mortality,and an independent risk factor for renal mortality.It is also more prevelant in hypertensive subjects Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
Age/Sex: 56 Yrs/M MRN:12004319 Lab No.-1 Date: 8/13/2012
UNIT REFERENCE RANGE
Unit: Biochemistry Name: Mr.Ramjas Agarwal Pt. Location: OPD Referred By: Self Specimen: Blood
PARAMETER RESULT
A 1C
(%)
* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Ramjas Agarwal Pt. Location: OPD Referred By: Self Specimen: Blood
PARAMETER RESULT UNIT
110.0
mg/dl
70 - 110
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
189.0
mg/dl
70 - 140
Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004
10.84 0.88
mg/dl mg/dl
6 to 20
0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Ramjas Agarwal Pt. Location: OPD Referred By: Self Specimen: Blood
PARAMETER RESULT UNIT
Microalbuminuria is the presence of albumin in the urine above the normal levels bu below the detectable range of conventional methods. Urine albumin levels from 20-200 mg/L are an indicator of early or possibly reversible glomerular damage.In diabetic patients ,microalbulinemia is associated with a four to six fold increase in cardiovascular mortality,and an independent risk factor for renal mortality.It is also more prevelant in hypertensive subjects Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.O.P.Srivastava Pt. Location: OPD Referred By: MHC Specimen: Blood PARAMETER RESULT Age/Sex: 57y/M
UNIT
27
IU/I
0 - 42
18
IU/I
0 - 42
83
IU/I
42 - 128
6.58
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
g/dl
3.2 - 5.0
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.O.P.Srivastava Pt. Location: OPD Referred By: MHC Specimen: Blood PARAMETER RESULT CK-MB
Method- Immunoinhibition
Age/Sex:
57y/M
UNIT U/L
25.9
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. GLYCOSYLATED HAEMOGLOBIN ESTIMATION BY (HPLC)
8.1 %
A 1C
(%)
* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.O.P.Srivastava Pt. Location: OPD Referred By: MHC Specimen: Blood PARAMETER RESULT Serum Calcium
(Method: arsenazo III)
Age/Sex:
57y/M
UNIT mg/dl
8.9
Serum Urea
Methodology- Urease- GLDH, Kinetic
19 0.8
mg/dl mg/dl
13 - 43 0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.O.P.Srivastava Pt. Location: OPD Referred By: MHC Specimen: Blood PARAMETER RESULT CK-MB
Method- Immunoinhibition
Age/Sex:
57y/M
UNIT U/L
25.9
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. GLYCOSYLATED HAEMOGLOBIN ESTIMATION BY (HPLC)
8.1 %
A 1C
(%)
* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.O.P.Srivastava Pt. Location: OPD Referred By: MHC Specimen: Blood PARAMETER RESULT Age/Sex: 57y/M
UNIT
0.05 0.22
mg/dl mg/dl
27
IU/I
0 - 42
18
IU/I
0 - 42
83
IU/I
42 - 128
6.58
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
g/dl
3.2 - 5.0
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.O.P.Srivastava Pt. Location: OPD Referred By: MHC Specimen: Blood PARAMETER RESULT Age/Sex: 57y/M
UNIT
27
IU/I
0 - 42
18
IU/I
0 - 42
83
IU/I
42 - 128
6.58
g/dl
6.0 - 8.3
Serum Albumin
(Method: Bromo Cresol Green BCG))
g/dl
3.2 - 5.0
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Mini Srivastava Pt. Location: OPD Referred By: Self Specimen: food particles PARAMETER RESULT Age/Sex: 48y/F
UNIT
Gastric aspirate
Total Bilirubin
(Method: Walter And Gerarde)
Direct Bilirubin
(Method: Walter And Gerarde)
Indirect Bilirubin
(Method: Walter And Gerarde)
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Ram Shankar Rathore Pt. Location: OPD Referred By: MHC Specimen: Blood PARAMETER RESULT Age/Sex: 50y/M MRN:11038556 Lab No.-1 Date: 04.09.2012 REFERENCE RANGE
UNIT
113.0
mg/dl
70 - 110
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
220.0
mg/dl
70 - 140
Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004
8.59 0.84
mg/dl mg/dl
6 to 20
0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Ram Shankar Rathore Pt. Location: OPD Referred By: MHC Specimen: Blood
PARAMETER RESULT UNIT
Microalbuminuria is the presence of albumin in the urine above the normal levels bu below the detectable range of conventional methods. Urine albumin levels from 20-200 mg/L are an indicator of early or possibly reversible glomerular damage.In diabetic patients ,microalbulinemia is associated with a four to six fold increase in cardiovascular mortality,and an independent risk factor for renal mortality.It is also more prevelant in hypertensive subjects Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
Age/Sex: 50y/M MRN:11038556 Lab No.-1 Date: 04.09.2012
UNIT REFERENCE RANGE
Unit: Biochemistry Name: Mr.Ram Shankar Rathore Pt. Location: OPD Referred By: MHC Specimen: Blood
PARAMETER RESULT
A 1C
(%)
* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs. Shalini Manchanda Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT UNIT
116.0
mg/dl
70 - 110
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
291
mg/dl
70 - 140
Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
0.71
mg/dl
0.70 - 1.30
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Method- Modified Jaffe"s, no deproteinization
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs. Shalini Manchanda Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT UNIT
A 1C
(%)
* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr. Girish Chandra Manchanda Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT UNIT
107.0
mg/dl
70 - 110
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
169
mg/dl
70 - 140
Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
0.75
mg/dl
0.70 - 1.30
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Method- Modified Jaffe"s, no deproteinization
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr. Girish Chandra Manchanda Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT UNIT
A 1C
(%)
* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Hon'ble Saharashri Ji Pt. Location: OPD Referred By: Dr. H.P.Kumar, MD Specimen: Blood
PARAMETER RESULT UNIT
Serum Copper
(Method: 3,5-Di Br Paesa)
91.0
g/dl
70- 140
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr. Ram Teerath Verma Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT UNIT
160.0
mg/dl
70 - 110
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
262
mg/dl
70 - 140
Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
0.81
mg/dl
0.70 - 1.30
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Method- Modified Jaffe"s, no deproteinization
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr. Joysuna Verma Pt. Location: Referred By: Dr. Specimen: Blood
PARAMETER RESULT UNIT
Date:
2/2/2013
REFERENCE RANGE
A 1C
(%)
* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications
147.0
mg/dl
70 - 110
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Dr.B P Gupta Pt. Location: OPD Referred By: Self Specimen: Blood
PARAMETER RESULT UNIT
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
1.38
mg/dl
0.70 - 1.30
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Method- Modified Jaffe"s, no deproteinization
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr. Joysuna Verma Pt. Location: Referred By: Dr. Specimen: Blood
PARAMETER RESULT UNIT
Date:
2/2/2013
REFERENCE RANGE
A 1C
(%)
* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr. Joysuna Verma Pt. Location: Referred By: Dr. Specimen: Blood
PARAMETER RESULT LIPID PROFILE UNIT
Date:
2/2/2013
REFERENCE RANGE
256 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)
Serum Triglycerides 501 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 36 mg/dl
(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)
219.8
mg/dl
100.1
mg/dl
10 to 40
7.2
mg/dl
Less 4.5
3.4
mg/dl
Less 3.0
Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002)
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Lee Sashi Pt. Location: OPD Referred By: National Pathology(48732) Specimen: Blood
PARAMETER RESULT UNIT
1.22
mmol/l
1.12 1.32
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Inam Zahra Pt. Location: OPD Referred By: National Pathology(48745) Specimen: Blood
PARAMETER RESULT UNIT
1.18
mmol/l
1.12 1.32
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Brijesh Singh Pt. Location: OPD Referred By: MHC Specimen: Blood PARAMETER RESULT Age/Sex: y/M MRN:12004535 Lab No.-204187 Date: 24.04.2013 REFERENCE RANGE
UNIT
115.0
mg/dl
70 - 110
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
140
mg/dl
70 - 140
Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004
6.57 0.89
mg/dl mg/dl
6 to 20
0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Brijesh Singh Pt. Location: OPD Referred By: MHC Specimen: Blood
PARAMETER RESULT LIPID PROFILE UNIT
156 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)
Serum Triglycerides 170 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 25 mg/dl
(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)
96.2
mg/dl
34
mg/dl
10 to 40
6.1
mg/dl
Less 4.5
3.8
mg/dl
Less 3.0
Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
Age/Sex: y/M MRN:12004535 Lab No.-204187 Date: 24.04.2013
RESULT UNIT REFERENCE RANGE
Unit: Biochemistry Name: Mr.Brijesh Singh Pt. Location: OPD Referred By: MHC Specimen: Blood
PARAMETER
A 1C
(%)
* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Brijesh Singh Pt. Location: OPD Referred By: MHC Specimen: Blood
PARAMETER RESULT UNIT
111.0
mg/dl
70 - 110
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
15.7
IU/I
0 - 42
12.31 0.88
mg/dl mg/dl
6 to 20
0.70 - 1.30
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
313.4
mg/dl
Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004
97.0
mg/dl
70 - 110
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
Serum Urea
Methodology- Urease- GLDH, Kinetic
47.8 4.16
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
130.0 6.2
mmol/l mmol/l
135 - 145
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
0.30 - 1.20
0.08 - 0.75
14.5
IU/I
Transminase(SGOT/AST)
(Method: IFCC Without Pyridoxal Phosphate))
19.8
IU/I
65.7
IU/I
7.71
g/dl
Serum Albumin
(Method: Bromo Cresol Green BCG))
g/dl 1.74 g/dl g/dl 2.56 ratio ratio 2.0- 3.5 >1
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..
Serum Calcium
(Method: arsenazo III)
10.1
mg/dl mg/dl
8.4- 10.4
5.2
1.3
mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
16.9
mg/dl
LIPID PROFILE
Total Serum Cholesterol
159.7 mg/dl
(Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)
Serum Triglycerides 112.9 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 21.2 mg/dl
(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)
115.9
mg/dl
22.58
mg/dl
mg/dl
mg/dl
Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
359
mg/dl
(Method: - GOD-POD) (Normal 140mg/dl, Impaired glucose tolerance 140-199 mg/dl, Diabetes mellitus 200mg/dl According to Amercian diabetes association, 2004 NOTE : Above test carried out by EM 360 automated biochemistry analyzer.
CK-MB
Method- Immunoinhibition
8.4
U/L
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
8.6 %
A 1C
(%)
* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications
mg/dl mg/dl
nmol/l
mg/dl mg/dl
116 - 127
Magnesium
Phosphorus
(Method: phosphomolybdate UV
Serum LDH
Method: DGKC IFCC
392.5
U/I
66 54.7
U/L U/L
1.16
mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
2.8 35
mg/dl mg/dl
0.8
Ratio
Magnesium
2.16
mg/dl
Apolipoprotein B (Apo-B)
(Method :Immunonephelometric assay)
68
apo-A1/apo-B Ratio
2.13
( Elevation of apo B (present in chylomicrons, VLDL, HDL and LDL), decrease in apo A-1 (present mostly in HDL), and decrease in the apo A -1/apo B ratio have been associated with increased risk of CHD) Lipoprotein (LP-a)
(Method :Immunonephelometric assay (Values of Lp-a >0.3g/L are associated with two fold increase of MI. If both LDL and Lp-a are raised the risk of 10
mg/d
Haptoglobin
0.639
g/L
Serum Haptoglobin is an acute phase reactant rises in response to stress,infection,acute inflammation and tissue necrosis. Levels increases after a hemolytic episode,which is dramatic following massive hemolytic episode in situations of hemolytic transfusion reaction,thermal burns,or autoimmune hemolytic anemia.It is also a useful measurement for serially monitoring patients who have a slow but steady rate of red cell breakdown such as by mechanical heart valves,,hemoglobinopathies,or exercise associated trauma Low Haptoglobin concentrations may be seen in liver diasese when hepatic synthetic capacity is impaired
18
IU/I
Concentration Hb- F Hb A2
<0.8 % 2.70%
HbA2 estimation is principally used in the diagnosis of -thalassemia trait (Heterzygous -thalassemia), in which it is elevated up to 7%. Co-existence of - thalassemia trait with iron deficiency may show normal HbA2 levels. In this case, retesting should be performed after the iron deficiency is corrected. Similarly, if the individual with - thalassemia trait has coexisting
thalassemia, the increase in HbA2 might be dampened down and appear equivocal. Elevated HbF is also found in cases of Hereditary Persistence of Fetal Hemoglobin, homozygous and thalassemia. The Tests carried out on automated D-10,Bio-Rad HLC analyser
CK-MB
Method- Immunoinhibition
26.4 452
CPK
Serum IRON
57.5
g/dl
Male Female
g/dl g/dl %
Iron is transported as Fe(111) bound to the plasma protein apotransferrin.Normally only about one third of the iron binding sites of transferrin are occupied by Fe(111).The additional amount of iron that can be bound is the unsaturated iron binding capacity (UIBC). The sum of the serum iron and UIBC represents TIBC.TIBC is a measurement for the maximum iron concentration that transferrin can bind. The serum TIBC varies in disorders of iron metabolism .In iron dediciency anemia the TIBC is elevated and the transferring saturation is lowered to 15% or less. Low serum iron associated with low TIBC is characteristic of the anemia of chronic disorders,malignant tumors,and infections. (Dr. Anju Shukla, MD) Associate Consultant
Checked by..
Serum LDH
351 U/I
Method: DGKC
CPK
495
U/L
38 - 174
TROPONIN T (Qualitative
POSITIVE
A positive result means that the concentration of troponin T in the sample is above the tests threshold value of 0.1ng/ml .This is evidence of cell damage to the myocardium. *Test performed by Troponin T Rapid test from Roche Diagnostics GmbH.
8.0
IU/m
Note : Rheumatoid factor (RF) is an antibody directed against the Fe portion of the IgG molecule Rheumatoid factor is not specific for Rheumatoid arthritis and is often seen in cases of chronic infections and other systemic inflammatory conditions
URINARY PROTEIN (24 Hrs) Urinary protein (24 Hrs) 329.6 mg/day
*MINIMAL proteinuria (<1.0g/day) present in postural proteinuria and transient proteinuria.It is also
seen with inactive phase of glomerular disease ,nephrosclerosis,chronic interstitial nephritis,congenital diseases such as polycystic disease and medullary cystic disease ,and renal tubular diseases. *Moderate proteinuria (1.0-4.0 g/day) found in vast majority of renal diseases ,as well as nephrosclerosis,multiple myeloma,toxic nephropathies along with degenerative,malignant and inflammatory conditions of lower urinary tract. *Heavy proteinuria(>4 g/day) characteristically seen with the nephritic syndrome.
111
mg/dl
70 - 110
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl According to Amercian diabetes association, 2004
13 1.27
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Serum Calcium
(Method: arsenazo III)
8.6
mg/dl
8.4- 10.4
Phosphorus
(Method: phosphomolybdate UV
2.93
mg/dl
3.98
mg/dl
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
1.13
mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
85
mg/dl
*The serum ascitis albumin gradient ,defind as the serum albumin concentration minus ascetic fluid albumin concentration is widely considered as the most reliable method to differentiate peritoneal transudates from exudates .Transudates has gradient >1.1g/dl while exudates has gradient < 1.1g/dl. *Recent study have found decreased glucose levels in most cases of tubercular ascites and about 50% of patients with abdominal carcinomatosis.Nevertheless ,glucose measurement are of little value since the sensitivity and specificity are generally too low to be of practical value.
2.4
mg/l
*CRP is an acute phase reactant appeared in plasma during many infectious or inflammatory conditions *Recent studies have established that individuals with higher base line levels of plasma CRP are at increased risk for CHD and stroke.
C reactive protein(C.R.P)
23.1
mg/L
*CRP is an acute phase reactant appeared in plasma during many infectious or inflammatory conditions CRP assay provides useful information for the diagnosis,therapy and monitoring of inflammatory processes and associated diseases. Increase in CRP values are non specific and should not be interpreted without a complete clinical history.
Note : above test carried out by BN ProSpec Nephlometer Automated Analyzer .
Microalbuminuria is the presence of albumin in the urine above the normal levels bu below the detectable range of conventional methods.
Urine albumin levels from 20-200 mg/L are an indicator of early or possibly reversible glomerular damage.In diabetic patients ,microalbulinemia is associated with a four to six fold increase in cardiovascular mortality,and an independent risk factor for renal mortality.It is also more prevelant in hypertensive subjects Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
CERULOPLASMIN
CERULOPLASMIN
25.1
mg/dl
Ceruloplasmin ,a late acute phase reactant is the prinicipal Copper containing protein of plasma.The most important clinical application of Ceruloplasmin is in the diagnosis of Wilsons disease,where typically concentration of Ceruloplasmin are reduced.Low levels of Ceruloplasmin may also be found in malnutrition,malabsorption,nephrosis and severe liver disese
Note :Test carried out by BN ProSpec Nephlometer fully automated analyzer
3434.8
mg/day
*MINIMAL proteinuria (<1.0g/day) present in postural proteinuria and transient proteinuria.It is also
seen with inactive phase of glomerular disease ,nephrosclerosis,chronic interstitial nephritis,congenital diseases such as polycystic disease and medullary cystic disease ,and renal tubular diseases. *Moderate proteinuria (1.0-4.0 g/day) found in vast majority of renal diseases ,as well as nephrosclerosis,multiple myeloma,toxic nephropathies along with degenerative,malignant and inflammatory conditions of lower urinary tract.
*Heavy proteinuria(>4 g/day) characteristically seen with the nephritic syndrome. URINARY CREATININE(24 Hrs) Urinary Creatinine (24 Hrs) 413.8 mg/day
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Homocysteine (HCY)
mol/L
Homocysteine is an amino acid derived from methionine ,requiring ,vitamin B6 ,vitamin B12 and folic acid for further metabolizing.Mutation of the gene coding for homocysteine metabolism ,e.g.MTHFR ,result in hyperhomocysteinemia.Deficiency of folic acid ,vitamin B6,vitamin B12 are associated with increased plasma levels of homocysteine. Hyperhomocysteinemia is found to be associated with an increased risk for ischemic heart disease,stroke,peripherial arterial disease, and deep vein thrombosis,as well as neural tube defect and preeclampsia of pregnancy.An increased frequency of hyperhomocysteinemia is observed especially in elderly,smokers,patients with renal disease,diabetes ,or on a strict vegetarian diet
Anti-Streptolysin O(ASL)
IU/ml
Quantitative determination of Anti-Streptolysin O (ASL) provides valuable information regarding post streptococcal infection (rheumatic fever,scarlet fever ,tonsillitis,glomerulonephritis,etc. As upper limit of the reference interval 200 IU/ml is accepted internationally ,however ASL concentration depends upon the age of the patients,on the geographical location,and on the local frequency of streptoicoccal infections.Since an individual result provides no information about a change of the ASL concentration ,an appropriate assessment is only possible if the assay is repeated after 1 or 2 week. Vanillylmandelic acid (VMA),Urine Volume,24 Hrs urine 10.7 2250 mg/24 hrs ml/24 hrs
Metanephrine,urine
128
g/24 hrs
*VMA is the end product of both adrenaline (epinephrine) & noradrenaline (norepinephrine) catabolism and reflect catecholamine production by chromaffin cells of the adrenal medulla and sympathetic nervous system.Quantitation of urinary VMA is valuable in the diagnosis and follow up of patients with Pheochromocytoma and related neurogenic tumors(Neuroblastoma,ganglioblastoma) *Metanephrine are metabolites of catecholamines and include metanephrine and normetanephrine .urine metanephrine determination is considered to be the most accurate single screening method for pheochromocytoma .Further ,in suspected cases of Pheochromocytoma ,where VMA and catecholamines are normal determination of urnary metanephrine is advisable.
* Transferrin receptor (TRs) also exist in a soluble form in the circulation.Iron deficiency causes rise in the levels of soluble TRs,which is proportional to the extent of iron deficiency in the tissue(= functional iron deficiency).Soluble TRs are usually not increased in anemia of chronic disease.Soluble TRs also vary with the rate of erythropoiesis .Its level is lower in patients with aplastic anemia,while patients with hemolytic anemia have higher values
Checked by..
103
InterpretationIt is an initial screening test for Average risk women for the early diagnosis of Gestational diabetes mellitus.
1-h plasma glucose level (after 50-g glucose load) >130 mg/dl >140 mg/dl
*( According to American diabetes Association ,2004 b) Pleural fluid Protein Pleural fluid albumin Serum pleural fluid albumin gradient Pleural fluid Glucose Pleural fluid lactate dehydrogenase(LDH) Pleural fluid /serum protein ratio Pleural fluid /serum LDH ratio 0.5 Ratio 3.6 1.94 g/dl g/dl
1.14 145
g/dl mg/dl
117
U/L
Ratio
Pleural fluid/serum protein ratio 0.50;(2) Pleural fluid serum LD ratio 0.60;(3)Pleural fluid LD 2/3 upper limit of normal serum LD;(3)Pleural fluid cholesterol >45 mg/dl;(4) Pleural fluid serum cholesterol ratio 0.30;(5)Serum- pleural fluid protein gradient 1.2 g/dl (5)Pleural fluid serum bilirubin ratio 0.60
SERUM IRON
33.7
Male Female
g/dl g/dl %
Iron is transported as Fe(111) bound to the plasma protein apotransferrin.Normally only about one third of the iron binding sites of transferrin are occupied by Fe(111).The additional amount of iron that can be bound is the unsaturated iron binding capacity (UIBC). The sum of the serum iron and UIBC represents TIBC.TIBC is a measurement for the maximum iron concentration that transferrin can bind. The serum TIBC varies in disorders of iron metabolism .In iron dediciency anemia the TIBC is elevated and the transferring saturation is lowered to 15% or less. Low serum iron associated with low TIBC is characteristic of the anemia of chronic disorders,malignant tumors,and infections. Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant
Checked by..
Ammonia
(Method: Enzymatic)
56.5
mol/l
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
858.7
92
IU/l U/L
11 - 50 10-7I
0.76
g/day
484.8
mg/day
*MINIMAL proteinuria (<1.0g/day) present in postural proteinuria and transient proteinuria.It is also
seen with inactive phase of glomerular disease ,nephrosclerosis,chronic interstitial nephritis,congenital diseases such as polycystic disease and medullary cystic disease ,and renal tubular diseases. *Moderate proteinuria (1.0-4.0 g/day) found in vast majority of renal diseases ,as well as nephrosclerosis,multiple myeloma,toxic nephropathies along with degenerative,malignant and inflammatory conditions of lower urinary tract. *Heavy proteinuria(>4 g/day) characteristically seen with the nephritic syndrome.
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Nupur Soni Pt. Location: OPD Referred By: Dr. Manjusha Specimen: Blood Tra. No - 5584 PARAMETER RESULT
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs.Mary Ghosh Hazra Pt. Location: OPD Referred By: Dr.S.K.Singh Specimen: Blood
PARAMETER RESULT
Tr.No-6826
UNIT
87.0
mg/dl
70 - 110
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
8.23 0.69
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Phosphorus
(Method: phosphomolybdate UV
3.28
9.39
Serum Calcium
(Method: arsenazo III)
mg/dl mg/dl
8.4- 10.4
6.35
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
1.24
mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs.Mary Ghosh Hazra Pt. Location: OPD Referred By: Dr.S.K.Singh Specimen: Blood
PARAMETER RESULT
Tr.No-6826
UNIT mg/dl mg/dl mg/dl
0.08 - 0.75
25.5
IU/I
26.6
IU/I
97.4
IU/I
7.46
g/dl
Serum Albumin
(Method: Bromo Cresol Green BCG))
g/dl 1.74 g/dl g/dl 2.56 ratio ratio 2.0- 3.5 >1
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs.Mary Ghosh Hazra Pt. Location: OPD Referred By: Dr.S.K.Singh Specimen: Blood
PARAMETER
Total Serum Cholesterol
Tr.No-6826
UNIT
RESULT
159.7 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)
Serum Triglycerides 112.9 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 21.2 mg/dl
(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)
115.9
mg/dl
22.58
mg/dl
mg/dl
mg/dl
Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs.Mary Ghosh Hazra Pt. Location: OPD Referred By: Dr.S.K.Singh Specimen: Blood
PARAMETER RESULT
Tr.No-6826
UNIT
5.5%
A 1C
(%)
* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods
*ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications
Checked by..
DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs.Mary Ghosh Hazra Pt. Location: OPD Referred By: Dr.S.K.Singh Specimen: Blood
PARAMETER ApolipoProtein Estimation Apolipoprotein A1 (Apo-A1)
(Method :Immunonephelometric assay) 145
Tr.No-6826
UNIT
RESULT
Apolipoprotein B (Apo-B)
(Method :Immunonephelometric assay)
68
apo-A1/apo-B Ratio
2.13
( Elevation of apo B (present in chylomicrons, VLDL, HDL and LDL), decrease in apo A-1 (present mostly in HDL), and decrease in the apo A -1/apo B ratio have been associated with increased risk of CHD)
Checked by..
Serum Calcium
(Method: arsenazo III)
8.3
mg/dl
8.4- 10.4
61.68
mg/dl
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
8.23
mg/dl
0.70 - 1.30
Phosphorus
(Method: phosphomolybdate UV
6.08
mg/dl
Serum Albumin
(Method: Bromo Cresol Green BCG))
3.9
g/dl
3.2 - 5.0
89 139.0
IU/I mmol/l
Serum Sodium
Serum Potassium
4.50
mmol/l
3.5 - 5.5
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
Pree HD
313.4
mg/dl
Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004
97.0
mg/dl
70 - 110
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
359
mg/dl
70 - 140
(Method: - GOD-POD) (Normal 140mg/dl, Impaired glucose tolerance 140-199 mg/dl, Diabetes mellitus 200mg/dl According to Amercian diabetes association, 2004
Ascitic fluid Albumin Ascitic fluid Protein Serum Ascitic fluid albumin gradient
1.81 3.82
g/dl g/dl
0.93
g/dl
81.9 177.2
mg/dl U/L
*Laboratory criteria for Ascitic fluid exudate (Light 1997) Ascitic fluid/serum protein ratio 0.50;(2) Ascitic fluid serum LD ratio 0.60;(3)Pleural fluid LD 2/3 upper limit of normal serum LD;(3)Ascitic fluid cholesterol >45 mg/dl;(4) Ascitic fluid serum cholesterol ratio 0.30;(5)Serum- Ascitic fluid protein gradient 1.2 g/dl (5)Ascitic fluid serum bilirubin ratio 0.60
mU/10
Interference:Reticulocytes have higher G-6-PDH levels than mature red cells.Therfore ,it is not recommended that this assay be performed after a severe hemolytic crisis ,since G6-PDH levels may appear falsely elevated .Testing may be more helpful after the level of mature red cells have retured to normal.
7.4
U/L
6.46
g/dl g/dl
79.6
mg/dl
STONE ANALYSIS
Chemically the stone consists of following
Calcium (Stone) Oxalate (Stone) Uric acid (stone)
+++ +++ ++
12.06 <0.5g fibrinogen <0.5g equivalent fibrinogen unit/ml equivalent unit/ml (g FEU/ml)
D-Dimer measure cross linked FDP,is a very sensitive marker for the activation of coagulation.Apart from DVT,PE,and DIC,D-Dimer may reflect other causes associated with fibrin formation such as trauma, pregnancy complication, malignant disease or vascular abnormalities.Elevated D-Dimer levels therefore have to be interpreted in the context of possible underlying diseases and clinical symptoms.
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..
95
mg/dl
70 - 110
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
313.4
mg/dl
Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Serum Calcium
(Method: arsenazo III)
Phosphorus
(Method: phosphomolybdate UV
7.92
mg/dl
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
1.1
mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
D-Dimer (Quantitative)
5.02
D-Dimer measure cross linked FDP,is a very sensitive marker for the activation of coagulation.Apart from DVT,PE,and DIC,D-Dimer may reflect other causes associated with fibrin formation such as trauma, pregnancy complication, malignant disease or vascular abnormalities.Elevated D-Dimer levels therefore have to be interpreted in the context of possible underlying diseases and clinical symptoms.
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
D-Dimer measure cross linked FDP,is a very sensitive marker for the activation of coagulation.Apart from DVT,PE,and DIC,D-Dimer may reflect other causes associated with fibrin formation such as trauma, pregnancy complication, malignant disease or vascular abnormalities.Elevated D-Dimer levels therefore have to be interpreted in the context of possible underlying diseases and clinical symptoms.
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
ORAL GLUCOSE TOLERANACE TEST G.T.T (after 100 gram of glucose) Fasting plasma glucose 1 hour plasma glucose 2 hour plasma glucose 2 hour plasma glucose 79.8 97.2 90.6 90.6 mg/dl mg/dl mg/dl mg/dl
*Gestational diabetes mellitus diagnosed if 2 plasma glucose levels are exceeded (American Diabetes Association ,2004b).
Checked by..
Serum Copper
(Method: 3,5-Di Br Paesa)
91.0
g/dl
8.6 %
6.4%
A 1C
(%)
* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications
Checked by..
95
mg/dl
70 - 110
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
313.4
mg/dl
Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Serum Calcium
(Method: arsenazo III)
Phosphorus
(Method: phosphomolybdate UV
7.92
mg/dl
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
1.1
mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
D-Dimer (Quantitative)
5.02
D-Dimer measure cross linked FDP,is a very sensitive marker for the activation of coagulation.Apart from DVT,PE,and DIC,D-Dimer may reflect other causes associated with fibrin formation such as trauma, pregnancy complication, malignant disease or vascular abnormalities.Elevated D-Dimer levels therefore have to be interpreted in the context of possible underlying diseases and clinical symptoms.
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
D-Dimer measure cross linked FDP,is a very sensitive marker for the activation of coagulation.Apart from DVT,PE,and DIC,D-Dimer may reflect other causes associated with fibrin formation such as trauma, pregnancy complication, malignant disease or vascular abnormalities.Elevated D-Dimer levels therefore have to be interpreted in the context of possible underlying diseases and clinical symptoms.
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
858.7
92
IU/l U/L
11 - 50 10-7I
ORAL GLUCOSE TOLERANACE TEST G.T.T (after 100 gram of glucose) Fasting plasma glucose 79.8 mg/dl
*Gestational diabetes mellitus diagnosed if 2 plasma glucose levels are exceeded (American Diabetes Association ,2004b).
Checked by..
70 - 140
70 - 110
13 - 43 0.70 - 1.30
0 - 42
0 - 42
42 - 128
6.0 - 8.3
1.12 1.32
6 to 20
10 to 40
Less 4.5
Less 3.0
70 - 140
s 200mg/dl
0-25
2.5 - 4.5
135 - 225
28 - 100 13 - 60
1.12 1.32
1.7 - 2.5
Less than 30
mated Analyzer.
0.3 to 2.0
0 - 42
-thalassemia), in which it is
0-25 38 - 174
59 - 158 37-145
112 - 346
250 - 450 13 - 45
only about one third of the iron that can be bound is the
c disorders,malignant
38 - 174
< 15.0
40-150 mg/day
70 - 110
6 to 20
0.70 - 1.30
8.4- 10.4
2.5 - 4.5
2.5 6.8
ochemistry analyzer.
1.12 1.32
Less than 3
flammatory conditions
asma CRP
less than 3
<20mg/L
20-60
40-150 mg/day
5-15 mol/L
up to 200 IU/ml
0.00 to 13.60
25-312
0.76-1.76 mg/L
ses rise in the levels of soluble ency).Soluble TRs are usually not ts level is lower in patients with
>0.5-- Exudate
>0.6 -Exudate
0;(3)Pleural fluid LD 2/3 ural fluid serum cholesterol serum bilirubin ratio 0.60
< 40
increased in pleural,peritoneal
ditis is 30 U/L
only about one third of the iron that can be bound is the
c disorders,malignant
1-2 g/day
40-150 mg/day
nephritis,congenital diseases
Y
27y/F MRN:SH/LKO/0005075/08/09 Lab No.:B-/06/856 17.6.2009 REFERENCE RANGE
70 - 110
6 to 20
0.70 - 1.30
2.5 - 4.5
8.4- 10.4 2.5 6.8
1.12 1.32
0 - 42
0 - 42
42 - 128
6.0 - 8.3
10 to 40
Less 4.5
Less 3.0
8.4- 10.4
6 to 20
0.70 - 1.30
2.5 - 4.5
3.2 - 5.0
3.5 - 5.5
70 - 140
70 - 110
70 - 140
s 200mg/dl
1.2g/dl- Exudate
(3)Pleural fluid LD 2/3 itic fluid serum cholesterol erum bilirubin ratio 0.60
245-299
< 40
increased in
pleural,peritoneal
rditis is 30 U/L
70 - 110
70 - 140
6 to 20
0.70 - 1.30 8.4- 10.4
2.5 - 4.5
2.5 6.8
ochemistry analyzer.
1.12 1.32
70- 140
70 - 110
70 - 140
6 to 20
0.70 - 1.30 8.4- 10.4
2.5 - 4.5
2.5 6.8
ochemistry analyzer.
1.12 1.32
95
95
mg/dl
70 - 110
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl According to Amercian diabetes association, 2004
7.2
mg/dl
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
0.69
mg/dl
0.70 - 1.30
Serum Calcium
(Method: arsenazo III)
8.7
mg/dl
8.4- 10.4
Phosphorus
(Method: phosphomolybdate UV
3.25
mg/dl
7.92
mg/dl
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
1.1
mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
142 105
Apolipoprotein B (Apo-B)
68
apo-A1/apo-B Ratio
2.13
1.35
Ratio Ratio
0.91 2.63
( Elevation of apo B (present in chylomicrons, VLDL, HDL and LDL), decrease in apo A-1 (present mostly in HDL), and decrease in the apo A -1/apo B ratio have been associated with increased risk of CHD)
Checked by..
8.6 %
6.4%
A 1C
(%)
* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended.
* Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications
Checked by..
95
mg/dl
70 - 110
(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl
313.4
mg/dl
Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004
Serum Creatinine
Method- Modified Jaffe"s, no deproteinization
Serum Calcium
(Method: arsenazo III)
Phosphorus
(Method: phosphomolybdate UV
7.92
mg/dl
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
1.1
mmol/l
(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..
D-Dimer (Quantitative)
5.02
D-Dimer measure cross linked FDP,is a very sensitive marker for the activation of coagulation.Apart from DVT,PE,and DIC,D-Dimer may reflect other causes associated with fibrin formation such as trauma, pregnancy complication, malignant disease or vascular abnormalities.Elevated D-Dimer levels therefore have to be interpreted in the context of possible underlying diseases and clinical symptoms.
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
D-Dimer measure cross linked FDP,is a very sensitive marker for the activation of coagulation.Apart from DVT,PE,and DIC,D-Dimer may reflect other causes associated with fibrin formation such as trauma, pregnancy complication, malignant disease or vascular abnormalities.Elevated D-Dimer levels therefore have to be interpreted in the context of possible underlying diseases and clinical symptoms.
Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
70 - 110
6 to 20
0.70 - 1.30
8.4- 10.4
2.5 - 4.5
2.5 6.8
ochemistry analyzer.
1.12 1.32
0.91 2.63
70 - 110
70 - 140
6 to 20
0.70 - 1.30 8.4- 10.4
2.5 - 4.5
2.5 6.8
ochemistry analyzer.
1.12 1.32